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Abstract 
Non-ribosomal peptide synthetases (NRPS) are large, modular enzymes that synthesise 
biologically active secondary metabolites from amino acid precursors without the need for a 
nucleic acid template. NRPS play an integral role in microbial physiology and also have 
potential applications in the synthesis of novel peptide molecules. Both of these aspects are 
examined in this thesis.  
Under conditions of iron starvation Pseudomonas syringae synthesises siderophores for active 
uptake of iron. The primary siderophore of P. syringae is pyoverdine, a fluorescent molecule 
that is assembled from amino acid (aa) precursors by NRPS. Five putative pyoverdine NRPS 
genes in P. syringae pv. phaseolicola 1448a (Ps1448a) were identified and characterised in 
silico and their role in pyoverdine biosynthesis was confirmed by gene knockout. Creation of 
pyoverdine null Ps1448a enabled identification of a previously uncharacterised temperature-
regulated secondary siderophore, achromobactin, which is NRPS independent and has lower 
affinity for iron. Pyoverdine and achromobactin null mutants were characterised in regard to 
iron uptake, virulence and growth in iron-limited conditions. Determination of the substrate 
specificity for the seven adenylation (A) domains of the Ps1448a pyoverdine sidechain NRPS 
was also attempted. Although ultimately unsuccessful, these attempts provided a rigorous 
assessment of methods for the expression, purification and biochemical characterisation of A-
domains.  
The Ps1448a NRPS were subsequently employed in domain swapping experiments to test 
condensation (C) domain specificity for aa substrates during peptide formation in vivo. 
Experiments in which the terminal C- and/or A-domain of the Pseudomonas aeruginosa 
(PAO1) pyoverdine NRPS system were replaced with alternative domains from Ps1448a and 
PAO1 were consistent with previous in vitro observations that C-domains exhibit strong 
sidechain and stereo-selectivity at the downstream aa position, but only stereo-selectivity at 
the upstream aa position. 
These results prompted investigation into the role of inter-domain communication in NRPS 
function, to test the hypothesis that the thiolation (T) domain enters into specific interactions 
with other domains, which might provide an alternative explanation for the diminished activity 
of recombinant NRPS enzymes. A recently characterised single-module NRPS, bpsA, was 
chosen as a reporter gene for these experiments based on its ability to generate blue pigment in 
Escherichia coli. Substitution of the native bpsA T-domain consistently impaired function, 
consistent with the hypothesis. It was shown that directed evolution could be applied to restore 
function in substituted T-domains. Mutations that restored function were mapped in silico, and 
a structural model for interaction between the thioester (TE) and T-domain of BpsA was 
derived. 
The utility of bpsA for discovery and characterisation of phosphopantetheinyl transferase 
(PPTase) enzymes was also investigated. In vivo and in vitro assays for determination of 
PPTase activity were developed and a high-throughput screen for discovery of new PPTases in 
environmental DNA libraries was successfully implemented.  
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Chapter 1 – Introduction 
 
1.1 – Non-Ribosomal Peptide Synthetases 
 
Non ribosomal peptide synthetases (NRPS) are enzymes found in many bacteria and fungi that 
catalyse the production of biologically active small peptides from aa precursors without the 
need for a nucleic acid template [1-3]. In non ribosomal peptide synthesis, the NRPS proteins 
themselves form the template that directs the number, order and identity of aa substrates found 
in the peptide product [4]. NRPS proteins consist of a series of discrete modules, each 
responsible for the recognition, activation and incorporation of a single aa substrate [5]. The 
first module in a NRPS system is known as the initiation module and the final module known 
as the termination module, intermediate to these are the elongation modules [1]. Each module 
contains a site for attachment of a 4’-phosphopantetheine (4’-PP) cofactor that serves to tether 
aa substrates and peptide intermediates via a thioester bond [6]. As synthesis proceeds, the 
growing peptide chain is passed from one 4’-PP cofactor to the next with the formation of a 
peptide bond displacing the thioester linkage. The termination module possesses thioesterase 
activity and cleaves the final product from its 4’-PP cofactor. In general the number of 
modules in a NRPS system corresponds to the number of aas in the molecule produced; 
furthermore the order in which these modules are encoded in the genome of the producer 
organism reflects the order in which aa substrates are incorporated into the peptide product. 
This phenomenon is known as the co-linearity rule [4, 7]. Modules within bacterial NRPS 
biosynthetic system are usually spread out over a number of interacting proteins; each protein 
typically contains 1-5 modules however up to 18 modules have been known to comprise a 
single NRPS protein [8]. Figure 1 outlines the modular structure and basic function of NRPS.  
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Figure 1.1 – Overview of NRPS function 
A hypothetical tri-modular NRPS enzyme consisting of a single initiation, elongation and termination module. 
Each module is responsible for selecting a single aa substrate which is then tethered to the enzyme via a 4’-PP 
cofactor. Formation of peptide bond 1 results in a di-peptide linked to the elongation module,  peptide bond  2 
results in formation of a tri-peptide linked to the termination module. Thioesterase activity of the termination 
module cleaves the tri-peptide product from the enzyme. 
 
 
NRPS enzymes are particularly interesting from a biotechnology perspective due to the 
immense diversity in structure and function of the molecules they synthesise. Unlike 
ribosomal peptide synthesis, which is restricted to simple linear extension using the 20 
proteinogenic aas (21 if the rare alternative aa selenocysteine is considered), NRPS can utilise 
over 400 molecules as substrates [9] to produce biologically active linear, cyclic and branched 
cyclic molecules [3, 10-12]. NRPS derived natural products include molecules with antibiotic, 
cytostatic, bio-surfactant and immunosuppressive activity and the utility of NRPS for drug 
discovery is not limited to discovery and characterisation of naturally occurring enzyme 
systems. The modular nature of NRPS makes them potentially amenable to manipulation, 
either rationally or randomly, in order to produce novel bio-active compounds [1, 12-14]. 
Manipulation of NRPS, while by no means straight forward, is possible as a number of 
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successful experiments have shown [13, 15-20]; however these same experiments have also 
shown that before NRPS manipulation can be freely used as a tool for generation of novel bio-
molecules a deeper understanding of the way in which these enzymes function is required.  
 
1.2 – An overview of core NRPS domains 
 
NRPS modules can be further broken down into a series of discrete domains. These domains 
are considered autonomous and usually retain catalytic activity when purified and 
characterised individually [1, 21, 22]. NRPS domains can either be core domains (required for 
synthesis of a peptide backbone) or accessory domains (catalysing chemical modification of aa 
constituents). There are three domains mandatory for the function of a NRPS elongation 
module: these are the adenylation (A) domain, the thiolation (T) domain (also known as the 
peptidyl carrier protein, or PCP domain) and the condensation (C) domain [1, 23]. The A-
domain serves three purposes: 1) aa substrate selection; 2) activation of that substrate in a 
reversible reaction that consumes ATP (Figure 1.2A reaction 1, 1.2B); 3) transfer of the 
activated amino adenylate to a 4’-PP cofactor on the T-domain.  
 
The T-domain is the site of aa/peptide linkage to the NRPS module. This linkage occurs via 
the formation of a thioester bond that displaces the adenyl group from the activated aa [1-3] 
(Figure 1.2A, reaction-2; and Figure 1.2C). The C-domain catalyses the condensation of 
substrates tethered to the 4’-PP cofactors of two adjacent modules [24](Figure 1.2 A, reaction-
3). The termination module (Figure 1.1) of an NRPS system contains a thioesterase (TE) 
domain. The TE-domain is present only once in any given NRPS system and is responsible for 
release of the final product from the enzyme system by cleavage of the terminal thioester 
linkage (Figure 1.2A, reaction-4).  
 
 
 
 
 
 4 
 
 
 
Figure 1.2 –Function of core domains  
(A) Overview of the reactions catalysed by each of the core NRPS domains. (B) Detail of aa adenylation 
catalysed by the A-domain (reaction 1 in panel A). The adenosine moiety of ATP is linked to the substrate aa via 
its hydroxyl group, liberating PPi (C) Detail of aa transfer to the 4’PP cofactor of the T-domain (reaction 2 in 
panel A).  The adenosine moiety is displaced as a result of nucleophilic attack by the activated sulphur group of 
the 4’ PP cofactor resulting a thioester linkage of the substrate aa to the T-domain. Panel A reproduced from [3], 
panels B and C adapted from [23]. 
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1.3 – Adenylation domain structure and catalytic mechanism 
 
A-domains consist of approximately 550 residues. To date the crystal structures for 3 separate 
A-domains have been solved, shedding some light on their mode of action. The first structure 
to be elucidated was that of the L-phenylalanine activating gramicidin synthetase module 
PheA [25], following this the structure of the 2,3-hydroxybenzoate (2,3-DHB) specific DhbE 
was solved [26] and most recently the structure of the D-alanine activator DltA has been 
determined [27]. Comparison of these three structures revealed a highly conserved fold for this 
enzyme family (Figure 3A), in spite of low sequence identity [3]. Although they catalyse a 
similar reaction, A-domains are structurally and evolutionarily unrelated to aa-tRNA 
synthetases [28]; instead the fold of A-domains is similar to that of other adenylate forming 
enzymes such as firefly luciferase from Phontinus pyralis and acetyl-CoA synthetase from 
Salmonella enterica [1, 3]. Interestingly, firefly luciferase and PheA share only 16% aa 
identity, but have the same general structure [25]. Since other NRPS A-domains exhibit much 
higher identity than this, the structure elucidated for PheA is likely to represent a prototype for 
the structure of all NRPS A-domains [29], an assumption that has been supported by the 
elucidation of subsequent A-domain structures [26, 27]. 
There are 10 motifs (A1-A10) that are highly conserved in all NRPS A-domains. Prior to the 
elucidation of the first A-domain crystal structure, site directed mutagenesis (SDM) [30-33] 
and photo-affinity labelling [34] experiments were used to probe the role of these conserved 
motifs in A-domain function. The results of these experiments suggested that these were the 
residues important for ATP binding, substrate α-amino and α-carboxyl group binding and 
ATPase activity;  processes common to all A-domains. In the crystal structure of PheA, most 
of the 10 core A-domain motifs were found to cluster around the substrate binding site, 
consistent with the putative role of these motifs in α amino/carboxyl recognition and ATP 
binding/hydrolysis. 
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Figure 1.3 – Adenylation domain structure                                                                                                             
A – Domain organisation and secondary structure elements of three adenylation domains are shown. In each case 
the active site residues are located between the large N-terminal (red) and small C-terminal (blue) sub-domains. 
PheA and DltA are shown with only ATP bound in the active site, DhbF is shown with its adenylated substrate 
(2,3-DHB-AMP) at the active site. 
B – Hydrogen bond network for aa adenylate binding in PheA*. The hydrogen bonds shown are those involved in 
interactions with the adenyl group (green) and the α-amino and α-carboxyl groups of the aa (red). These 
interactions are common to all α-aa activating A-domains, and accordingly, the residues involved are highly 
conserved. Panel A reproduced from [3], panel B adapted from [25]. 
*In the crystal structure solved for this enzyme the aa adenylate was hydrolysed to phe and AMP  
A 
B 
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The structures of all A-domains thus far elucidated consist of two sub-domains, a large N 
terminal domain of ~ 450 aa and a small C terminal domain of ~ 100 aa. The two sub-domains 
are linked by a hinge region of 5-10 aa (Figure 1.3A), and the active site of the A-domain is 
located at the interface of these two sub-domains [25-27]. A-domains are dynamic entities, the 
relative orientation of the large and small sub-domains changes during the catalytic cycle and 
the domain adopts three distinct conformations. Based on structural data and information 
about key residues involved in each of the catalytic steps of the A-domain (substrate binding, 
adenylation, transfer to the T-domain) a model for A-domain conformation switching and 
function has been proposed [27]. In this model, outlined in Figure 1.4, the open conformation 
promotes entry of the substrate aa, and ATP/Mg2+ cofactors to the active site cleft. Binding of 
ATP promotes rearrangement of the large and small sub-domains, bringing all active site 
residues together and leading to aa adenylation. After adenylation 4’-PPi release is proposed to 
trigger rotation of the two domains relative to each other by 140 ° bringing in to place residues 
involved in thiolation. The reactive adenylated substrate is precisely positioned, and 
presumably stabilised by hydrophobic and van der Waals interactions as well as an extensive 
network of hydrogen bonds (Figure 1.3b) [25-27]. There are 10 key residues that form the 
peptide binding pocket of the A-domain, and the identity of these residues plays a key role in 
determining which aa an A-domain will activate. In the majority of cases the identity of these 
residues can be used to predict A-domain specificity [25, 29, 35, 36]. 
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Figure 1.4 – The A-domain reaction cycle 
In the open conformation, entry of the aa substrate, ATP and Mg2+ into the active site is promoted. Recruitment 
of the correct substrate triggers a conformational switch to the closed state, in which the C-terminal sub-domain 
(blue) covers the substrate binding cleft of the N-terminal (red) sub-domain bringing together residues involved 
in substrate adenylation. Release of PPi results in rotation of the C-terminal sub-domain relative to the N-terminal 
sub-domain by 140°, this brings together residues involved in the subsequent thiolation reaction, after the aa has 
been transferred to a cognate T-domain the A-domain is reset to the open, substrate-binding conformation. 
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1.3.1 – A-domain specificity and the non-ribosomal code 
Solving the crystal structure of the first NRPS A-domain, allowed Conti and co-workers [25] 
to determine exactly which residues lined the phenylalanine binding pocket of PheA. Of these 
10 residues, two (asp235 and lys517) are common to all α-aa activating A-domains [25, 29, 
35]. These invariant residues are involved in the formation of hydrogen bonds with the α-
amino and α-carboxyl groups of the substrate (Figure 1.3B); the remaining eight residues 
surrounded the phe side chain and were proposed to be involved in substrate selection. It is 
possible to determine the position of the 10 residues of the aa binding pocket from sequence 
data alone by virtue of their position relative to the conserved motifs A4 and A5; and once 
extracted from the sequence, these residues serve as a basis for substrate prediction by 
comparison with equivalent residues from a database of A-domains of known specificity [25, 
35-38].  
 
Following the determination of the binding pocket of PheA Conti et al [25] used this process 
to show that the identity of the eight variable residues of the peptide binding pocket, when 
aligned for 24 A-domains is correlated with substrate specificity. The idea that the 10 residues 
of the binding pocket confer specificity was confirmed in a subsequent study performed by 
Stachelhaus and colleagues [36]. In this work the 10aa signature sequences from 160 A-
domains were extracted and aligned against each other. In the resulting phylogenetic tree, 
signature sequences clustered according to substrate specificity, and were only slightly 
affected by organism of origin. This result validated the method for binding pocket extraction 
as well as the role of the 10 aa signature in substrate selection. By determining a consensus 
sequence for each of the specificity clusters it was possible to derive a non-ribosomal code in 
which a particular 10 aa signature recognises a particular substrate, or set of structurally 
related substrates.  
 
In order to further validate the newly derived non-ribosomal code, SDM experiments were 
employed; among these were mutations that, based on in silico predictions, completely 
switched the specificity of AspA from asp to asn by introducing a single point mutation. A 
similar study performed by Challis and co-workers [35] developed a two dimensional model 
of the aa binding pocket, onto which the corresponding residues of other adenylation domains 
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could be superimposed. This model made it easy to identify residues likely to be involved in 
key interactions with substrates and led to the development of an algorithm for automated 
prediction of A-domain specificity using sequence data. One notable difference between the 
two models is that residues occupying a position equivalent to cys322 of PheA were omitted 
from the model proposed by Challis et al [35] on the basis that the side chain of this residue 
points away from the binding pocket of PheA [25]. Subsequent to this however, a three-
dimensional model of the substrate binding pocket of the L-thr activating enzyme PvdD [37] 
suggested that the PvdD equivalent of this position (his806) formed hydrogen bonds with the 
side chain of pvdD bound L-thr. The same study also found that the substrate binding pocket 
of PvdD would likely be highly selective for L-thr over other threonine isomers; this was 
supported by biochemical characterisation that showed an unusually high stereo-selectivity for 
L-thr over D-thr and L-allo-thr.  
 
The most recent advancement in prediction of A-domain specificities has been the 
development of heuristic transductive support vector machines (TSVM) prediction software 
[39]. This method generates a profile based on the physical and chemical properties of the aas 
in the entire eight angstrom binding pocket of an A-domain (which includes but is not limited 
to the 10 residues extracted for use by the previous methods). The program then evaluates 
which substrate this profile best matches based on what it has “learned” from A-domains of 
known specificity. In a study encompassing all 1240 A-domains for which sequence data were 
available, the TSVM based software was able to give predictions for an additional 18% of 
sequences when compared to the 10 residue extraction methods. The fact that this method was 
able to give improved prediction power suggests the 10 residues of the non-ribosomal code 
while certainly the most significant, are not the only contributors to A-domain specificity. 
 
1.4 – The Thiolation domain 
 
4’-PP cofactor attachment to NRPS enzymes occurs at the T-domain. T-domains contain a 
highly conserved signature motif LGG(HD)S(LI), where the underlined serine residue in this 
motif is absolutely conserved and is the site of 4’-PP linkage to the T-domain [40]. The 
attachment of a 4’-PP cofactor to every T domain in an NRPS system is absolutely required 
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for function as it is the site of substrate aa and peptide intermediate linkage to the enzyme 
complex during synthesis [6, 40].The conversion from inactive/apo to active/holo T-domain 
occurs by nucleophilic attack of the serine β hydroxyl on the pyrophosphate linkage of 
coenzyme A (CoA), resulting in transfer of a 4’-PP group to the serine and liberation of ADP 
(Figure 1.5). This reaction is catalysed by a class of enzymes known as phosphopantetheinyl 
transferases (PPTases)[40-42]. The 4’-PPgroup, once attached, is proposed to function as a 
swinging arm that allows flexible positioning of substrates and intermediates during synthesis 
[1-3].  
 
 
Figure 1.5 – Post translational activation of T-domains 
The serine side chain in the core T-domain motif LGG(HD)S(LI) is the site of 4’-PP cofactor attachment. The PP 
group is derived from CoA and its attachment is catalysed by a PPTase in a Mg2+ dependent reaction. Figure 
reproduced from [40]. 
 
NMR studies revealed the solution structure of the TycC3 T-domain from Bacillus brevis to be 
a simple four α-helical bundle extending 37 residues either side of the 4’-PP attachment site. 
This was the first structural elucidation of a NRPS T-domain comparison, and showed that the 
overall topology of the T-domain resembled that of Acyl carrier proteins (ACPs) from fatty 
acid and poly ketide synthetases but with different length, polarity and relative orientation of 
the helices in each case [43].  
The T-domain is required to interact with multiple protein partners at various stages of 
synthesis (Figure 1.6). First, an apo T-domain must be recognised and activated by a PPTase 
enzyme to give the activated holo T-domain. The holo T-domain must then recognise a 
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specific A-domain which catalyses substrate loading on to the 4’-PP cofactor to give an 
acylated T-domain. Acylated T-domains must then interact with the appropriate C-domain to 
position substrates for peptide bond formation. Accurate temporal and spatial control of T-
domain interactions is therefore essential to NRPS function and fidelity, although it remains 
unclear how such a simple domain recognises the correct protein partners at the correct time 
[3, 43]. It is likely that these interactions are modulated by conformational changes in the 
protein that result in presentation of specific residues involved in partner recognition, and 
there is strong evidence that this is the case. Investigating the interactions between T-Domains 
and other NRPS domains became a major focus of this PhD project and is discussed at length 
in Chapter 6. 
  
 
Figure 1.6 – Thiolation domain interactions during synthesis 
A: Apo T-domains must be recognised by a cognate phosphopantetheinyl transferase (PPTase) and 
converted to the active holo form by the addition of a 4’-PP group. B: Holo T-domains must be recognised by the 
correct A-domain to allow transfer of an aa substrate to the 4’-PP group. C: Adjacent T-domains must present 
substrates to a C-domain to facilitate the condensation reaction. 
D: T-domains located in a termination module present the final product to a TE-domain for release from the 
enzyme system. 
 
In a more recent NMR study of TycC3 T-domain structure [44], Koglin et al. describe three 
distinct, slowly inter-converting conformations associated with particular T-domain states. 
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One of these, the A-state, is seen exclusively in apo T-domains while another, the H-state, is 
seen only for holo T-domains. The third conformer, the A/H state, is common to both apo and 
holo T-domains. Of the three states, the A/H state is the most compact, with the four α-helices 
arranged in a distorted anti-parallel bundle with the third helix protruding from the main 
globular body of the protein. The A-state is the most flexible conformation. In this state the 
third helix is not present and the residues instead form an extended loop which is embedded in 
the core of the protein. In the H-state helix III is again unravelled, and the relative orientation 
of helices I, II and IV is altered. This alteration results in the 4’-PP cofactor being displaced by 
100 ° relative to its position on the A/H state, corresponding to a 16Å relocation of the active 
thiol group toward the C-terminal of the domain (Figure 1.7). The active site serine (S45) is 
proposed to be important in modulating these conformational changes with the free hydroxyl 
forming different hydrogen bonds in the A vs. the A/H state (to R47 and H44 respectively). 
Mutation of the active site serine was found to lock the T-domain in the A state, providing 
supporting evidence for the importance of S45 in modulating conformational switches [44].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 – T-domain conformational switching 
Switching of the T-domain between the A/H (A) and H states (B) causes the 4’-PP cofactor (red) to move in a 
100° arc, resulting in a 16Å shift of the active thiol group (yellow) toward the C-terminal of the domain. Residues 
that contact the 4’-PP group in each conformation are indicated. Panel C is the same image rotated 90° to 
highlight the swinging motion of the 4’-PP group. Figure reproduced from [44]. 
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1.5 – The Condensation domain 
 
Peptide bond formation in NRPS is controlled by the C-domain. During the condensation 
reaction the α-ammonium group of the downstream 4’-PP linked aa acceptor carries out 
nucleophilic attack on the carbonyl group of an upstream 4’-PP linked peptide donor. This 
process breaks the thioester linkage of the upstream peptide and results in its translocation 
onto the downstream module [3, 45] (Figure 1.8).   
 
 
 
 
 
Figure 1.8 – C-domain function 
The C-domain catalyses condensation and peptide chain translocation during synthesis. The amino group of the 
downstream aa acceptor carries out nucleophilic attack on the thioester linked peptide donor, as a result, the 
thioester linkage is broken and the peptide donor is translocated to the downstream T-domain. 
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C-domains show no significant sequence homology to any proteins other than NRPS and until 
1998 there was no biochemical data available on these domains, in fact they were initially 
considered to be nothing more than inactive spacers between adjacent AT di-domains [7]. This 
view changed following identification of a HHxxxDG motif conserved in all known C-
domains [46]. This motif is also found in the active site of CoA-dependent acyl transferase 
proteins, such as chloramphenicol acyl transferase, leading to the proposition that the C-
domain is responsible for peptide bond formation and that this reaction proceeds by a similar 
mechanism to that elucidated for chloramphenicol acyl transferase [46]. In this model, the 
second histidine of the HHxxxDG motif (HCAT) is essential for catalysis as it acts as a base, 
deprotonating the α-ammonium group of the acceptor peptide. 
  
The putative role of the C-domain in peptide bond formation was subsequently confirmed 
when it was found that the C-domain of tycB1 was able to catalyse peptide bond formation 
between two T-domain linked substrates in vitro [24]. In the same study the essential role of 
HCAT was also supported by mutational analysis. More detailed mutational analysis of the 
condensation domain [45] led to a model for peptide bond formation in NRPS that is 
dependent on acid base catalysis, the mechanism for which is outlined in Figure 1.9A. The 
role of  HCAT as a catalytic base in the C domain has recently been challenged, with newer 
structural data suggesting that electrostatic interactions, rather than general acid base catalysis, 
may control peptide bond formation by the C-domain [47]. In the newer model, HCAT is 
calculated to be protonated at physiological pH and so is unable to act as a base; instead it is 
proposed instead to participate in hydrogen bonding that stabilises the tetrahedral intermediate 
of the condensation reaction (Figure 1.9B). 
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Figure 1.9 – Two proposed mechanisms for peptide bond formation in NRPS: 
A – The mechanism proposed by Bergendahl and co-workers. HCAT (his 147) acts as a base, deprotonating the α-
ammonium group of the aa acceptor (AA1) and promoting nucleophilic attack on the carboxyl group of AA2. 
The hydroxyl group of tyr166 serves to stabilise the subsequent tetrahedral intermediate. his147 is invariant in all 
C-domains, but tyr166 may be replaced by another residue with a free hydroxyl group. Figure reproduced from 
[45]. 
B – The mechanism proposed by Samel and co-workers. This mechanism is based on structural data and pKa 
calculations for the TycC6 C-domain. HCAT (his224) is protonated at physiological pH and therefore unable to act 
as a base, instead it participates in a hydrogen bonding network that stabilises the tetrahedral intermediate of the 
reaction. The sulfate ion (red) was found to be co-crystalised at the active site of the domain and is believed to 
take the place normally occupied by the tetrahedral intermediate of the condensation reaction. Figure reproduced 
from [47].  
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1.5.1 – C-domain specificity 
The substrate specificity of C-domains is poorly understood compared to that of A-domains; 
this is mainly due to the difficulty of readily detecting the product of a condensation reaction. 
There are however some data available on the specificity of C-domains. The first study of C-
domain selectivity [48] used a two module system (ApheTE-CAproT) in which L-phe and an L-
pro specifying A-domain, along with their cognate T-domains and a C-domain, catalyse the 
production of free diketopiperazines or enzyme bound dipeptides, both of which can be 
detected if one of the aas in the condensation reaction has been radio-labelled. The selectivity 
for donor and acceptor residues was tested by artificial loading of T-domains with native and 
non-native aa-CoA conjugates. This study found low selectivity at the peptide donor site and 
high specificity at the aa acceptor for both chirality and size of the aa side-chain (Figure 10A). 
One limitation of this study was the inclusion of an Epimerisation (E) domain in the donor 
module (ApheTE). As discussed in Section 1.8, E-domains catalyse the conversion of aas from 
L to D-isomers, so inclusion of this domain would have resulted in any T-linked donor 
substrates being converted to their D-isomers before condensation. As such, no conclusion 
regarding stereo-specificity for donor residues can be drawn from this study. A subsequent 
study [49] used non-native aminoacyl-N-acetylcysteamine thioesters (aminoacyl-SNACs) as 
free substrates for the same condensation domain (CAproT), thereby eliminating the need for 
the first (ApheTE) module and preventing the epimerisation associated with using enzyme 
linked substrates. Results of this second study confirmed high selectivity at the acceptor site 
but also found stereo-selectivity at the donor site that had not previously been apparent. 
Overall, the results from both of these experiments suggest that condensation domains display 
stringent selectivity for both aa side-chain and chirality of the aminoacyl acceptor and are 
selective only for chirality at the donor site. It should be noted however that in both cases the 
in vitro assays employed may not be representative of in vivo synthesis conditions; this is 
particularly relevant to the use of aminoacyl-SNACs as C-domain substrates, as these are not 
linked to an upstream T-domain.  
 
1.5.2 – C-domain evolution and specialisation  
Phylogenetic analysis of available C-domain sequences showed that five broad categories 
could be identified based on sequence at key positions. The categories reflected specialisation 
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of the C-domain to a particular function in an NRPS assembly line and were as follows: 
Starter C-domain, located in the first module of a synthetase system; dual E/C domains, those 
which catalyse not only condensation but also epimerisation; heterocyclisation domains, those 
which catalyse both condensation and heterocyclisation of substrates; LCL C-domains, those 
which catalyse condensation between an L isomer at both the donor and acceptor site; and 
DCL C-domains, those which catalyse the condensation of a D-isomer at the donor site to an 
L-isomer at the acceptor site [50]. It is not immediately obvious why distinct LCL and DLC 
C-domains have evolved, but this may stem from the nature of epimerisation reactions (1.8) in 
NRPS. DCL C-domains are located immediately after an epimerisation domain however E-
domains generate a mixture of both D and L-isomers. Discrimination between the two isomers 
by a DCL C-domain is therefore essential for incorporation of the correct (D) isomer in the 
final peptide product [1, 50, 51].  
 
1.5.3 – C-domain structure   
To date there are three published structures for NRPS C-domains. The first to be solved was 
for the stand alone C-domain VibH [52], then subsequently the structure of a T-C di-domain 
[47] was elucidated. Most recently the structure of a C-domain in the context of an entire 
NRPS termination module was solved [53]. All of the structures revealed that the C-domain 
consists of two structurally similar sub-domains, each of which resemble the well known 
chloramphenicol acyl transferase fold. C-domains do not possess a deep substrate binding 
pocket, but rather have a substrate cleft formed by a V-shaped arrangement of the two sub-
domains that contains the active site HCAT [47, 52] (Figure 1.10).  The structure of the C-domain 
possesses distinct donor (peptide) and acceptor (aa) substrate faces, which are the sites of 
interaction with upstream and downstream T-domains respectively [47, 52]. While structural 
data has allowed a detailed understanding of the mechanism of peptide bond formation in 
NRPS, there is still no definitive structural basis for the selectivity exhibited by the C-domain.   
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Figure 1.10 – The C-domain of TycC6  
The two sub-domains have been coloured green and blue. HCAT (black) is located in the cleft between these two 
domains. In this structure a sulfate (red) was found at the active site. This sulfate ion is believed to be 
representative of the tetrahedral intermediate of a condensation reaction. The image was generated from pdb file 
2JGP [47] using Deepview. 
 
 
1.6 – The Thioesterase Domain 
 
TE-domains are found only once in an NRPS system and are always located in the terminal 
module[1]. TE-domains catalyse the release of the peptide product from its 4’PP cofactor via 
cleavage of the thioester bond. The role of the TE-domain in product release was initially 
assigned based on sequence similarity with TE-domains from FAS and PKS, and later 
confirmed by mutagenesis and module rearrangement experiments [54]. Relocation of the 
surfactin synthetase TE-domain from the terminal module to various internal modules was 
shown to result in generation of truncated products, the identity of which corresponded to the 
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new location of the TE-domain. Deletion of the same thioesterase domain resulted in complete 
ablation of surfactin synthesis, both results being consistent with the proposed role of the TE-
domain in chain termination and product release [54]. 
 
1.6.1 – Mechanism of product release by TE-domains 
NRPS TE-domains contain a highly conserved ser-asp-his catalytic triad. This combination of 
nucleophile-acid-histidine is a well characterised motif common to enzymes of the α/β-
hydrolase family [54-58]. Mutagenesis studies using the TE-domain from the E. coli NRPS 
EntF found that both the ser and his residues were essential for catalysis whereas the asp was 
not [59], indicating that this enzyme contained a catalytic dyad, rather than the typical triad. 
As illustrated in Figure 1.11, product release by NRPS TE-domains involves formation of a 
peptidyl-O-TE intermediate in which the peptide chain to be released is transferred from the 
terminal T-domain to the side chain of the catalytic ser residue in the TE-domain. During this 
process the catalytic his residue acts as a base activating the ser for nucleophilic attack on the 
thioester linked substrate (Figure 1.11, inset box). Most commonly the TE-linked intermediate 
is subsequently cleaved from the enzyme by intra-molecular cyclisation to generate a 
macrocyclic lactone (where the hydroxyl group acts as a nucleophile) or lactam (where the 
amino group acts as a nucleophile). Less commonly, hydrolysis of the intermediate results in 
release of a linear peptide [56, 57, 59-61]. If the nucleophile in the cyclisation reaction is the 
N-terminal amino group (as in Figure 1.11) a cyclic lactam will be generated, whereas use of 
an amino or hydroxyl group located in the side-chain of an internal aa leads to the generation 
of a branched cyclic lactam or lactone, respectively.    
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Figure 1.11 – Product release by TE-domains 
A peptide chain linked to the terminal T-domain of an NRPS system is transferred to the side chain of a serine 
group in the TE-domain to generate an O-linked intermediate, which can then be released by either hydrolysis or 
cyclisation. In this example the nucleophile in the cyclisation reaction is the N-terminal amino group and the 
macrocycle generated is a lactam. The role of the catalytic ser and his residues during substrate transfer is shown 
in the inset box.  
 
 
1.6.2 – TE-domain structure 
To date, the structures for two TE-domains have been elucidated by X-ray crystallography 
[55, 62]. In each case, as expected, the overall fold of the domain resembled that of the α/β-
hydrolase family. Like C-domains, TE-domains possess a deep substrate cleft that can 
accommodate linear peptide intermediates; this cleft is lined with hydrophobic and aromatic 
residues and contains the ser-his-asp catalytic triad. The hydrophobic environment of the 
substrate binding cleft is presumed to exclude water molecules and thereby prevent aberrant 
hydrolysis of linear peptide intermediates [55, 62, 63]. There have been two alternative models 
proposed for exclusion of water from the TE substrate binding cleft. Bruner and co-workers  
proposed a model in which the globular bulk of the TE-domain forms a bowl-like structure 
which is sealed by a protruding helix after substrate entry [55]. A subsequent model has been 
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proposed by Samel and co-workers in which part of the peptide chain not directly involved in 
cyclisation forms a lid that seals the substrate cleft from water [62]. The latter of these models 
is more consistent with existing biochemical data which has shown that TE-domains exhibit 
low specificity for residues that do not directly participate in a cyclisation reaction, as would 
be expected if these residues were excluded from the substrate binding cleft [3, 64, 65]. 
 
1.6.3 – Type II TE-domains 
Type II TE-domains, unlike those discussed in the preceding sections, do not catalyse product 
release from an NRPS enzyme. The role of the type II TE-domain is to repair misprimed T-
domains which would otherwise terminally inhibit an enzyme system [66-68]. In NRPS, the 
two types of T-domain mispriming that can occur are: attachment of acetylated 4’PP derived 
from acetyl-CoA; or transfer of an incorrect substrate by an A-domain. Both of these events 
are believed to be common. In the case of acetylated 4’-PP attachment, poor discrimination 
between CoA and acetyl-CoA by a PPTase enzyme is the cause of mispriming, whereas 
promiscuous activation of non-cognate aa substrates by an A-domain is the cause of incorrect 
substrate attachment. Type II TE-domains are therefore essential for efficient product 
synthesis by NRPS enzymes, as without them assembly lines would rapidly stall due to the 
inability of misprimed T-domains to be processed by downstream partners. 
 
1.7 – Phosphopantetheinyl transferases 
 
PPTases catalyse the post translational attachment of a 4’-PP group to carrier proteins (T-
domains) of NRPS, PKS and FAS [40, 42]. PPTases can be divided into two broad classes 
based on primary aa sequence and substrate specificity. The first of these classes to be 
discovered was the AcpS type PPTases. These proteins are approximately 120 aa in length and 
catalyse post translational activation of acyl carrier proteins (ACPs) found in FAS and PKS 
[40, 69]. The second class, the Sfp type PPTase are approximately 240 aa in length and 
preferentially activate T-domains found in NRPS and PKS clusters. Sfp type PPTases can be 
further divided into broad specificity and narrow specificity types. Broad specificity PPTases 
such as PcpS [69] of P. aeruginosa, and the prototypical Sfp of B. subtilis [40, 70] can activate 
a wide range of T-domains of both primary and secondary metabolic pathways. Narrow 
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specificity PPTases such as EntD of the E. coli enterobactin pathway are specialised, and act 
only on T-domains of proteins found in a particular secondary metabolite cluster [42]. 
 
1.8 – NRPS tailoring domains 
In addition to the core domains already described, NRPS can be further embellished with a 
number of tailoring domains. These are domains that catalyse chemical modification of aa 
constituents that are essential for biological activity of the final product of an assembly line. 
Tailoring domains can be integrated into specific points in a NRPS assembly line where they 
modify particular enzyme linked intermediates, or they can act as stand alone enzymes that 
modify a peptide after it is released from an assembly line [71, 72]. An exhaustive discussion 
of tailoring domains is beyond the scope of this thesis, however a brief outline of some of the 
more common tailoring domains and reactions is given below. 
 
The most commonly occurring of the tailoring domains is the epimerisation (E) domain; E-
domains are usually inserted after a T-domain to give a module with the domain order CATE. 
E-domains catalyse racemisation of an L-aa to yield a mixture of D and L-isomers [71, 72] 
and act preferentially on aas immediately after their incorporation into a peptide chain [73, 
74]. Although E-domains produce a racemic mixture, selectivity for the D-isomer by the next 
C-domain ensures incorporation of only the D-isomer into the final product [50, 51, 73].  
 
Methyl transferase (MT) domains catalyse methylation of aas and are typically integrated 
into an assembly line after an adenylation domain to give a module with the domain order 
CA(MT)T. MT-domains can catalyse attachment of a methyl group to a nitrogen (N-MT), 
carbon (C-MT) or oxygen (O-MT) atom of a specific aa [72]. N-MT domains (Figure 1.12) 
are most common of the MT domains; for example, synthesis of the immunosuppressant 
cyclosporin requires methylation of seven of the 11 aas in the molecule [75]. N-methylation of 
aas may also be catalysed by a stand-alone MT enzyme following release of a peptide from an 
assembly line, as is the case with synthesis of the vancomycin group antibiotic 
chloroeremomycin [76]. 
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Figure 1.12 – N-methylation of amino acids by MT-domains in an NRPS module 
Transfer of a methyl group to the α-ammonium of an enzyme linked intermediate is catalysed by an N-MT 
domain, with methylation occuring prior to peptide bond formation and requiring a S-adenosinyl methionine 
(SAM) cofactor. Figure reproduced from [72]. 
 
Cyclisation (Cy) domains are variants of condensation domains that catalyse heterocyclisation 
prior to product release from an NRPS complex. Cy domains can act on the side chain of 
either cysteine or serine/threonine residues, with the former yielding a five-membered 
thiazoline and the latter a five-membered oxazoline (Figure 1.13). 
 
 
Figure 1.13 – Formation of thiazoline and oxazoline groups by Cy domains  
A – In this example the Cy domain first catalyses a condensation reaction between salicylic acid (Sal) and 
cysteine, and subsequently intra-molecular cyclisation of the cysteine side chain to yield a five-membered 
thiazoline group.   
B – In this example the condensation reaction is between di-hydroxybenzanoate (DHB) and threonine. 
Subsequent cyclisation yields a five-membered oxazoline group. Figure reproduced from [72]. 
 
β-Hydroxylation of aas contained within NRPS-derived secondary metabolites is another 
common tailoring reaction. This most commonly occurs at tyrosine residues, as in synthesis of 
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the antibiotics nikkomycin and vancomycin [72, 77]; aspartic acid residues, as in synthesis of 
the phytotoxin syringomycin [78]; or histidine residues, as in the synthesis of the antibiotic 
bleomycin. β-Hydroxylation is carried out by standalone enzymes and can occur either before 
of after product release from an NRPS complex [72, 78].  
 
Glycosylation of NRPS-derived peptides by dedicated glycosyltransferase enzymes (Gtfs) 
occurs after a nonribosomal product is released from the NRPS template. The most prominent 
example of this is the addition of various deoxy sugars to vancomycin type antibiotics [72]. 
 
Finally, there are a number of examples of FMN dependent oxidation (Ox) domains that are 
integrated into NRPS assembly lines. Ox domains are found either immediately after an A-
domain as seen in the bleomycin synthetase system [79], or in some cases integrated into the 
A-domain [80]. In the case of bleomycin synthesis, oxidation is coupled to cyclisation, with 
the thiazoline formed by a Cy domain being oxidised to a thiazole by a subsequent Ox 
domain. A particularly interesting example of an integrated oxidation domain is found in the 
enzyme BpsA, synthesising the pigment indigoidine. In this enzyme, although the Ox domain 
is integrated into the A-domain, it appears to act on its substrate (L-gln) after this residue has 
been released from the NRPS enzyme [80]. 
 
1.9 – Manipulation of NRPS 
 
Of all the potential biotechnological applications of NRPS research by far the most interesting 
– and potentially lucrative – is the construction of hybrid enzyme systems. The goal of such 
endeavours is either to alter the structure of an existing natural product – and in doing so 
modify its activity – or to generate entirely new compounds in a random combinatorial fashion 
[13, 14, 81-83]. The former strategy would be particularly useful for modification of NRPS-
derived antibiotics – such as daptomycin [15, 16] and surfactin [20, 84] – to modulate activity 
or circumvent bacterial resistance mechanisms, whereas the latter strategy could be used to 
generate libraries of new molecules that could be screened for novel biological activities [13, 
14, 65, 82]. One needs only to look at the variety of molecules currently known to be 
synthesised by NRPS complexes to see that the diversity of structures that can be created by 
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varying combinations of the number, type, order and configuration of aas in a peptide chain is 
astounding [9, 12]. Whether or not these complexes can be easily manipulated to unlock this 
potential remains to be seen. As discussed in the preceding sections of this chapter, much 
progress has been made toward understanding the function and structure of NRPS enzymes; 
however this is only beginning to be translated into truly robust platforms for the production 
of novel bioactive molecules. The synthesis of novel daptomycin derivatives (outlined 1.9.2) 
is the only example to date of NRPS manipulation that has allowed the generation of novel 
bioactive compounds with efficiency that could allow for large scale production.   
 
1.9.1 – Module swaps and site directed mutagenesis  
The general strategy for modification experiments in prokaryotes thus far has been to create 
deletion mutants lacking a particular domain or module that can subsequently be replaced by a 
modified DNA sequence via homologous recombination [20, 84], or complemented with a 
plasmid based expression vector encoding a modified protein [85]. Early attempts at 
engineering NRPS systems by A-domain swapping succeeded in generating altered products 
but often at a drastically reduced rate. For example, Stachelhaus et al. [20] successfully altered 
the structure of the lipopeptide antibiotic surfactin by substitution of the seventh and final AT 
bi-domain from surfactin synthetase for AT bi-domains from the gramicidin and ACV 
synthetase enzymes [20]. Using this strategy it was possible to recover modified surfactin in 
which the terminal leu residue had been exchanged for a cys (Figure 1.14), however the yield 
of altered product was only about 0.5-1.0% of the wild type enzyme system. This result was 
subsequently expanded upon by the same group, who conducted further manipulation 
experiments using the surfactin biosynthesis system [84]. In this later work, an internal leu-
specifying AT bi-domain was exchanged for foreign modules. Using this strategy it was 
possible to derive modified surfactin in which the second leu residue was replaced with orn, 
however the products of the new enzyme system were unexpectedly truncated and the 
modified surfactin was again synthesised at a greatly reduced rate relative to wild type.  
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Figure 1.14 – Module swapping in the surfactin biosynthesis system 
Swapping of a leu-specifying minimal module (AT) for one specifying cys resulted in the production of modified 
surfactin in which the seventh and final aa had changed from a leu to a cys.  
A – Overview of the module swapping scheme.  
B – Products of the modified (red arrow) and un-modified (blue arrow) synthetase systems. Arrows identify the 
side chain of the aa which was modified and are colour coded to match the boxed modules that were responsible 
for their incorporation into surfactin. Figure adapted from [13]. 
 
 
As discussed in Section 1.3.1, elucidation of the crystal structure of a phe activating A-domain 
[25] has allowed determination of specificity conferring residues and proposition of a “non-
ribosomal code” [29, 35-39, 86]. This, in turn, has allowed an additional strategy for NRPS 
modification by targeted alteration of specific residues within an A-domain, to alter or relax its 
specificity and affect incorporation of a novel aa. Modification of existing A-domains by site-
directed mutagenesis (SDM) is an alternative strategy for generation of novel NRPS derived 
molecules. Eppelmann and colleagues, for example [86], altered the specificity of two A-
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domains within the surfactin biosynthesis system using SDM. The specificity of an L-glu 
activating A-domain was altered to L-gln by targeted modification of putative specificity 
conferring residues, resulting in an A-domain which activated L-gln as efficiently as its wild 
type progenitor activated L-glu. They also altered the specificity of an asp-activating A-
domain to asn, but this time the new enzyme exhibited a 10-fold decrease in aa activation 
activity compared to wild type. Analysis of the products of the modified enzyme systems 
showed unexpected levels of wild type peptide product as well as the anticipated modified 
peptide. The pioneering work outlined in the previous two paragraphs showed that 
manipulation of NRPS to produce novel bio-active molecules was possible, but also indicated 
that efficient production of novel molecules would require consideration of more than just A-
domain specificity. 
 
1.9.2 – Combinatorial biosynthesis using the daptomycin synthetase 
system 
More recently domain swapping experiments have been conducted by Cubist Pharmaceuticals, 
Inc., using the daptomycin biosynthetic cluster of Streptomyces roseosporus[16, 87]. These 
experiments aimed at modifying the structure of daptomycin in four different ways. First the 
terminal synthetase gene, dptD encoding an NRPS composed of two modules was deleted and 
complemented in trans by chromosomal integration of equivalent genes from related antibiotic 
synthetase systems [88, 89]. Each of the genes used to complement the dptD deletion specified 
a different aa in the final module but were nonetheless able to complement the mutation, 
resulting in production of modified daptomycin derivatives with a new aa incorporated (Figure 
1.15). Remarkably, the modified synthetase system generated by this simple subunit exchange 
strategy resulted in strains producing modified daptomycin with up to 69% the efficiency of 
wild type. 
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Figure 1.15 – Subunit exchange to produce novel daptomycin derivatives  
The dptD gene encodes the final two modules of the daptomycin synthetase system in Streptomyces roseosporus. 
It is a bi-modular gene with the domain order CAT-CATTE. Deletion of this gene followed by complementation 
with bi-modular termination genes from related synthetase systems (iptD or cdaPS3) results in production of 
daptomycin in which the final aa has changed from kynurenine (kyn) to ile, val or trp. Figure reproduced from 
[16]. 
 
 
A second strategy was one of module exchange within the gene dptBC [88, 90]. The third and 
sixth modules of dptBC have the domain order CATE with A-domains specifying alanine and 
serine respectively. Hybrid genes were created in which module three was replaced by a 
duplicate of module six and vice versa (Figure 1.16). In each case the expected product was 
generated with good yield.  
 
 
 30 
 
Figure 1.16 – Module swapping to produce novel daptomycin derivatives in  
Streptomyces  roseosporus 
Replacement of the ala 8 module of dptBC with a duplicate of the ser 11 module, and vice versa, resulted in 
production of the expected modified daptomycins with good yield.  
A – A schematic representation of the dptBC gene, A-domains are colour coded to match the structures in the 
bottom panel.  
B – Simplified representation of the cyclic portion of wild type and modified daptomycins with the aas 
incorporated by the DptBC protein colour coded, aas incorporated by other synthetase proteins are shown in 
black.                                                                                         
 
The third modification technique was deletion of dptI, a C-MT enzyme responsible for 
methylating the third carbon of the glutamic acid residue in daptomycin. As expected, deletion 
of dptI from the S. roseosporus genome resulted in a strain producing non-methylated 
daptomycin. In addition to these genetic modification strategies, the natural propensity for S. 
roseosporus to incorporate variant fatty acid side chains into daptomycin further increases the 
potential of this system for combinatorial biosynthesis. Using different combinations of the 
three modifications outlined above, it is theoretically possible to derive 72 different 
daptomycin derivatives. This combinatorial approach has been tested, and each of the 72 
possible derivatives was indeed detected [91]. The minimal inhibitory concentration of each 
derivative with Staphylococcus aureus was determined and in some cases found to be 
A 
B 
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comparable to that of wild type daptomycin. The experiments conducted using the daptomycin 
system are a significant step toward unlocking the potential of NRPS enzymes for 
combinatorial biosynthesis, and demonstrate how a number of modification strategies can be 
combined to generate a diverse library of compounds with novel biological activity.   
 
A fourth modification technique, that of module swapping, was also investigated using the 
daptomycin system [15]. These experiments were particularly interesting as they identified 
flexible linker regions within the final module of the synthetase system that were tolerant of aa 
substitutions, insertions and deletions. Perhaps the most interesting outcome of this research 
was development of a hypothesis that an intimate link exists between the TE-domain of the 
final module and its preceding T-domain. Disruption of the native T-TE linkage in the final 
module was found to result in a completely non-functional synthetase system while disruption 
of the C-A and the A-T linkers were well tolerated. This result is consistent with a variety of 
structural and biochemical data indicating that T-domains must make specific spatial and 
temporal interactions as they shuttle intermediates between catalytic centres in an enzyme [11, 
53, 92-94].   
 
1.9.3 Development of an NRPS tool box 
As far as biotechnological applications are concerned, the ultimate goal of NRPS research is to 
develop a set of rules which can be used to freely recombine the diverse set of catalytic 
activities present in various NRPS modules, domains and enzymes. In just over a decade the 
field has progressed from proof of principle in the surfactin synthetase system to practical 
application in the daptomycin system; however there is still no consensus on exactly how 
NRPS manipulation should be conducted. What is becoming clear is that NRPS domains can 
no longer be considered simply as a set of discrete enzymes. Data from structural, biochemical 
and manipulation experiments has shown that precisely coordinated interaction between 
modules and domains occurs, and that in order to realise the potential applications of these 
fascinating enzymes this interaction must be examined in detail.  
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1.10 – Aims of this study 
 
The initial aim of this work was to characterise the NRPS proteins involved in synthesis of the 
siderophore (iron carrier) pyoverdine in Pseudomonas syringe. Although the ultimate goal of 
this characterisation attempt was to provide raw material for subsequent domain swapping 
experiments, it also afforded an opportunity to investigate the biosynthesis and physiological 
significance of siderophores in P. syringae.  
 
Characterisation of NRPS modules involved in pyoverdine synthesis in P. syringae enabled 
them to be used in module swapping experiments with the aim of probing C-domain 
specificity for the peptide donor in a condensation reaction. It was hypothesised, based on 
previous experiments [85], that C-domain specificity for the donor substrate in a condensation 
reaction might result in inactivity following module swapping. This hypothesis was tested in 
the experiments described in Chapter 5 of this thesis.  
 
The results from the module swapping experiments described in Chapter 5 provided evidence 
against the initial hypothesis of C-domain donor specificity and prompted an investigation into 
the role of interdomain interactions in NRPS function. Subsequent experiments, described in 
Chapter 6, aimed to test the hypothesis that NRPS T-domains enter into specific interactions 
with other domains and that disruption of these interactions is a possible cause of inactivity in 
recombinant NRPS proteins. A recently characterised pigment-synthesising NRPS, BpsA, was 
employed as a reporter gene in domain swapping and directed evolution experiments which 
were conducted in order to determine key residues involved in T-domain interactions with 
other domains in BpsA. 
 
BpsA proved to be a powerful reporter gene for directed evolution experiments by virtue of its 
ability to synthesise a readily detectable pigment in E. coli. Synthesis of this pigment is 
dependent on BpsA being activated by 4’-PP attachment to its T-domain, a reaction which can 
only be catalysed by PPTase capable of recognising the BpsA T-domain. The dependence of 
BpsA activity on PPTase activation suggested that this enzyme might also serve as a reporter 
for characterisation and discovery of PPTase enzymes. The experiments described in Chapter 
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7 of this thesis aimed to derive systems for PPTase characterisation and discovery based on 
the unique properties of BpsA. 
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Chapter 2 – Material and methods 
 
2.1 – General reagents and materials 
 
Unless otherwise noted, all chemicals were obtained from Sigma Aldrich and were of 
analytical quality. 32PPi was obtained from Perkin Elmer. HisbindTM protein purification resin 
and buffers were obtained from Novagen. AlkphosTM kit, CDP StarTM detection reagent and 
Hybond N+TM for Southern blotting were obtained from Amersham. EnzcheckTM 
Pyrophosphate detection kit was obtained from Invitrogen. IPTG (isopropyl β-beta-D-
thiogalactoside) and Xgal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) were obtained 
from Bioline. EDDHA (ethylene-diamine-di-hydroxyphenylacetic acid) was kindly supplied 
by Professor Ian Lamont of Otago University.  
 
2.2 – Enzymes 
 
Restriction endonucleases, calf intestinal phosphatase (CIP), yeast inorganic pyrophosphatase 
(YIPP), T4 DNA polymerase and PhusionTM high fidelity polymerase were obtained from 
New England Biolabs. Bioline Red™ Taq polymerase mastermix was obtained from Bioline. 
T4 DNA Ligase was obtained from Fermentas. 
 
2.3 – Bacterial strains and plasmids 
 
2.3.1 – Bacterial strains 
The strains of E. coli, P. syringae, P. aeruginosa and P. putida used in this study are given in 
Tables 2.1-2.3, respectively.  
 
Table 2.1 – E.coli strains used in this study 
Strain Relevant characteristics* Source 
DH5α supE44 DlacU169 (Ø80 lacZ DM5) hsdR17 Invitrogen 
DH5α-λpir supE44 DlacU169 (Ø80 lacZ DM5) hsdR17 λ(pir) ATCC 
BL21 F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3) Novagen 
* Standard genotype abbreviations are used, a list of these can be found at 
http://openwetware.org/wiki/E._coli_genotypes#Nomenclature_.26_Abbreviations 
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Table 2.2 – P. aeruginosa strains used in this study 
 
Strain Relevant characteristics Source 
PAO1 Wild-type ATCC 
PAO1∆ pvdD pvdD deletion mutant, Pvd- [85] 
∆ pvdD, Pa(Thr)Thr PAO1∆ pvdD with Pa(Thr)Thr inserted at attB This study 
∆ pvdD, Pa(fOHOrn)Thr PAO1∆ pvdD with Pa(fOHOrn)Thr integrated at attB This study 
∆ pvdD, Ps(Asp)Thr PAO1∆ pvdD with Ps(Asp)Thr integrated at attB This study 
∆ pvdD, Ps(Thr)Thr PAO1∆ pvdD with Ps(Thr)Thr integrated at attB This study 
∆ pvdD, Ps(Thr)Ser PAO1∆ pvdD with Ps(Thr)Ser integrated at attB This study 
 
 
Table 2.3 – P. syringae strains used in this study 
 
Strain Relevant characteristics Source 
1448a Wild-type [95] 
1448a∆pspph1911 pspph1911 deletion mutant, Pvd- This study 
1448a∆pspph1923 pspph1923 deletion mutant, Pvd- This study 
1448a∆pspph1924 pspph1924 deletion mutant, Pvd- This study 
1448a∆pspph1925 pspph1925 deletion mutant, Pvd- This study 
1448a∆pspph1926 pspph1926 deletion mutant, Pvd- This study 
1448a∆acsA acsA deletion mutant, Acr- This study 
1448a∆pspph1924∆acsA Deletion of pspph1924 and acsA, Pvd-/ Acr- This study 
1448a∆pspph1924∆acsA∆ybt Deletion of pspph1924, acsA and ybt, Pvd-/ Acr- This study 
 
 
2.3.2 – Plasmids 
 
Table 2.4- Plasmids used in this study 
Plasmid Relevant characteristics Reference 
pET28a(+) LacIq ,T7prom, KanR, ColE1ori Novagen 
pCDFDuet1 LacIq ,T7prom, specR, CDFori Novagen 
pDM4 Suicide vector for gene deletion-ChlR, sacB,  [96] 
pDM4::1911 pDM4 + pspph1911 mutagenic fragment  This study 
pDM4::1923 pDM4 + pspph1923 mutagenic fragment This study 
pDM4::1924 pDM4 + pspph1924 mutagenic fragment This study 
pDM4::1925 pDM4 + pspph1925 mutagenic fragment This study 
pDM4::1926 pDM4 + pspph1926 mutagenic fragment This study 
pDM4::acsA pDM4 + acsA mutagenic fragment This study 
pDM4::ybt pDM4 + ybt  mutagenic fragment This study 
pAT23 pET28a(+) with AT domains form Pspph1923 (NdeI-XhoI) This study 
pAT241 pET28a(+) with AT domains form module 1 of Pspph1924 (NdeI-HindIII) This study 
pAT242 pET28a(+) with AT domains form module 2 of Pspph1924 (NdeI-HindIII) This study 
pAT251 pET28a(+) with AT domains form module 1 of Pspph1925 (NdeI-EcoRI) This study 
pAT252 pET28a(+) with AT domains form module 2 of Pspph1925 (NdeI-HindIII) This study 
pAT261 pET28a(+) with AT domains form module 1 of Pspph1926 (NdeI-HindIII) This study 
pAT262 pET28a(+) with AT domains form module 2 of Pspph1926 (NdeI-HindIII) This study 
pXAT241 pAT241 with alternative AT domain boundaries  This study 
pXAT251 pAT251 with alternative AT domain boundaries This study 
pSW196 Integration proficient vector allowing arabinose regulated expression of genes 
introduced into chromosomal attB site-GmR 
[97] 
pSMC pSW196 based staging vector allowing introduction of foreign CA domains This study 
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into second module of pvdD via SpeI and NotI restriction sites 
Pa(Thr)Thr pSMC + CA domains from second module of pvdD This study 
Pa(fOHOrn)Thr pSMC + CA domains from first module of pvdD This study 
Ps(Asp)Thr pSMC + CA domains from second module of pspph1924 This study 
Ps(Thr)Thr pSMC + CA domains from first module of pspph1925 This study 
Ps(Thr)Ser pSMC + CA domains from second first module of pspph1925 This study 
pET::BpsA pET28a + bpsA (NdeI-HindIII) This study 
pSX::BpsA pSX + bpsA (NdeI-HindIII) This study 
pBPSA1 pET28a based staging vector allowing introduction of foreign T-domains into 
bpsA using substitution scheme one 
This study 
pBPSA2 pET28a based staging vector allowing introduction of foreign T-domains into 
bpsA using substitution scheme two 
This study 
pLBPSA3 pCDFduet based staging vector allowing introduction of foreign T-domains 
into bpsA using substitution scheme three 
This study 
oBPSA pBPSA1 + T-domain from bpsA This study 
oDhbF pBPSA1 + T-domain from first module of B. subtilis dhbF This study 
oPvdD pBPSA1 + T-domain from first module of P. aeruginosa pvdD This study 
oPST pBPSA1 + T-domain from second module of P. syringae pspph1926  This study 
oEntF pBPSA1 + T-domain from E. coli entF This study 
oEntB pBPSA1 + T-domain from E. coli entB This study 
nBPSA pBPSA2 + T-domain from first module of B. subtilis dhbF This study 
nEntF pBPSA2 + T-domain from E. coli entF This study 
nPvdD pBPSA2 + T-domain from first module of P. aeruginosa pvdD This study 
nPST pBPSA2 + T-domain from second module of P. syringae pspph1926 This study 
slBPSA pBPSA3 + T-domain from bpsA, expresses WT BpsA protein This study 
slPvdD pBPSA3 + T-domain from first module of P. aeruginosa pvdD This study 
slEntF pBPSA3 + T-domain from E. coli entF This study 
slEntB pBPSA3 + T-domain from E. coli entB This study 
slDhbF pBPSA3 + T-domain from first module of B. subtilis dhbF This study 
pSX pUCP22 backbone with expression region from pUCX, allows IPTG regulated 
expression of his-Tagged proteins in Pseudomonas species 
This study 
pUCP22 Source of pSX vector backbone – Ori1600, GmR [98] 
pUCX LacIq ,tacProm, AmpR, ColE1ori [99] 
pSX::231 pSX + AT domains from pspph1923 This study 
pSX::23a pSX + A domain from pspph1923 This study 
pSX::251 pSX + AT domains from first module of pspph1925 This study 
pSX::252 pSX + AT domains from second module of pspph1925 This study 
pNEO pUCX in which the original colE1 ori has been replaced with a p15 ori This study 
pNEO::KT pNEO + P. putida KT2440 PPTase This study 
pNEO:sfp pNEO + sfp (PPTase from B. subtitlis)  This study 
pNEO::pcpS pNEO + pcpS (PPTase from P. aeruginosa) This study 
pET::KT pET28a + P. putida KT2440  PPTase This study 
pET::sfp pET28a + sfp  This study 
pET::pcpS pET28a + pcpS This study 
pCDF::KT pCDF + P. putida KT2440  PPTase This study 
pCDF::sfp pCDF + sfp This study 
pCDF:: pCDF + pcpS This study 
pSX::1923 pSX + entire Pspph1923 gene, for complementation of gene deletion This study 
pSX::1925 pSX + entire Pspph1925 gene, for complementation of gene deletion This study 
pUCP22::PvdS* pUCP22 with pvdS gene of P. aeruginosa ligated into EcoRI site of MCS  Lamont lab 
*Constructed in laboratory of Iain Lamont, Otago University, New Zealand 
 
2.4 – Oligonucleotide primers 
Primers were designed using Vector NTI® and ordered from IDT custom oligonucleotide 
service. Primers were reconstituted to a final concentration of 100 µM in 1 x TE buffer for 
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storage at -20 °C. Working stocks were prepared by dilution to 10 µM with sterile ddH2O. The 
names and sequences of all primers used in this study are given in Table 2.5. 
 
Table 2.5 – Primers used in this study 
Restriction sites are indicated in bold, homology regions for overlap PCR are underlined. 
 
Primer name and 
function 
Sequence (5’→3’) 
Primers for mutagenic fragments 
1911_Lup_XhoI GGGGCTCGAGGCCTTGCACACGCCGGATC 
1911_Ldown AGACGCACTGTCCAGCGTATCG 
1911_Rup_hom CGTCGATACGCTGGACAGTGCGTCTAGCGTGCCGGTGTTCGTG 
1911_Rdwn_ XbaI CCCCTCTAGACTTGCGGTCAAGCTTGCC 
1923_Lup_EcoRI GGGGGGATTCGATGTACGTGCGTAACTACGGC 
1923_L_dwn GTTCATGGGTCGATCCTTGC 
1923_Rup_Hom ATTCAGCAAGGATCGACCCATGAACGCATGACCGGGACCACCG 
1923_Rdwn_BamHI GGGGGGATCCTTCGGTTTCAGCACGGCCG 
1924_Lup_XhoI GGGGCTCGAGATGACCGGGACCACCGCT 
1924_Ldwn AGCCAGACCGGACAAATCAATG 
1924_Rup_Hom CAGCATTGATTTGTCCGGTCTGGCTCTGAAGACCGAGCTCCGTGC 
1924_Rdwn_XbaI CCCCTCTAGAGTCCAGCGCATGGTCACTTTC 
1925_L_Up_SacI GGGGGGAGCTCACAGTTGCTTGACTCCGTTA 
1925_L_down  GCACTTCCTGATCGACATAA 
1925_R_up_hom GAGCGTTATGTCGATCAGGAAGTGCAAACACTGCCCGATTACAT 
1925_R_dwn_HindIII GGGGGAAGCTTTTTTTCAATATCGGACAAGC 
1926_Lup_XhoI GGGGCTCGAGATGGACAAGTCTGCAGCAGAGC 
1926_Ldwn  TTCGATGTCGGCTGGCGC 
1926_Rup_Hom CTCGGTTGCGCCAGCCGACATCGAAGTGGGGCTTATCGAAACCGC 
1926_Rdwn_XbaI CCCCTCTAGATCACACAAGCCGCTCGGC 
acsA_Lup_XhoI GGGGCTCGAGATGAACTTCACTTCACTCGCCG 
acsA_Ldwn CTCCAGAAACAGCGCTATGCC 
acsA_Rup_Hom AAAGGGCATAGCGCTGTTTCTGGAGTGGCTTGAGCGTAACGGCA 
acsA_Rdwn_XbaI GGGGTCTAGATCAGGTTGCACGGCGCAA 
YBKO_Lup_XhoI CCCCCTCGAGATGTACACATCGACCAGAAAAGC 
YBKO_Ldwn CTGATACAGATGACAGCC 
YBKO_Rup_hom TGGAGTCGGCTGTCATCTGTATCAGCTGGCTGAGCAACCCCAG 
YBKO_Rdwn_XbaI CCCCTCTAGATCATGAACCACCTCCGCT 
Inserts for AT/A domain overexpression constructs 
231_fwd _NdeI GGGGCATATGGAGCGCGCTCAGTTGCTGGATA 
231_rev _XhoI GGGGCTCGAGTCATGCGCCAAATTCCTCCA 
23a_rev _XhoI GGGGCTCGAGTCACTGGCTTGAATCGGGCGCTG 
241_fwd_NdeI GGGGCATATGCCGTTGTTCAGCCTCGGTG 
241_rev_HindIII GGGGAAGCTTTCATGCCACCGAGGCCAGCTG 
242_fwd_NdeI GGGGCATATGGCACGTCTCGGCGAGTTGA 
242_rev_HindIII GGGGAAGCTTCTAAGCAATCAAATTATC 
251_fwd_NdeI GGGGCATATGAGCGTCGAAGAACGGCAAGA 
251_rwv_EcoRI GGGGGAATTCTCACGCAGCCTGGGCGAAAGCT 
252fwd_NdeI GGGGCATATGGCCGAACAGCAGCAGATTGT 
252rev_HindIII GGGGAAGCTTTCAGATACCCGCCATTTCATTC 
261_fwd_NdeI GGGGCATATGCGACTTGCCGATCAGCCG 
261_rev_HindIII GGGGAAGCTTTCATGCCACCGAGGCCAACTG 
262_fwd_NdeI GGGGCATATGGAACAGCAGCAGATTGTTCGCG 
262_rev_HindIII  GGGGAAGCTTTCACATGAAATCGGCCAGCTCAC 
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EntF_A_Fwd_NheI GGGGGCTAGCGATATTATGCTGCCAGGTGAGT 
EntF_A_Rev_HindIII GGGGAAGCTTTCACTTCAGTTCAGGCAACGGTA 
Inserts for AT-domain overexpression constructs with alternative domain boundaries (pXAT) 
x241fw_ndeI GGGGCATATGATTCCCGAAATGCTTGCG 
x241rev_HindIII GGGGAAGCTTTCACAACGGCAGCGAGCCACT 
x251fw_NdeI GGGGCATATGTGCCGCGACGCCAAC 
x251rev_HindIII GGGGAAGCTTTCACAGCGGCTGGCTGCGGTC 
Primers for construction of pSMC staging vector 
pvdDmod1_Fwd_EcoRI CCCCGAATTC CATATGCAAGCACTCATAGAGAAGGTG 
pvdDmod1_Rev_SpeI  CCCCACTAGTCAATCCCTGGGCGAACGC 
pvdDTTE_Fwd_NotI CCCCGCGGCCGCGTCGCAGCAGGCCTATCGAGCGC 
pvdDTTE_Rev_SacI  CCCCGAGCTCTCAGCGCCCGGCACGCTCCAGGGCGGCCCGGA 
Primers for introduction of CA domains into pSMC 
pvdD-CA1_Fwd_XbaI  CCCCTCTAGAGGTGTCAATCTCTTCGAG 
pvdD-CA2_Fwd_XbaI  GGGGTCTAGAACGACGGATGCGGTCTCGACGA 
pvdD-CA 1+2_Rev_NotI  CCCCGCGGCCGCATCCGGTTGCGGCAACGCCTGC 
CA Ser(Thr)_Fwd_XbaI  CCCCTCTAGAGGGCAGGGCAATGCTGCG 
CA Ser(Thr)_Rev_NotI CCCCGCGGCCGCGTCTGGTGTCGGCAGGGC 
CA-Thr(Thr)_Fwd_XbaI CCCCTCTAGAAATCTCTACGGGGTCACACCGA 
CA-Thr(Thr)_Rev_NotI CCCCGCGGCCGCATCCGGCGCGGGCAGCGCCTTG 
CA-Thr(Asp)_Fwd_XbaI CCCCTCTAGAACGACGGATGCGGTCTCGACGATACCGCTTGC 
CGATCGGCAGGAAGATATCTACCCGCTGTCGC 
CA-Thr(Asp)_Rev_NotI CCCCGCGGCCGCATCCGGCGCGGGCAGCGCCTTG 
Primers for creation of pBPSA1 
pBPSA1_Lup CCCCCATATGACTCTTCAGGAGACCAGCGT 
pBPSA1_Ldwn GGGGGAATTCGGTACCCTCCGTCTCCGTGCGCGGGG 
pBPSA1_Rup CCCCAAGCTTGCTAGCGAGCGCGAGGTCGCCCAGGAGTCC 
pBPSA1_Rdwn CCCCCTCGAGTCACTCGCCGAGCAGGTAGC 
Primers for substitution of T-domains into pBPSA1 
oBPSAT_Fwd GGGGCATATGGGTACCAAGGAGATCGCGGCGGTCTG 
oBPSAT_Rev GGGGGCTAGCCAGGCGGCGGGCCAGCTTCTCGA 
oPvdDT_Fwd CCCCCATATGGGTACCCAGCGCATCGCAGCGATC 
oPvdDT_Rev CCCCGCTAGCCAATCCCTGGGCGAACGC 
oDhbFT_Fwd GGGGCATATGGGTACCGAGATATTGTGTGACTTGTTTGCAG 
oDhbFT_Fwd_Rev GGGGGCTAGCAAGATGGGCAGCGAGTCCGGCTACT 
oEntFT_Fwd CCCCCATATGGGTACCACGATTATCGCCGCGGCA 
oEntFT_Rev CCCCGCTAGCAATAATCGTTGCCAGTTT 
oEntBT_Fwd CCCCCATATGGGTACCGCGGCGCTGCGTGAGGTG 
oEntBT_Rev CCCCGCTAGCGAGTAGCTTCCACCAGGC 
oPsT_Fwd CCCCCATATGGGTACCCAACGTCTTGCCGCGTTG 
oPsT_Rev CCCCGCTAGCCATGAAATCGGCCAGCTC 
Primers for creation of pBPSA2 
pBPSA2_Lup CCCCCATATGACTCTTCAGGAGACCAGC 
pBPSA2_Ldwn CCCCGAATTCGGTACCGGGGCGCTCGACGAGCTC 
pBPSA2_Rup CCCCGGTACCCCGCTAGCCGCGAGGTCGCCCAGGAG 
pBPSA2_Rdwn CCCCAAGCTTTCACTCGCCGAGCAGGTA 
Primers for substitution of T-domains into pBPSA2 
nBPSAT_Fwd CCCCCATATGGGTACCTTCGTCGCCCCGCGCACG 
nBPSAT_Rev CCCCGCTAGCCTCCAGGCGGCGGGCCAG 
nPvdDT_Fwd CCCCCATATGGGTACCTATCGAGCGCCCGGTAGC 
nPvdDT_Rev CCCCGCTAGCTTCCAATCCCTGGGCGAA 
nEntFT_Fwd CCCCCATATGGGTACCGGGCGTGCGCCGAAAGCG 
nEntFT_Rev CCCCGCTAGCATCAATAATCGTTGCCAG 
nPsT_Fwd CCCCCATATGGGTACCCACGTCGCGCCACGTACG 
nPsT_Rev CCCCGCTAGCACGCATGAAATCGGCCAG 
Primers for creation of pBPSA3 
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pBPSA3_Lup CCCCGGATCCGATGACTCTTCAGGAGACCAGCG 
pBPSA3_Ldwn AGCTAAGCTTAGCTATGCATTGACCTGGTCGGAGGCGG 
pBPSA3_Rup AGCTAAGCTTAGCTACTAGTCGCTTCGTCCGCCTGCACG 
pBPSA3_Rdwn CCCCCTCGAGTCACTCGCCGAGCAGGTAGC 
Primers for substitution of T-domains into pBPSA3 
  
slBPSAT_Fwd AGCTCTGCAGAGCTCGTCGAGCGCCCCTTCGTCGCCCCGCGCACG 
slBPSAT_Rev AGCTTCTAGACTCCTGGGCGACCTCGCGCTCCAGGCGGCGGGCCAG 
slPvdDT_Fwd AGCTCTGCAGAGCTCGTCGAGCGCCCCTATCGAGCGCCCGGTAGC 
slPvdDT_Rev AGCTTCTAGACTCCTGGGCGACCTCGCGTTCCAATCCCTGGGCGAA 
slDhbFT_Fwd AGCTCTGCAGAGCTCGTCGAGCGCCCCGATCGGGCCCCGCGGACT 
slDhbFT_Fwd_Rev GCTTCTAGACTCCTGGGCGACCTCGCGATCAAGATGGGCAGCGA 
slEntFT_Fwd AGCTCTGCAGAGCTCGTCGAGCGCCCCGGGCGTGCGCCGAAAGCG 
slEntFT_Rev AGCTTCTAGACTCCTGGGCGACCTCGCGATCAATAATCGTTGCCAG 
slEntBT_Fwd AGCTCTGCAGAGCTCGTCGAGCGCCCCCTGCCAGCACCTATCCC 
slEntBT_Rev AGCTTCTAGACTCCTGGGCGACCTCGCGGGAGAGTAGCTTCCAC 
Primers for PPTase amplification 
PP_PPTase_fwd_NdeI GGGGCATATGAACACACTTCCCGCCTGC 
PP_PPTase_rev_SalI GGGGGTCGACTCAGACGCTGACCAGGCTCA 
pcpS_fwd_NdeI GGGGCATATGCGCGCCATGAACGACCG 
pcpS_rev_SalI GGGGGTCGACTCAGGCGCCGACCGCCACCA 
sfp_fwd_NdeI GGGGCATATGAAGATTTACGGAATTTA 
sfp_rev_SalI GGGGGTCGACTTATAAAAGCTCTTCGTACG 
 
 
 
 
 
 
 
2.5 – Media  
 
Unless otherwise noted all media components were dissolved in ddH20 and sterilised by 
autoclaving. 
 
LB 
LB was obtained as a premixed powder from Sigma or HiMedia and when reconstituted 
contained: 5 g/L yeast extract, 10 g/L bacto tryptone, 10 g/L NaCl. 
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King’s B medium 
20 g/L bacto peptone (DIFCO), 1 % v/v glycerol, 1.5 g/L K2HPO4, 6.1 mM MgSO4. MgSO4 
was added from a sterile 1 M stock after autoclaving to avoid precipitation. 
 
M9 minimal medium 
5 x M9 salts were obtained as a premixed powder from Sigma and when reconstituted 
contained 64 g/L Na2HPO4, 15 g/L KH2PO4, 2.5 g/L NaCl, 5 g/L NH4Cl. M9 Minimal 
medium was prepared immediately prior to use and contained (per litre): 778 mL sterile 
ddH20, 200 mL 5 x M9 salts, 2 mL sterile 1M MgSO4,  20 mL sterile 20 % w/v glucose, 100 µl 
sterile 1 M  CaCl2. 
  
TYM medium  
2 % bacto-tryptone, 0.5 % yeast extract, 100 mM NaCl, 10 mM MgCl2. MgCl2 added after 
autoclaving from a sterile 1 M stock.   
 
ZYP5052 autoinduction medium 
ZY Base: 10 g/L N-Z Amines AS, 5 g/L yeast extract 
50 x 5052: 250 g/L glycerol (=200 mL/L), 25 g/L D-glucose, 100 g/ L α-lactose 
20 x NPS: 66 g/ L (NH4)2SO4, 136 g/L KH2PO4, 142 g/L Na2HPO4 
 
ZYP5052 was prepared immediately prior to use and contained (per litre): 929 mL ZY base, 
20 mL 50 x 5052, 50 mL 20 x NPS, 1 mL 1M MgSO4.   
 
2.5.1 – Media supplements 
All antibiotic stocks were made to 1000 x the media concentration indicated for E. coli in 
Table 2.5. IPTG stocks were prepared to a final concentration of 100 mg/mL. With the 
following exceptions, media supplements were dissolved in ddH20 and filter sterilised using a 
0.22 µM filter: Tetracycline  was dissolved in 100 % ethanol, rifampicin was dissolved in 50 
% methanol with sufficient NaOH to facilitate solubility, chloramphenicol was dissolved in 50 
% ethanol, Xgal stocks were prepared to a final concentration of 24 mg/mL in 100 % dimethyl 
formamide , EDDHA stocks were prepared to a final concentration of 50 mg/mL in ddH20 
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with sufficient NaOH to facilitate solubility and filter sterilised using a 0.22 µM filter. Unless 
otherwise noted final media concentration of antibiotics is as listed for each organism in Table 
2.6. 
 
Table 2.6 – Antibiotics used in this study 
Antibiotic E. coli 
(µg/mL) 
P. syringae 
(µg/mL) 
P. aeruginosa 
(µg/mL) 
P. putida 
(µg/mL) 
Ampicillin 100 100 - - 
Kanamycin 50 - - - 
Spectinomycin 50 - - - 
Chloramphenicol 34 - - - 
Gentamycin 20 20 100 50 
Tetracycline 10 10 100 50 
Rifampicin - 100 - - 
Carbenicillin - 100 300 100 
 
 
2.6 – Growth and maintenance of bacteria 
  
LB was used for routine growth and maintenance of all bacterial strains. Growth temperatures 
used were typically: 37 °C for E. coli and P. aeruginosa, 30 °C for P. putida and 28 °C for P. 
syringae. For liquid cultures aeration was provided by shaking at 200-300 rpm. Medium-term 
maintenance was achieved by storing agar plates containing bacteria at 4 °C for up to two 
weeks. For long-term maintenance of strains, an aliquot of overnight culture was mixed 1:1 
with 80 % glycerol and stored at -80 °C. To ensure maintenance of plasmids with antibiotic 
resistance markers, the appropriate antibiotic(s) were added to liquid and solid media. 
 
2.7 – Routine molecular biology  
 
2.7.1 – PCR protocols 
 
Standard PCR reactions 
Where PCR products were to be used in downstream cloning applications, amplification was 
conducted using the NEB Phusion™ high fidelity polymerase kit. For screening purposes and 
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splicing by overlap, PCR Bioline Biomix Red™ Taq polymerase mastermix was employed. 
Standard reactions set up according to manufacturer’s directions were usually sufficient for 
good amplification. In rare instances, systematic variation of the concentration of one or all of 
the following components was required to achieve amplification: MgCl2, DNA template, 
primers, DMSO. 
 
Overlap PCR for mutagenic fragment generation 
For the generation of mutagenic fragments, two separate standard PCR reactions were carried 
out to amplify ~400 b.p from the 5’ and 3’ end of the gene to be deleted. Following cleanup 
100-200 ng of each of these fragments was added to a standard 50 µL Biomix red reaction 
without primer or genomic template addition. Splicing of the two fragments, mediated by a 25 
b.p homology region on one of the primers was then carried out by conducting three primer-
less cycles – as indicated in the overlap amplification protocol – after three cycles primers 
were added to the concentration recommended by the manufacturer and the remainder of the 
amplification protocol continued.    
 
Amplification protocols  
The following thermocycler protocols were used for amplification using Phusion or Biomix 
red. In rare cases it was necessary to systematically vary one or all of the cycle parameters to 
achieve amplification. 
 
Phusion PCR protocol  
98 C 60 s 
 
98 C 15 s  
72 C 30 s (-1 C /cycle)      10 cycles 
72 C 30 s per kilobase  
 
98 C 15 s  
62 C 30 s      25 cycles 
72 C 30 s per kilobase  
 
 72 C 5 min 
 12 C on hold 
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Biomix red PCR protocol 
 
95 C 5 min 
 
95 C 30 s  
56 ° C 30 s      10 cycles 
72 C 1 min per kilobase  
 
95 C 30 s  
52 ° C 30 s      20 cycles 
72 C 1 min per kilobase  
 
72 C 10 min 
 12 C on hold 
 
 
 
Overlap PCR protocol 
 
95 C 5 min 
 
95 C 30 s  
50° C 30 s      3 cycles – no primers 
72 C 1 min per kilobase  
   
Primers added to reaction held at 95 °C  
 
95 C 30 s  
56 ° C 30 s      10 cycles 
72 C 1 min per kilobase  
 
 
 
95 C 30 s  
52 ° C 30 s      20 cycles 
72 C 1 min per kilobase  
72 C 10 min 
 12 C on hold 
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2.7.1 – Isolation purification and manipulation of DNA 
 
Isolation and purification 
Small-scale preparation of plasmid DNA was carried out using either the Zymogen Zyppy™ 
or Qiagen Minispin™ kit. Preparation of genomic DNA was achieved using a Qiagen 
DNeasy™ Kit. Deproteinisation and buffer exchange of PCR products, restriction digests and 
ligation mixtures was carried out using Zymogen Zymospin™ columns. In all cases the 
manufacturer’s protocol was followed. Where necessary, DNA samples were quantified and 
assessed for purity using a Nanodrop™ spectrometer or by agarose gel electrophoresis. 
 
Restriction digests 
Unless otherwise noted, restriction digests were carried out according to the manufacturer’s 
directions. Before use in ligations, digests were heat inactivated and cleaned using a 
Zymospin™ column. 
 
Ligations 
Ligations were typically set up using a 1:6 molar ratio of vector:insert with enzyme and buffer 
concentration, as specified in the manufacturer’s directions. Total DNA concentration was 
kept below 10 ng/µL. For transformation by electroporation, ligations were cleaned using a 
Zymospin™ column. Negative controls containing no insert DNA were set up and 
transformed in parallel to assess vector self-ligation and residual uncut vector DNA. 
 
2.7.2 – Preparation and transformation of competent cells 
 
2.7.2.1 – Preparation and transformation of chemically competent E. coli  
This protocol is based on the method described in [100]. 
 
Reagents 
TFBI: 30 mM KOAc, 50 mM MnCl2, 100 mM KCl, 10 mM CaCl2 15 % w/v, glycerol. pH 
adjusted to 5.8 with 0.2 M acetic acid, solution sterilised using a 0.22 µM filter. 
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TFBII: 10 mM Na-MOPS pH7.0, 10 mM KCl, 75 mM CaCl2 15% w/v glycerol. Solution 
sterilised using a 0.22 µM filter. 
 
Preparation 
The desired strain was streaked onto TYM agar and incubated overnight at 37 °C. A single 
colony was then inoculated into 3 mL TYM broth and incubated at 37 °C/200 rpm for 12-16 h. 
1 mL of this overnight was then used to inoculate 40 mL of TYM in a baffled, sterile 250 mL 
conical flask. The resulting culture was grown at 37 °C/200 rpm until an OD 600 of 0.35-0.4 
was reached at which point the culture was transferred into a sterile 50 mL tube and placed on 
ice for 5 min. Cells were then collected by centrifugation (2500 rcf, 4 °C, 10 min) and 
supernatant decanted off. The resulting cell pellet was resuspended in 2 mL ice-cold TFBI by 
gentle pipetting before addition of a further 38 mL ice-cold TFBI. The cells were then kept on 
ice for 2 h and again harvested by centrifugation (2500 rcf, 2 °C, 10 min). The resulting cell 
pellet was resuspended in 4 mL ice cold TFB II and 100 µL aliquots distributed into pre-
chilled 1.5 mL microfuge tubes on ice. Cell aliquots were then snap-frozen using liquid 
nitrogen or a metal tube block cooled to -80 °C. Frozen aliquots of cells were stored at -80 °C 
until needed. When appropriate for plasmid maintenance, antibiotics were added to TYM 
broth and agar.  
 
Transformation 
Cell aliquots were removed from storage and placed on ice until thawed. ~ 10 ng Plasmid 
DNA or up to 200 ng ligation mixture was then added in a volume not exceeding 1/10th that of 
the cell aliquot. Following addition of DNA, the tube was flicked gently to mix and kept on 
ice for 30 min. Cells were then heat shocked by placing in a water bath at 42 °C for 2 min. 
Following heat shock cells were placed immediately on ice for 5 min, before the addition of 9 
vols sterile LB broth. Transformations were then incubated at 37 °C/200 rpm for 45-60 min to 
recover. After recovery cells were plated on LB agar containing appropriate antibiotics. For 
plasmids aliquots of 100 µL were plated. For ligations an aliquot of 100 µL was plated 
followed by collection of remaining cells by centrifugation (13,000 rcf, 20 s). The supernatant 
was then decanted leaving ~ 100 uL residual medium, in which the cell pellet was resuspended 
and then plated.   
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2.7.2.2 – Preparation and transformation of electrocompetent E. coli 
This protocol is based on the method described in [101]. 
 
Reagents 
GYT: 0.25 % bacto tryptone, 0.125 % yeast extract, 10 % v/v glycerol. Sterilise by 
autoclaving. 
 
Preparation 
The desired strain was streaked onto LB agar and incubated overnight at 37 °C. A single 
colony was then inoculated into 25 mL LB broth and incubated at 37 °C/200 rpm for 12-16 h. 
10 mL of the overnight culture was then used to inoculate 500 mL LB medium in a baffled, 
sterile 2000 mL conical flask. The resulting culture was grown at 37 °C/200 rpm until an OD 
600 of 0.35-0.4 was reached, at which point the culture was transferred into 10 sterile 50 mL 
tubes and placed on ice for 15-30 min with occasional swirling. Cells were then collected by 
centrifugation (1000 rcf, 30min, 2 °C) and the pellets resuspended in a total volume of 500 mL 
ice cold sterile ddH2O by gentle pipetting. Following this first washing step cells were again 
collected by centrifugation (1000 rcf, 30min, 2 °C) and the resulting pellet resuspended in 250 
mL ice-cold sterile 10 % v/v glycerol. Cells were again pelleted by centrifugation (1000 rcf, 
30min, 2 °C) and the resulting pellet resuspended in 125 mL ice cold sterile 10 % v/v glycerol. 
Cells were again collected by centrifugation and the pellet resuspended in 500 µL ice cold 
sterile GYT. The OD 600 of a 1/100 dilution of the cell mixture was then determined and 
GYT added to give a final concentration of 2-3 x 1010 cells/mL (OD 600 1.0 = 2.5 x 108 
cells/mL). 40 µL aliquots were then distributed into pre-chilled 1.5 mL microfuge tubes on 
ice. Cell aliquots were then snap-frozen using liquid nitrogen or a metal tube block cooled to -
80 °C. Frozen aliquots of cells were stored at -80 °C until needed. When appropriate for 
plasmid maintenance, antibiotics were added to LB broth and agar for growth steps.  
 
Transformation 
Cell aliquots were removed from storage and placed on ice until thawed. 50 ng ligation/40 µL 
cell mixture was then added in a volume not exceeding 1/10th that of the cell aliquot.  
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Following addition of DNA, the tube was flicked gently to mix and the contents transferred to 
an ice cold, sterile 2 mM gap electroporation cuvette. Cells were then electroporated (2.5 kV, 
25 µF, 100Ω) and 10 vols. SOC broth was immediately added and the mixture transferred to a 
sterile 15 mL centrifuge. Cells were then incubated at 37 °C/200 rpm for 1 h before plating on 
LB medium containing appropriate antibiotics. When likely transformation efficiency was 
unknown, 100 µl of neat transformation as well as 100 µL of a 1/10 and 1/100 dilution were 
plated to ensure single colonies were obtained.  
 
2.7.2.2 – Preparation and transformation of electrocompetent Pseudomonas. 
This protocol is based on the method described in [102] and was used for the preparation of 
electrocompetent P. aeruginosa, P. syringae and P. putida. 
 
A 50 mL culture of the desired strain was grown until stationary phase under the appropriate 
conditions. For each competent cell aliquot to be prepared 6 mL culture was aliquoted into 4 x 
1.5 mL microfuge tubes. Cells were then pelleted by centrifugation (13,000 rpm, 30 s) and 
each pellet washed twice in 1 mL sterile 300 mM sucrose. After the final wash step the four 
cell pellets were resuspended in a final volume of 100 µL sterile 300 mM sucrose and 
transferred to a sterile 2 mm gap electroporation cuvette. For transformation, 50 ng replicative 
or up to 500 ng non-replicative (KO) plasmid was added in a volume not exceeding 5 µL and 
the cuvette gently flicked to mix. Cells were then electroporated (2.5 kV, 25 µF, 200Ω) and 
1mL LB broth immediately added. Following transfer to a sterile 15 mL tube, cells were 
allowed to recover for 1 h (strain appropriate growth conditions) before plating 100 µL 
aliquots on LB agar containing appropriate antibiotics. For maximum efficiency of 
transformation all preparation steps were conducted at room temperature [102]. 
 
2.7.2.3 – Identification of recombinant clones 
 
Colony PCR 
The first step for identification of clones harbouring desired inserts on a plate arising from 
transformation of a ligation was colony PCR. Standard biomix red PCR reactions with a final 
volume of 15 µL were set up on ice for each clone to be screened. Where possible, a primer 
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targeting plasmid sequence was used in combination with a primer targeting insert sequence to 
avoid non-specific amplification. Colonies to be screened were picked using a sterile pipette 
tip and streaked onto a numbered plate containing appropriate antibiotics. The residual 
bacteria on the tip were then transferred into a PCR reaction and released by gentle swirling. 
Reactions were then subjected to the Biomix red amplification protocol described in Section 
2.7.2. Typically, two controls were included in each screen these were: a reaction in which a 
clone from a vector-only control plate was used as template and a reaction inoculated with a 
pipette tip that had been touched to a region of the vector + insert agar plate not containing any 
colonies. The former assessed non-specific amplification form plasmid and genomic DNA 
sequences, the latter amplification of residual PCR product spread onto the surface of a plate. 
Following amplification 7 µL aliquots of each reaction were analysed by agarose gel 
electrophoresis and 3 mL overnight cultures set up for clones showing amplification of the 
correct sized product. 
 
Confirmation by restriction digest 
Plasmid DNA from PCR positive clones was prepared from overnight cultures as described in 
2.7.1. Digests of plasmid DNA from each clone were then set up as described in Section 2.7.1, 
using a combination of enzymes that would generate a diagnostic fragment in insert positive 
clones. Following incubation, digest were assessed for liberation of diagnostic fragment by 
agarose gel electrophoresis and plasmid DNA from positives sent for sequence analysis. 
 
Sequencing of DNA  
Sequencing was preformed by Macrogen inc. DNA samples and primers for sequencing were 
prepared according to the company’s specifications of concentration and purity. Sequence 
quality was assessed using Contig Express™ and insert identity confirmed by alignment of 
sequences against a template obtained from genbank.  
 
2.7.3 – In frame deletion of genes from the chromosome of Ps1448a 
Primers for generation of mutagenic fragment were designed using VectorNTI™ such that the 
resulting 800 b.p overlap PCR product would contain 400 b.p from each end of the gene, and 
lack the internal region. These fragments were designed to maintain the original reading frame 
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of the gene in order to avoid polar effects following chromosomal integration. Mutagenic 
fragments were restriction digested and ligated into cut pDM4 vector following the protocols 
outlined in Section 2.7.1. Ligations were transformed into chemically competent DH5α-λpir 
cells as described in 2.7.2.1 and recombinant clones identified as described in 2.7.2.3.  
 
Once a mutagenic plasmid for deletion of a target gene had been obtained, this was delivered 
to cells using the electroporation protocol described in Section 2.7.2.2. Primary integration 
events were selected on plates containing 70 µg/mL Chl and 100 µg/mL Rif and presence of 
the mutagenic plasmid confirmed by colony PCR as described in 2.7.2.3. The second 
recombination event was then forced by growing integrants overnight in LB medium 
containing 5 % w/v sucrose and plating aliquots on LB medium containing 10 % w/v sucrose. 
After development, 20-40 colonies were patched onto LB medium with and without 70 µg/mL 
Chl. Colonies which had reverted to Chl sensitivity were taken to be double crossover events. 
Double crossovers were subjected to an initial screen for presence of the mutagenic fragment 
using colony PCR (Section 2.7.2.3). Genomic DNA was then prepared from positive clones 
and again assessed the presence of the truncated gene and the absence of intervening sequence 
by standard PCR using Biomix red. Final conformation was obtained by southern blotting 
using an Amersham Alkphos™ kit according to the manufacturer’s protocol. Analysis by 
Southern blot was carried out for ∆ 1926 and ∆ 1924.  
 
2.8 – Siderophore characterisation 
 
2.8.1 – CAS agar assays for iron uptake 
One hundred mL Chromeazurol S (CAS) dye for the detection of siderophores [103] was 
made by dissolving 60.5 mg CAS powder (Sigma) in 50 mL distilled water. To this 10 mL of 
a 1 mM solution of FeCl3 was added. The entire solution was then poured slowly with stirring 
into 40 mL distilled water containing 72.9 mg dissolved HDTMA (Sigma) and autoclaved to 
sterilise. To make agar plates, freshly autoclaved KB agar was cooled to 60 °C before adding 1 
part CAS dye to 9 parts medium. Plates were immediately poured, and at this point exhibited a 
dark green colour. Strains were inoculated into dried CAS plates by picking a large colony 
with a sterile 100 µl pipette tip and piercing the tip approximately 5 mm into the surface of the 
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agar plates. Duplicate plates were then incubated upside down at 28 °C for 24 h. After 24 h 
incubation in the 28 °C condition, one of the plates was removed from the incubator and 
maintained at 22 °C. Plates were photographed with minimal exposure to temperature change 
at 24, 48 and 72 h. The entire assay was repeated three times; results presented are from a 
single assay and are representative of all repeats. 
 
2.8.2 – CAS media assays for iron uptake 
Strains were inoculated in triplicate into 200 µl KB media in a 96 well plate to an initial 
OD600 of 0.1, with outer wells filled with sterile H2O to minimize evaporation. Replicate 
plates were then covered but not sealed and incubated for 24 h at 28 °C or 22 °C with shaking. 
The next day cells were pelleted by centrifugation (4000 g, 15 min) and 150 µl of supernatant 
was transferred to fresh wells in a flat bottomed 96 well plate. To each well 30 µl of CAS dye 
(prepared as described above) was added using a multi-channel pipette. Plates were 
immediately placed into the plate reader and OD 655 values recorded every 5 min for 50 min, 
then again at 65 min and 125 min. 
 
2.8.2 – EDDHA Inhibitory Concentration (IC50) assays 
A 2-fold serial dilution series of KB media containing from 200-0.195 µg/mL of the iron 
chelator EDDHA was established in 96 well plates. Strains were inoculated in quadruplicate to 
an initial OD 600 of 0.1 from cultures synchronised by sub-inoculation over two nights, giving 
a final volume of 125 µl per well. Unsealed plates were then incubated for 24 h at 28 °C or 22 
°C with shaking. Wells were diluted 1:1 with KB in order to be within the linear range of the 
plate reader, and OD 600 values were measured. For each temperature the assay was repeated 
twice with consistent results.  
     
2.8.3 – Ps1448a pathogenicity tests in Phaseolus vulgaris 
Single colonies from fresh 48 h KB agar plates were picked using a sterile hypodermic needle. 
Strains were then inoculated into snap bean pods (Phaseolus vulgaris) by piercing the surface 
of the bean approximately 5 mm. Each strain was inoculated in triplicate together with a WT 
positive control. Bean pods were then placed in a sealed humid container or alternatively, for 
on plant assessment, pods were left attached to parental plants growing indoors at 20-25 °C. 
 51 
Results were recorded every 24 h. Development of water soaked lesions similar to those of 
WT strain was taken as a positive result. The assay was repeated in triplicate. 
 
2.8.4. – Achromobactin purification 
The protocol for achromobactin purification was adapted from that described in [104]. 
 
Reagents 
Solvent A: 9:1:10 v/v methanol:H2O:ethyl acetate 
Solvent B: 9:1 v/v methanol:H 2O 
 
Procedure 
Two hundred mL of M9 minimal medium, in which succinic acid was the carbon source, was 
inoculated with 10 mL pyoverdine null P. syringae from a stationary phase culture grown in 
the same medium. The resulting culture was grown for 72 h (22 °C, 200 rpm) before removal 
of cells by centrifugation (5000 rcf, 30 min). The supernatant was then sterilised by passing 
through a 0.22 µM filter and then the volume reduced to 20 mL by rotary evaporation 
(temperature not exceeding 45 °C). 180 mL methanol was then added, at which point salt from 
the culture medium precipitated out of solution. Precipitate was removed by centrifugation 
(12,000 rcf, 20 min) followed by filtration (0.45 µM). The solution was then mixed 1:1 with 
ethyl acetate and 100 mL of the resulting solution applied to a glass chromatography column  
containing 40 cc silica beads pre-equilibrated with solvent A. 100 mL Solvent A was then 
applied to the column, followed by 100 mL solvent B. The elutate from the solvent B step was 
captured in 10 mL fractions. Siderophore activity of the fractions was then assessed by adding 
30 µL CAS reagent to a 150 µL aliquot of each fraction and incubating for 10 min at room 
temperature. The fraction which resulted in the greatest discolouration of the CAS dye was 
then reduced in volume to 2 mL by rotary evaporation (temperature not exceeding 40 °C) and 
1 mL of the solution removed. The remaining 1 mL was evaporated to dryness and 
resuspended in 1 mL ddH2O. Both of these 1 mL samples were then sent to the Centre for 
Protein Research at the University of Otago for MS analysis. 
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2.8.5 – Pyoverdine purification 
Pyoverdine purification was achieved using the method described in [105]. Pyoverdine 
containing culture supernatant was prepared as described in Section 2.8.4 except an 
achromobactin null P. syringae was used. The pH of the resulting 200 mL culture supernatant 
was adjusted to 6.0 using concentrated HCl. Approximately 40 mL wet Amberlite XAD-4 
resin, which had been previously activated according to the manufacturer’s directions, was 
then added to the acidified culture supernatant. The mixture was then shaken for ~ 90 min at 
200 rpm, after which the beads were discernibly green, indicating pyoverdine adsorption. The 
supernatant was then discarded and the beads washed five times with 200 mL ddH20 by 
shaking at 200 rpm for 15 min. After this the beads were washed with 500 mL ddH20 (5 min, 
200 rpm), then 500 mL 15 % v/v methanol (5 min, 200 rpm). Pyoverdine was then removed 
from the beads by shaking with 100 mL 50 % v/v methanol (200 rpm, 2h) and the resulting 
solution freeze-dried. Purified pyoverdine was then resuspended in 1 mL ddH2O and, 
following confirmation of siderophore activity by CAS assay, sent to the Centre for Protein 
Research at the University of Otago for MS analysis.  
2.8.6 – Assessment of pyoverdine production in wild type and 
recombinant P. aeruginosa strains 
 
Qualitative assessment of pyoverdine production on agar plates 
Strains were streaked onto KB agar plates with and without 0.4 % arabinose and incubated for 
16 h at 37 °C. Plates were then photographed under natural and UV light. 
 
Quantitative assessment of pyoverdine production  
Synchronised overnight cultures were used to inoculate triplicate cultures for each strain in a 
96 well plate to a uniform density in a final volume of 200 µl. Following 16 h growth (37 °C 
200 rpm) cells were pelleted by centrifugation (4000 rcf, 10 min) and supernatant removed to 
fresh wells. Pyoverdine concentration was analysed by measuring the optical density at 405 
nm and/or emission at 450 nm after excitation at 403 nm. 
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2.8.7 – Determination of intracellular pyoverdine levels by flow cytometry 
 
Triplicate cultures for each strain were established in a 96 well plate as described above. The 
growth medium used was KB supplemented with 0.4 % arabinose. 50 µl from each replicate 
was then collected and pooled in a single 1.5 mL microfuge tube. Cells were then washed 
twice with 1 mL sterile PBS by centrifugation and resuspension. Following the second 
washing step cell suspensions were analysed using an LSRII flow cytometer. Excitation was 
with a violet laser (405nm) and emission detected with a 450/50 bandpass filter. A total of 
5000 events were collected for each condition and events graphed against relative 
fluorescence. 
 
 
2.9 – Protein expression and purification 
 
2.9.1 – Protein expression 
 
2.9.1.1 – Expression under standard conditions 
For expression under standard conditions, an overnight culture (37 °C/200rpm) of the 
expression strain was grown in LB broth containing appropriate antibiotics. An expression 
culture using the same medium was inoculated with this overnight to a final OD 600 of 0.1 
grown at 37 °C/200 rpm until an OD 600 of between 0.6 and 1.0 was reached. At this point 
IPTG was added to a final concentration of 0.5 mM to induce expression. Expression was 
allowed to proceed for 4-6 h before collection of cells by centrifugation (400 rcf, 4 °C, 15 
min) for solubility analysis by SDS PAGE and/or purification.  
 
2.9.1.2 – Betaine sorbitol expression protocol for improving solubility 
For improved solubility of recombinant NRPS proteins, the following modifications were 
applied to the standard expression protocol described in Section 2.9.1.1: 1 M D-sorbitol and 
2.5 mM glycine betaine were included in the overnight starter and expression cultures. The 
overnight culture was grown at 37 °C/200 rpm, the expression culture was grown at 18 
°C/200rpm. Under these conditions it took between 24 and 36 h for an expression culture to 
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reach an OD 600 of 0.6-1.0, at which point expression was induced as previously described. 
Expression was allowed to proceed for a further 24-48 h at 18 °C/200 rpm before harvest of 
cells. 
 
2.9.1.3 – Expression in Pseudomonas hosts 
For expression from Pseudomonas strains, the following amendments were made to the 
standard expression protocol. Growth of starter cultures was conducted using LB broth and 
strain appropriate incubation conditions. Growth of expression cultures was conducted at 25 
°C. A final concentration of 5.0 mM IPTG was used to induce expression. Expression was 
allowed to proceed for 16-24 h before harvest of cells.  
 
2.9.1.4 – Co-expression of molecular chaperone proteins 
Protein expression from a molecular chaperone background was conducted as for standard 
expression except after reaching an OD 600 of 0.6-1.0; cultures were placed at 18 °C/200 rpm 
for 45-90 min before addition of IPTG to induce expression. Expression was allowed to 
proceed for an additional 26-24 h at 18 °C/200 rpm before harvest of cells. Table 2.7 outlines 
the combinations of molecular chaperone proteins expressed by each chaperone strain used in 
this study. 
 
Table 2.7 – Chaperone strains 1-4[106] 
 
 
 
 
 
2.9.1.5 – Auto induction protocol 
An overnight starter culture of the desired strain was grown in LB medium containing 
appropriate antibiotics and 0.4 % w/v D-glucose. This starter culture was then used to 
inoculate ZYP5052 medium expression culture containing appropriate antibiotics. The volume 
of starter culture used to inoculate was 1/50 the amount of ZYP5052 used in the expression 
culture. The expression culture was then incubated at 16 °C/250 rpm until an OD 600 of over 
2.5 was reached, at this point expression levels of target protein were determined by SDS 
Strain Plasmids Chaperone proteins expressed 
1 pBB530 + pBB535 dnaK, dnaJ, grpE 
2 pBB540 + pBB535 dnaK, dnaJ, grpE, clpB 
3 pBB540 + pBB542 dnaK, dnaJ, grpE, clpB, groESL high concentration 
4 pBB540 + pBB550 dnaK, dnaJ, grpE, clpB, groESL low concentration 
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PAGE analysis. If expression was deemed sufficient for subsequent purification, the culture 
was harvested by centrifugation (4000 rcf, 4°C, 15 min). 
 
2.9.2 – Protein purification by Ni-NTA affinity chromatography 
 
2.9.2.1 – Cell lysis and fraction separation 
For protein purification, cell pellets were gently resuspended in 1 x Hisbind™ Binding buffer 
on ice and lysed by either French press or sonication. The amount of buffer used to resuspend 
pellets was 1/20 of the expression culture volume. For lysis by French press three passages at 
40,000 psi were conducted, the French press chamber was chilled to 2 °C prior to lysis. For 
sonication, resuspended cells were placed in an ice bath and sonicated at 70% maximum 
output, with 50% duty cycle and 10 s bursts until consistency indicated sufficient lysis 
(usually 2-3 min). Following lysis, soluble and insoluble fractions were separated by 
centrifugation (17,000 rcf 2°C, 20 min) and the soluble fraction stored on ice until 
purification. 
 
2.9.2.2 – Standard Ni-NTA affinity chromatography 
Unless otherwise noted, purification of 6his-tagged proteins was achieved using a Novgen 
Hisbind™ Ni-NTA chromatography kit, according to the manufactures directions, a final 
volume of 1.5 mL settled resin was used for purification unless otherwise noted. Eluted 
protein was captured in 1.5 mL fractions for analysis by SDS PAGE. The first time any 
protein was purified, flow-through from lysate application and all washing steps was also 
analysed by SDS PAGE to evaluate binding efficiency and wash stringency.  
 
2.9.2.3 – Purification of denatured proteins followed by refolding treatment 
For refolding of denatured proteins, inclusion bodies containing target protein were dissolved 
in binding buffer containing 8 M urea and 1 mM β-mercaptoethanol, passed through a 0.45 
µM filter and applied to a 1.5 mL Hisbind column pre-equilibrated with the same buffer. The 
recommended washing steps were then carried out using buffers with the addition of 8 M urea 
and 1 mM β-mercaptoethanol. A final washing step of 3 mL 1 x binding buffer with 8 M urea 
and 1 mM β-mercaptoethanol was then conducted. After washing a linear concentration 
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gradient of 8-0 M urea was applied to the column over a period of 24 h using the apparatus 
illustrated in Figure 4.15. The total flow through volume used to achieve this gradient was 200 
mL. After urea removal, refolded protein was eluted from the column using standard elution 
buffer according to the manufacturer’s (Novagen Hisbind kit) directions and captured in 1.5 
mL fractions for analysis by SDS PAGE.      
 
2.9.2.4 – Special amendments to purification procedures 
For purification of BpsA it was found that protein binding to the column was weak resulting in 
protein elution during the second more stringent wash step. In order to achieve protein of good 
purity, it was necessary to fully saturate the column’s binding capacity by applying an excess 
of cell lysate. To achieve this, a 2000 mL expression culture was set up using the auto 
induction protocol described in Section 2.9.1.5. The entire soluble fraction (100 mL) resulting 
from this culture was then applied to a 7 mL pre-equilibrated Hisbind resin. Flow-through 
from the soluble fraction was collected and again applied to the column. After this, 
purification was conducted according to the manufacturer’s protocol except the volume of the 
first wash step was tripled and the second wash step eliminated.  
 
For purification of PPTase enzymes it was found that proteins precipitated immediately once 
eluted from the column. To prevent this 10 % v/v glycerol was added to all His bind buffers 
and all buffers kept ice cold during the purification. Following elution all fractions were 
immediately desalted and stored at -20 °C in 50 mM sodium phosphate buffer (pH 7.8) 
containing 50 % w/v glycerol. 
  
2.9.2.5 – Buffer exchange, storage and quantification of recombinant proteins 
Buffer exchange was achieved using GE Healthcare Hitrap™ desalting columns, according to 
the manufacturer’s protocol. Storage buffer for proteins was 50 mM Tris-Cl 50% w/v glycerol, 
the pH of which was the same as that of the assay solution in which proteins were to be 
employed. Proteins were stored at -20 °C and kept on ice at all times when in use. 
Quantification of recombinant proteins was achieved using Biorad DC Kit according to the 
manufacturer’s directions. 
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2.9.3 – SDS-polyacrylamide gel electrophoresis 
SDS-PAGE was performed using 12 % SDS-polyacrylamide gels prepared according to the 
method of Laemmli [107]. Gels were cast and run using the Biorad Protean II ™ system, 
according to the manufacturer’s directions. Preparation of samples, as well as gel staining and 
destaining, was carried out as described by Sambrook and Russell [108]. 
 
2.9.3.1 – Molecular weight markers 
Two molecular weight markers for the estimation of protein size were employed in this study. 
Gels pictured in Chapter 4 used Fermentas broad range molecular weight marker while those 
pictured in Chapter 7 used NEB broad range molecular weight marker. The molecular weight 
of each band present in these markers is shown in Figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 – Molecular weight markers used in this study 
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2.10 – A-domain specificity assays 
 
2.10.1 – ATP/32PPi exchange assays  
These protocols are based on the original method described  in [109]. 
Reagents 
Stop solution: 3.5 % w/v perchloric acid, 100 mM PPi, 1.6 % w/v activated charcoal 
PPi washing solution: 100 mM PPi, pH 8.0 
Elution buffer: 0.3 M ammonia in 50 % v/v methanol  
 
EA1 protocol 
Triplicate 100 µL reactions were set up for each substrate in 1.5 mL microfuge tubes. Each 
reaction contained 2.5 mM ATP, 5 mM aa substrate, 0.5 mM EDTA, 12.5 mM MgCl2, 2.5 
mM 32PPi [0.0028 µCi/mM], 2.5 µg enzyme, 25 mM tris pH 7.7. Enzyme was added last to 
initiate reactions. Triplicate no-enzyme and no-enzyme/no-substrate controls were also run. 
Reactions were incubated at 28 °C for 30 min before termination by addition of 400 µL stop 
solution. Terminated reactions were mixed briefly and charcoal collected by application to a 
0.45 µM filter by syringe. Collected charcoal was then washed three times with 3 mL PPi 
washing solution and two times with 5 mL ddH2O. ATP was then eluted from the charcoal by 
application of 6 mL elution buffer, which was collected in a scintillation vial containing 9 mL 
ddH20. Cerenkov counts were then measured directly from scintillation vials using a Wallac 
1400 liquid scintillation counter.   
 
EA2 protocol 
Triplicate 100 µL reactions were set up for each substrate in 1.5 mL microfuge tubes. Each 
reaction contained: 2 mM ATP, 5 mM aa substrate, 0.5 mM EDTA, 10 mM MgCl2, 100 mM 
NaCl, 0.1 mM 32PPi [7 µCi/mM] , 2.5 µg enzyme, 50 mM tris pH 7.7. Enzyme was added last 
to initiate reactions. Reactions were incubated at 28 °C for 30 min before termination by 
addition of 200 µL stop solution. Terminated reactions were mixed briefly and charcoal 
collected by centrifugation (13,000 rpm 1 min). Charcoal was then washed two times with 1 
mL ddH2O. After the final wash step charcoal pellets were resuspended in 1 mL ddH2O and 
transferred to scintillation vials containing 14 mL ddH2O. Vials were left for 30 min to allow 
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charcoal to settle. Cerenkov counts were then measured directly from scintillation vials using a 
Wallac 1400 liquid scintillation counter.   
 
2.10.2 – PPi release assay RA1 
This assay is based on the method described in [110] and measures PPi liberated from ATP by 
and A-domain in the presence of an amino acid substrate. The rate of PPi release is indicative 
of substrate preference. PPi is detected in a two step enzymatic reaction. Firstly PPi is cleaved 
into two equivalents of Pi by inorganic pyrophosphatase (IP), Pi created in this fashion is then 
linked to 2-amino-6-mercapto-7-methylpurine ribonucleoside (MESG) by purine nucleoside 
phosphorylase (PNP). The addition of Pi to MESG results in a shift of absorbance maximum 
form 330 to 360 nM. Absorbance at 360 nM is therefore an indirect measure of the amount 
PPi liberated from ATP by an A-domain. 
 
End point assay 
 
Reagents 
Detection reagent: 0.5 mM MESG, 1 U PNP 0.03 U IP, 50 mM Tris-HCl (pH 7.7)  in sterile 
ddH2O. 
 
Triplicate reactions for each substrate were established in a 96 well plate and contained, in a 
final volume of 100 µL: 50 mM Tris-HCl (pH 7.7), 10 mM MgCl2, 1 mM ATP, 5-20 µg 
enzyme and 1.25 mM aa substrate. Reactions were then incubated for 60 min at 28 °C, after 
which 100 µL detection reagent was added. Plates were then incubated at room temperature 
for 20 min before measurement of A360 using a microplate reader. For PPi standard curve 
generation, 100 µL detection reagent was added to mock reactions, without enzyme or 
substrate, containing a triplicate two fold serial dilutions series (40-2.5 µM) of sodium 
pyrophosphate followed by incubation and A360 measurement steps. 
 
Continuous release assay 
Triplicate reactions for each substrate were established in a 96 well plate and contained in a 
final volume of 100 µL: 50 mM Tris-HCl (pH 7.7), 10 mM MgCl2, 1 mM ATP, 5-20 µg 
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enzyme, 0.25 mM MESG, 1 U PNP, 0.03 U IP and 2 mM aa substrate. Reactions were 
initiated by addition of enzyme and the plate incubated in a microplate reader set to take A360 
measurements every 60 s.  
 
2.10.3 – PPi release assay RA2 
This assay is based on the method described in [111]. Like RA1 it detects A-domain activity 
by measuring levels of PPi released from ATP and then cleaved into two equivalents of Pi by 
IP. Addition of the detection reagents results in the formation of a green complex, the amount 
of which is proportional to Pi levels in the sample. 
 
Detection Reagents 
PPgreen reagent A: 4.2 % w/v sodium molybdate in 4 M sulfuric acid 
PPgreen reagent B: 0.135 % w/v brilliant green dye in sterile ddH2O 
 
Triplicate reactions for each substrate were established in a 96 well plate and contained in a 
final volume of 100 µL: 50 mM Tris-HCl (pH 7.7), 10 mM MgCl2, 1 mM ATP, 5-20 µg 
enzyme, 0.03 U IP and 1.25 mM aa substrate. Plates were then incubated for 30 min at 28 °C, 
after which reactions were terminated by addition of 20 µL PPgreen reagent A per well. Plates 
were then tapped gently to mix, and 20 µL PPgreen reagent B added to each well. Plates were 
again mixed by tapping and A650 measured immediately using a microplate reader. For PPi 
standard curve generation, mock reactions, without enzyme or substrate, containing a triplicate 
two-fold serial dilutions series (50 – 0.25 µM) were used. 
 
2.11 – Directed evolution Protocols 
The protocols used for directed evolution were continually refined throughout the course of 
this study and the final optimised version of each aspect is given below. These protocols allow 
the generation of libraries of 1-5x106 insert containing clones from a single epPCR reaction. 
Libraries of this size were more than sufficient for recovery of multiple improved clones.  
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2.11.1 – Library generation 
 
2.11.1.1 – Vector preparation 
For preparation of vector for directed evolution, 16 µg of plasmid DNA (prepared as described 
in Section 2.7.1) was heated to 70 °C for 20 min to relieve super-coiling and then digested 
with 50 U of each restriction enzyme in a final volume of 400 µL. Buffer composition and 
incubation temperature was as recommended by the enzyme manufacturer. After 5 h 
incubation, an additional 20 U of each enzyme was added, and the digest incubated for a 
further 12-14 h. Following this, digests were heat inactivated (80 °C, 20 min) and purified 
using a 20 µg capacity zymospin® clean up column. Digested vector was eluted from the 
clean up column using 30 µL sterile ddH2O and the concentration of the resulting solution 
determined. This was generally between 250-350 ng/µL. A 200 ng sample of vector was then 
analysed by agarose gel electrophoresis to ensure no degradation had occurred. Aliquots of 5 
µL were then prepared and stored at – 20 °C.   
 
2.11.1.2 – Determination of vector quality 
Before being employed in directed evolution experiments the quality of prepared vector was 
assessed. To achieve this, the native T-domain of bpsA was amplified using Phusion® high 
fidelity polymerase and prepared for ligation as described in Section 2.11.1.4. A control 
ligation was then set up as described in 2.11.1.5, except with digested bpsA T-domain in place 
of epPCR. The ligation was then transformed into chemically competent cells (2.7.2.1) 
harbouring an activating PPTase and aliquots of the transformation mixture plated on pigment 
development agar (LB, 100 mM L-gln, 0.5 mM IPTG). Plates were then incubated for 12-14 h 
at 37 °C before induction of protein expression and as described in 2.11.2. Plates were then 
left at room temperature for 12-16 h before determination of transformation efficiency and 
percentage of colonies containing insert. Determination of insert percentage was achieved by 
counting blue and white colonies on an entire plate (containing at least 200 colonies). Blue 
colonies indicated correct ligation of the T-domain insert into the prepared vector, white 
colonies indicated vector self ligation or out-of-frame ligation. If the percentage of blue 
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colonies was 70 or higher, the vector was deemed of sufficient quality for use in directed 
evolution experiments.  
   
2.11.1.3 – Error prone PCR 
Error prone PCR was carried out using a Stratagene Mutazyme II® kit, according to the 
manufacturer’s directions. Optimal error rate (as assessed by number of improved clones 
recovered) was achieved using 100 ng of purified PCR product as template per 50 µL reaction, 
with 30 amplification cycles. Template was prepared by amplification of the appropriate T-
domain sequence using Phusion polymerase. Prior to thermocyling, reactions were divided 
into four to reduce the number of clonal mutations in the final library. Amplicon size and 
quality was assessed by agarose gel electrophoresis of a 3 µL aliquot. 
 
2.11.1.4 – Insert preparation 
50 µL epPCR reactions were purified using a 5 µg capacity zymospin® column, with elution 
achieved using 20 µL sterile ddH2O. The entire eluent was then digested for 5 h with 30 U of 
each enzyme, in a final volume of 50 µL. Buffer composition and incubation temperature was 
as recommended by the enzyme manufacturer. Following digest, reactions were heat 
inactivated (80 °C, 20 min) and purified using 5 µg capacity zymospin® column (elution 
volume 20 µL, sdH20).  
 
2.11.1.5 – Ligation 
Ligations were set up as described in 2.7.1 with the following amendments: Total amount of 
DNA per ligation was 1.0-1.5 µg. Ligations were incubated overnight at 16 °C, after which an 
additional 2 U of ligase were added, and the reaction incubated for a further 8 h at 16 °C. The 
optimal molar ratio of vector to insert for achieving maximum ligation efficiency was found to 
be 1:6. 
 
2.11.1.6 – Control reactions 
One positive and two negative control reactions were run for each directed evolution 
experiment. For the positive control, the native T-domain of BpsA was amplified using high-
fidelity polymerase, digested and ligated and transformed using the same conditions as for ep-
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library generation. The purpose of the positive control was to give a reliable estimate of 
percent insert containing clones using the process described in Section 2.11.1.2. The first 
negative control reaction was set up in the same way, except using the T-domain to be 
evolved, amplified with high fidelity polymerase. Inclusion of this negative control was 
important to check for contamination of pcr reagents with WT bpsA DNA, which would result 
in a large number of false positives. The second negative control was a plasmid containing the 
original recombinant bpsA gene which the experiment aimed to improve. Colonies arising 
from transformation of this control were used as a reference point for determination of 
improved clones. 
 
 
2.11.1.7 – Transformation and library storage 
Prior to transformation, ligations were purified using a 5 µg capacity Zymospin column 
(elution volume 20 µL, sdH2O). Purified ligations were then transformed into 
electrocompetent E. coli BL21 cells, harbouring a plasmid for expression of an activating 
PPTase. Electrocompetent cells were prepared and transformed as described in Section 
2.7.2.2, with the following amendments: The volume of cells used was 60 µL per 50 ng 
ligation to be transformed. Cells and ligations were mixed on ice and then aliquoted into 
chilled cuvettes (80 µL/cuvette). Following electroporation, 1 mL SOC medium was 
immediately added to each cuvette. All cells for a single ligation were then pooled in a single 
15 mL tube and recovered for 1 hr (37 °C, 200 rpm). Following recovery, cells were mixed 1:1 
with sterile 80 % glycerol and 0.5 mL aliquots dispensed. These aliquots were then placed at -
80 °C. A single aliquot was then thawed on ice and serial dilutions plated on pigment 
development agar (LB, 100 mM L-gln, 0.5 mM IPTG) containing appropriate antibiotics in 
order to determine the optimal plating volume for screening. Libraries stored as frozen 
transformation aliquots remain viable for at least 3 months. For evolution of oDhbF, libraries 
were transformed into chemically competent cells. The use of electrocompetent cells was 
subsequently adopted to improve transformation efficiency.  
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2.11.2 – First tier screening 
For screening, cells were thawed on ice and plated on LB agar containing 100 mM L-gln and 
strain appropriate anitbioitcs. The volume of cells used per plate was adjusted so that ~ 10,000 
insert containing clones would be present. After 12 h of incubation at 37 °C, expression was 
induced in plates. Induction was achieved by IPTG addition using the method described in 
Section 6.5.1. Plates were then incubated at ~ 20 °C and monitored for colour development. 
Colonies which developed colouration before negative controls were taken to be hits. These 
putative improved clones were picked from plates and small scale overnight growth cultures 
set up for preparation of glycerol stocks. Due to the high density of colonies on a single plate, 
it was often impossible to recover improved clones without risk of contamination. In such 
cases, clones were picked as accurately as possible using a toothpick and resuspended in 100 
µL GYT. Single colonies were obtained by streaking this suspension on a portion of an agar 
plate. Subsequent induction of this plate allowed recovery of improved clones without 
contaminants. Improved clones were then grown overnight in LB medium supplemented with 
0.4 % glucose and appropriate antibiotics. Duplicate glycerol stocks of improved clones were 
then prepared in a 96 well plate.    
 
2.11.3 – Second tier screening 
For second tier screening, up to 45 improved clones, along with a positive and negative 
control, were stored as duplicate glycerol stocks in a 96 well plate. From this plate duplicate 
overnight cultures were established in LB supplemented with 0.4 % glucose and appropriate 
antibiotics. Set up of overnight cultures was achieved in a 96 well plate using a 96-pin 
inoculating tool. Overnight cultures were grown for 16-20 h (37 °C 200 rpm) before transfer 
of 20 µL of each culture into a fresh well containing 130 µL LB supplemented with 115 mM 
L-gln, 0.6 mM IPTG and appropriate antibiotics. Assay plates set up in this fashion contained 
duplicate cultures for each clone from two separate overnights. Assay plates were then 
wrapped in foil and incubated for 6-24 h (18 °C, 200 rpm), depending on activity of improved 
clones. After incubation cells were collected at the corner of each well by centrifugation and 
OD 590 values determined using a microplate reader. Assays were repeated at least twice 
before determination of clones for sequence analysis. 
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2.12 – Indigoidine quantification  
In vivo pigment synthesis efficiencies for recombinant BpsA proteins described in Section 6.6 
required multiple assays using the protocol outlined in Section 2.11.3. Each of these assays 
was terminated at a different time point between 3 and 36 h. This was necessary due to the fact 
that pigment synthesis for more efficient proteins was found to saturate before activity of 
slower proteins was detectable. The values presented are derived as follows: quadruplicate 
values for slBpsA (WT) and oBpsA were determined after 3 h, at which point pigment 
production was not saturated for WT. A separate quadruplicate assay was then run to obtain a 
value for slEntF by comparison to oBpsa after 12 h. Quadruplicate values for oPsT and  nBpsa 
were then obtained in a separate assay by comparison to slEntF after 36 h. The activity of 
oDhbF and oEntF was too low to detect by measurement of supernatant OD 590 however 
these variants did produce discernable pigmentation after 48 h incubation on pigment 
development agar. The remaining variants did not produce discernable pigmentation, 
appearing identical to an empty plasmid control on pigment development agar. These variants 
were deemed completely inactive. 
 
2.13 – Enzyme kinetics 
 
2.13.1 – Activation of BpsA by 4’-PP attachment 
Reactions for pre-activation of BpsA prior to use in kinetic assay (2.13.2) contained: 0.83 µM  
BpsA, 1 µM PP1183 (PPTase), 1 mM MgCl2, 0.1 mM CoA and 50 mM sodium phosphate 
buffer pH 7.8. Reactions were incubated for 30 min at 28 °C.   
 
2.13.2 – Determination of kinetic parameters for BpsA 
For derivation of kinetic parameters a two-fold serial dilution series from 20-0.156 mM ATP 
was established in triplicate in a final volume of 100 µL in a 96 well plate. Each well also 
contained: 4 mM L-gln, 1 mM MgCl2 and 50 mM sodium phosphate buffer pH 7.8. Reactions 
were initiated by addition of 100 µL activated BpsA solution and A590 readings taken every 
10 s in a microplate reader. Maximum velocity values for each reaction were determined by 
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measuring the steepest gradient over six consecutive data points using Softmax Pro®. 
Derivation of kinetic parameters was achieved by analysis of data using the one site saturation 
regression function of SigmaPlot®. 
 
2.13.3 – Determination of kinetic parameters for PPTases 
Reactions were established for a duplicate two-fold serial dilution series from 25.0-0.78 µM 
CoA in a 96 well plate. In addition to CoA, each reaction contained, in a final volume of 200 
µL: 4 mM L-gln, 1 mM ATP, 1.64 µM BpsA (inactive), 1.03 µM PPTase. BpsA was added 
last to initiate reactions and A590 readings taken every 10 s in a microplate reader. Average 
velocity of the pigment synthesis reaction between every three data points (20 s) was 
determined using Softmax Pro®. Velocity values were plotted using Microsoft Excel® and a 
maximum acceleration value determined from the linear portion of the resulting plot. 
Maximum acceleration values were analysed using Sigmaplot® to derive kinetic parameters. 
The units for the Vmax values derived from this analysis were “change in gradient per 
second”; the calculations used to convert these into “amount of BpsA activated per second” 
are outlined in Appendix 2. 
 
2.14 – Screening of soil derived eDNA library for PPTase genes 
 
The protocol used for eDNA library screening is essentially the same as that outlined in 
Sections 2.11.1.7 and 2.11.3 except electrocompetent BL21 cells did not contain an activating 
PPTase and instead contained the plasmid for expression of WT BpsA. Following recovery, 
plasmid DNA was prepared from hits and isolation of the pRSET plasmid containing the 
eDNA insert for sequencing was achieved by transformation into chemically competent E. 
coli cells followed by selection on medium containing ampicillin only. Inserts were sequenced 
using both T7 promoter and T7 terminator primers which anneal to plasmid sequences 
immediately upstream and downstream of the insert respectively.     
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2.15 –In silico manipulation using Vector NTI and DeepView 
 
2.15.1 – Design of scheme three for seamless T-domain substitution into 
BpsA 
Substitution scheme three (Section 6.5.3) achieves a seamless transition between BpsA 
sequence and the sequence of a substituted T-domain by utilising silent restriction sites that do 
not alter aa sequence of the protein arising from expression constructs. The program 
VectorNTI® (VNTI) was used to identify silent restriction site candidates and design primers 
for generation of swapping plasmid as follows:  
1) A list of restriction enzymes that do not cut the vector (pCDFduet1), BpsA gene or T-
domain inserts was generated using the restriction report function of VNTI.   
2) The resulting enzymes were then saved as a subset in the restriction enzyme database of 
VNTI. Additional hybrid sequences which arise from the ligation of two separate restriction 
enzyme cuts producing compatible ends were entered into the database manually and were 
also saved in this subset.  
3) Positions at which these restriction sites could be introduced were then determined using 
the mutagenesis function of VNTI. This resulted in the identification of a hybrid NsiI-PstI site 
upstream and a hybid XbaI-SpeI site downstream of the region of T-domain substitution.  
Introduction of these hybrid sites did not alter aa sequence encoded at the splice point.  
4) Primers were then designed to amplify the regions up and downstream of the T-domain of 
BpsA using the amplify selection function of VNTI. The products of amplification by these 
primers were cloned into pCDFduet to generate a staging vector.  
5) For amplification of T-domains for substitution into the staging vector the amplify selection 
function was again used. The BpsA sequence between the silent splice points and the desired 
point of T-domain introduction was added manually to the 5’ end of the up and downstream 
primers as illustrated in Figure 2.2. The exact location of the transition points between BpsA 
sequence and that of an introduced T-domain is illustrated in Figure 6.6. 
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Figure 2.2 – Substitution scheme three cloning 
strategy 
Amplification of the regions up and downstream of the BpsA 
T-domain using primers A+B and C+D respectively allowed 
generation of a construct in which the BpsA gene lacked its 
native T-domain and contained an NsiI and a SpeI site into 
which foreign domains could be introduced. Primers E and F 
for amplification of substitute T-domains (PvdD T-domain in 
this example) had 5’ sequence elements added that would 
replace the missing BpsA sequence indicated by the blue and 
green lines. Ligation of T-domains into BpsA resulted in an 
upstream NsiI-PstI hybrid site and a downstream XbaI-SpeI 
hybrid site, indicated by dark blue bars. Introduction of these 
sites did not alter the aa sequence encoded at these points. 
The result of this is a seamless transition between BpsA 
sequence (light blue) and T-domain sequence (red).  
 
 
2.15.2 – Structural modelling  
The structural model of the T-TE interaction region of BpsA presented in Chapter 6 was 
generated using the first conformer of PDB file 2roqA (solution structure of the T and TE 
domains of E. coli EntF) as a template. Determination of suitability of this template and 
generation of an alignment was achieved using the template identification tool of the Swiss 
Model SIB server (http://swissmodel.expasy.org/). The resulting alignment was visualised in 
DeepView and subjected to preliminary visual assessment to ensure that conserved elements 
of the T-domain in the target and template structures occupied equivalent positions. The 
preliminary model was then submitted to the online server for refinement. Following 
refinement it was found that the loop region between the T and TE-domains was poorly fitted 
to the 2roq template, alternative conformations of this region were generated using the 
iterative magic fit, explore alternative conformation and energy minimisation functions of 
DeepView. Alternative fits were subjected to preliminary analysis using DeepView and those 
containing residues making clashes or buried charges not present in 2roq were discarded. This 
resulted in a three separate models in which the loop region between the T and TE-domains of 
BpsA was in a similar conformation to that seen in 2roq. These models were again submitted 
for refinement. The quality of the refined models was then assessed using the Qmean [112] 
online server. The model which returned the highest score from this assessment is presented in 
Chapter 6.  
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Chapter 3 – Siderophores in Pseudomonas syringae: 
Synthesis and physiological significance 
 
3.1 – Summary 
 
Pseudomonas syringae pv. phaseolicola 1448a (Ps1448a), the causative agent of bean halo 
blight, is a bacterium capable of occupying diverse biological niches. Under conditions of iron 
starvation Ps1448a synthesises siderophores for active uptake of iron. The primary 
siderophore of Ps1448a is pyoverdine, a fluorescent molecule that is assembled from aa 
precursors NRPS.  Five putative pyoverdine NRPS genes in Ps1448a were identified and 
characterised in silico and their role in pyoverdine biosynthesis was confirmed by gene 
knockout. Creation of pyoverdine null Ps1448a enabled identification of a previously 
uncharacterised temperature-regulated secondary siderophore, achromobactin, which is not 
synthesised by NRPS and has a lower affinity for iron. Pyoverdine and achromobactin null 
mutants were characterised in regard to iron uptake, virulence and growth in iron limited 
conditions. Results of these studies show that although achromobactin has potential to 
contribute to fitness under iron-limiting conditions, these effects are masked by the presence 
of pyoverdine, which is a significantly more effective siderophore. Neither pyoverdine nor 
achromobactin appear to be required for Ps1448a to cause bean halo blight, indicating that 
these siderophores are not promising targets for crop protection strategies. Ps1448a also has 
the genetic potential to synthesise a third siderophore, yersiniabactin although no evidence 
was found that this siderophore was produced during iron starvation, and deletion of a 
yersiniabactin NRPS from the chromosome of Ps1448a did not impair pathogenicity. Both 
achromobactin and pyoverdine were purified from the culture supernatant of iron starved 
Ps1448a for analysis by mass spectrometry. MALDI TOF and MS/MS analysis allowed the 
assignment of structures for both of these molecules. The characterisation work described in 
this chapter allowed a functional role to be assigned to each of the modules in the pyoverdine 
biosynthetic NRPS of Ps1448a. This was an important prerequisite for the module swapping 
experiments described in Chapter 5 of this thesis. 
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3.2 – Introduction 
 
Acquisition of iron is essential for bacterial growth. However, due to insolubility at neutral pH 
the bioavailability of iron is extremely low in most environments. To circumvent this problem 
many bacteria respond to iron starvation by synthesising high affinity iron-chelating molecules 
known as siderophores. These siderophores are secreted into the extracellular environment 
where they bind ferric iron and are then actively transported back into the cell via specific 
ferric-siderophore receptors [113]. Siderophores are especially important in the biology of 
fluorescent pseudomonads, a genus renowned for occupying a very wide range of 
environmental niches. These bacteria synthesise the peptide-derived molecule pyoverdine as 
their primary siderophore, together with secondary siderophores which have lower affinity for 
iron [114]. Although pseudomonads are not obligate pathogens, many species are capable of 
causing disease in a wide variety of hosts [115, 116]. As iron restriction is a key host defence 
mechanism, pyoverdine is frequently identified as an important virulence factor [114, 117].  
 
3.2.1 – Pyoverdine synthesis in fluorescent pseudomonads 
Pyoverdine is synthesised from aa precursors by NRPS [118, 119]. It is pyoverdine that 
provides the fluorescent Pseudomonas species with their defining fluorescence and yellow-
green pigmentation under conditions of iron limitation [120]. These properties derive from an 
invariant dihydroxyquinoline chromophore, to which is attached an acyl moiety and a strain-
specific peptide side chain [121]. More than 50 different pyoverdine structures have been 
described to date [122] and the variability of the peptide side chain of pyoverdines from 
different strains reflects rapid evolution of both the NRPS that synthesise this side chain and 
the outer membrane receptors that recognise ferric pyoverdine [123]. Analysis of the 
pyoverdine locus of different P. aeruginosa strains has shown that it is the most divergent 
region in the core genome and that its evolution has been substantially shaped by horizontal 
gene transfer [105, 123, 124]. The diversification of pyoverdine structures is particularly 
interesting when viewed in the context of recent NRPS manipulation experiments [1, 14, 81] – 
the barriers to variation of pyoverdine structures that have evidently been surmounted by 
genetic recombination and evolution of the corresponding NRPS modules are the same 
barriers that often preclude artificial modification of biotechnologically relevant NRPS 
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systems [85, 125]. The wide variety of pyoverdine structures that derive from a limited pool of 
NRPS modules arranged in different combinations – together with the genetic tractability of 
many Pseudomonas species and the ability to detect pyoverdine production at nanomolar 
levels by UV-fluorescent screening [126] – make the pyoverdine synthetases potentially a very 
attractive model system to study NRPS recombination. However, in terms of providing ‘raw 
material’ for such work, experimental studies of pyoverdine NRPS genes to date have 
primarily focused on just a single species, P. aeruginosa. This work aimed to extend this focus 
to another fluorescent pseudomonad, Pseudomonas syringae pv. phaseolicola 1448a 
(Ps1448a), which secretes an alternative form of pyoverdine to PAO1. The NRPS modules 
characterised in this work provide the raw material for subsequent manipulation experiments 
described in Chapter 5. 
  
3.2.2 – Regulation of pyoverdine synthesis 
Regulation of pyoverdine synthesis has been most extensively studied in P. aeruginosa, 
however the proteins involved in this regulatory mechanisms are found in other fluorescent 
pseudomonads [127, 128] and the regulatory pathways elucidated for P. aeruginosa are 
thought to be representative of all fluorescent Pseudomonas species [129]. Pyoverdine 
synthesis is regulated by Fur (ferric uptake regulator) protein, the master regulator of iron 
responsive genes in Pseudomonas and other bacteria. When complexed with Fe2+, Fur 
represses the expression of genes containing a “Fur box” in their promoter sequence by 
binding to this element. During iron starvation, Fur is not complexed with Fe2+ due to low 
intracellular concentration. As a result Fur mediated repression of genes containing a Fur box 
is relieved [127, 128].  
 
As with many iron responsive genes, those involved in pyoverdine biosynthesis and 
export/import are not directly regulated by Fur and do not contain Fur boxes in their 
promoters. Rather, regulation is indirectly mediated by Fur via expression of the sigma factors 
pvdS and fpvI and the anti-sigma factor fpvR. During iron starvation Fur repression of these 
genes is relieved, leading to their expression. The presence of PvdS enables expression of 
pyoverdine genes by association of this sigma factor with the core subunit of RNA polymerase 
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(RNAP). Once in association with PvdS, RNAP is able to initiate transcription of pyoverdine 
genes at an element in their promoter known as the iron starvation (IS) box [119, 127, 128].   
 
Expression of pyoverdine transport and biosynthetic genes is also positively regulated by 
binding of ferric (holo) pyoverdine to its outer membrane receptor FpvA. When pyoverdine is 
not successfully scavenging iron from the environment, apo-pyoverdine is bound to FpvA. In 
this state the anti-sigma factor FpvR which is associated with the membrane receptor complex 
sequesters PvdS at the inner face of the bacterial membrane, down-regulating expression of 
pyoverdine transport and biosynthetic genes. Conversely, the binding of holo pyoverdine to 
FpvA causes the release of PvdS and up-
regulation of expression. Due to this dual 
regulatory mechanism, pyoverdine 
biosynthesis and transport is maximally 
induced only when cells are starved of 
iron and pyoverdine is able to 
successfully sequester iron from the 
environment [119, 127, 128, 130]. Figure 
3.1 outlines pyoverdine regulation in P. 
aeruginosa. 
 
 
 
Figure 3.1 – Regulation of pyoverdine synthesis and transport in P. aeruginosa 
When intracellular iron concentration is low, Fur repression of pvdS and fpvR expression is relieved. Association 
of PvdS with the core subunit of RNAP enables transcription of pyoverdine biosynthesis and transport genes. An 
additional layer of regulation is provided by the anti-sigma factor FpvR. In the absence of ferri-pyoverdine 
binding to its receptor FpvA, PvdS is sequestered at the cytosolic face of the cell membrane by FpvR. Binding of 
ferri-pyoverdine to FpvR induces release of PvdS by an unknown mechanism resulting in up-regulation of 
expression of pyoverdine biosynthesis and transport genes. Figure reproduced from [130]. 
 
3.2.3 – NRPS independent siderophores 
During the course of this study pyoverdine null mutants were generated, revealing that 
Ps1448a produces achromobactin as a secondary siderophore, and enabling us to genetically 
and functionally characterise this siderophore also. In contrast to pyoverdine, achromobactin is 
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synthesised by a mechanism that is entirely independent of NRPS enzymes. NRPS-
independent siderophores have been studied much less intensively than their NRPS-dependent 
counterparts, and their mechanisms of synthesis have only recently begun to be deciphered. 
Three types (A, B and C) of NRPS-independent siderophore synthetase enzymes have been 
identified to date, each responsible for the attachment of a different functional group to a citric 
acid backbone [131, 132]. The achromobactin biosynthetic pathway is a particularly valuable 
resource for the study of these enzymes as it relies on the action of all three types of synthetase 
[131, 133]. Achromobactin has been shown to be important for virulence and growth under 
iron limitation in Dickeya dadantii (formerly Erwinia chrysanthemi)[134], but the contribution 
of achromobactin to these activities in Ps1448a has not previously been characterised. We 
therefore examined the roles of both achromobactin and pyoverdine in virulence of Ps1448a, 
as well as their relative contribution to iron uptake and growth under more precisely defined 
conditions.   
 
3.3 – Identification and in silico characterisation of the pyoverdine 
NRPS genes 
The biosynthesis of pyoverdine has been extensively studied in P. aeruginosa PAO1; most, if 
not all, of the genes required for pyoverdine synthesis in this strain have now been identified 
[121, 127, 135]. Unlike P. aeruginosa, P. syringae does not appear to exhibit a high degree of 
variability in pyoverdine structure from strain to strain; all fluorescent P. syringae strains 
examined thus far produce an identical pyoverdine molecule [136, 137]. We made use of the 
publicly available genome sequence for Ps1448a [138] (GenBank accession numbers 
CP000058 to 60) to carry out an in silico analysis of Ps1448a pyoverdine genes. This was 
achieved by conducting a BLASTP search of individual sequences from proteins known to be 
involved in pyoverdine synthesis in PAO1 against the Ps1448a protein database. Results of 
this analysis are summarised in Table 3.1, with PAO1 functions as described in [127]. The 
genomic organisation of pyoverdine genes in Ps1448a is similar, but not identical, to that of 
PAO1 (Figure 3.2). The only PAO1 gene that clearly lacks an ortholog in Ps1448a is PvdF, an 
enzyme required for generating the N5-formyl-N5-hydroxyornithine residues that are present in 
the PAO1 (but not Ps1448a) pyoverdine sidechain. In its place Ps1448a contains a gene 
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(Pspph1922; marked * in Figure 1) with a predicted protein product that is 37 % identical to 
the aspartate hydroxylase SyrP, required for synthesis of the NRPS-derived phytotoxin 
syringomycin in Pseudomonas syringae pv. syringae [78]. Pspph1922 very likely catalyses β-
hydroxylation of the two hydroxyaspartate residues that play an equivalent iron-chelating role 
to the N5-formyl-N5-hydroxyornithine residues of PAO1 pyoverdine.  
 
Table 3.1 – Summary of PAO1 and Ps1448a pyoverdine gene alignment results 
 PAO1 gene Function in P. aeruginosa PAO1 Ps1448a ortholog(s)† 
1 pvdY Regulatory protein 1515 
2 pvdX Regulatory protein 3568 
3 pvdS ECF iron sigma factor 1909 
4 pvdG Thioesterase (34% identity with GrsT thioesterase from 
Bacillus brevis) 
1910 
5 pvdL Chromophore peptide synthetase 1911 
6 pvdH Aminotransferase 1912 
7 Pa2412 MbtH-like protein (no known function) 1913 
8 Pa2411 Thioesterase (36% identity with thioesterase GrsT 
from Bacillus brevis) 
1910 
9 Pa2403-2410 No known function, however expression of these genes 
is co-regulated with pyoverdine synthesis genes. 2408 
and 2409 are predicted to encode an ABC transporter 
1914-1921 
* Not present (Likely pyoverdine aspartate hydroxylase of Ps1448a) 1922 
10 pvdDIJ Pyoverdine side chain NRPS 1923-1926 
11 fpvA Ferripyoverdine receptor protein 1870, 1927, 1928 
12 pvdE ABC transporter (secretion) 1929 
13 pvdF N5-hydroxyornithine transformylase Not present 
14 pvdO No known function 1930 
15 pvdN 26% identity with isopenicillin N epimerase from 
Streptomyces clavuligerus 
1931 
16 pvdM Dipeptidase (23% identity with porcine dipeptidase) 1932 
17 pvdP No known function 1933 
18 Pa2391 Porin (over 30% identity with outer membrane factor 
(OMF) proteins of RND/MFP/OMF-type efflux 
systems) 
1934 
19 Pa2390 ABC transporter (over 40% identity with resistance-
nodulation-division (RND)-type transporter 
components of RND/MFP/OMF-type efflux systems) 
1935/macB 
20 Pa2389 Periplasmic protein (over 30% identity with 
periplasmic membrane fusion proteins (MFP) of 
RND/MFP/OMF-type efflux systems) 
1936 
21 fpvR Antisigma factor for PvdS and FpvI 2117, 4764 
22 fpvI ECF sigma factor required for expression of fpvA 4765, 1175, 1093, 
2747, 1909 
23 pvdA L-ornithine hydroxylase 2415, 3753 
24 pvdQ Acylase (38% identity with Aculeacin A acylase from 
Actinoplanes utahensis) 
1937 
 
†Gene numbers for Ps1448a are as annotated in the Pseudomonas genome database. Genes were presumed to be 
orthologs if they belonged to the same COG group. Hits are listed in order of significance, with those falling 
within the Ps1448a pyoverdine locus (as pictured in Figure 1) listed in bold. 
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Figure 3.2 – A Comparison of the pyoverdine loci of P. aeruginosa PAO1 and Ps1448a 
The core PAO1 pyoverdine genes fall into two closely linked clusters, 11 kb apart. In contrast, the core Ps1448a 
genes form a single contiguous cluster. Genes are colour coded according to their function, as indicated in the 
key; and orthologous genes in each organism have been assigned the same number, corresponding to the 
annotations in Table 1. The green highlighted region details the modular structure of the Ps1448a pyoverdine 
NRPS genes (C = condensation domain, A = Adenylation domain, T = Thiolation domain, E = Epimerisation 
domain, TE = Thioesterase). A-domains are colour coded to correspond with the aa residue that each incorporates 
into the Ps1448a pyoverdine molecule (as pictured in B). 
 
 76 
Ps1448a contains 5 NRPS genes that lie within the pyoverdine locus (Fig 3.2).  The gene 
Pspph1911 presumably governs synthesis of the pyoverdine chromophore, as it shares 72.36 
% predicted aa identity with the chromophore NRPS gene pvdL of P. aeruginosa PAO1 and 
homologs of this gene are present in all fluorescent pseudomonads that have been examined 
[121, 139, 140]. Likewise, the four contiguous genes Pspph1923-1926 were strong candidates 
for encoding the side-chain NRPS of Ps1448a, with the total number of NRPS modules in 
these genes (7) corresponding exactly with the number of aas in the Ps1448a pyoverdine 
sidechain. Analysis of these genes using the TIGR online NRPS analysis tool 
(http://www.tigr.org/jravel/nrps/) (which analyses an 8-residue signature sequence that is 
predictive of the aa substrate specificity for an individual NRPS module [35]) as well as the 
more recently developed TSVM heuristic prediction software [39] shows that their predicted 
substrates, assuming the co-linearity that is typical of NRPS clusters [7], are entirely 
consistent with the residues that are believed to make up the pyoverdine molecule of Ps1448a 
(Table 2). Substrate specificities predicted by alignment of 10 residue signature sequences 
[36] against the database of known A-domains found at the TSVM NRPS predictor server 
were also consistent with the analysis above (Table 2; alignments not shown).  
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Table 3.2 – In silico prediction of A-domain specificity for Ps1448a pyoverdine  
sidechain NRPS  
A domain 8 residue signature 
alignment 
Identity of best 
match 
TSVM prediction 
congruent? 
1923 DGEDHGTV  
| |  |:| 
DAESIGSV 
BacB-M1-Lys 
bacitracin synthetase 2 
No:  
val=leu=ile=abu=iva-
like specificity  
1924 mod1 DLTKIGHV  
||||:||: 
DLTKVGHI  
SrfAB-M2-Asp 
surfactin synthetase B          
Yes: 
asp=asn=glu=gln=aad-
like specificity  
1924 mod2 DFWNIGMV 
||||||||  
DFWNIGMV 
PvdD-M2-Thr 
pyoverdine synthetase 
Yes: 
thr=dht-like specificity  
1925 mod1 DFWNIGMV 
||||||||  
DFWNIGMV  
PvdD-M2-Thr 
pyoverdine synthetase 
Yes: 
thr=dht-like specificity  
1925mod2 DVWHVSLI 
|||||||| 
DVWHVSLI  
PvdJ-M1-Ser 
pyoverdine synthetase                 
Yes: 
ser-like specificity  
1926 mod1 DLTKIGHV  
||||:||: 
DLTKVGHI  
SrfAB-M2-Asp 
surfactin synthetase B          
Yes: 
asp=asn=glu=gln=aad-
like specificity  
1926 mod2 DVWHVSLI 
|||||||| 
DVWHVSLI  
PvdJ-M1-Ser 
pyoverdine synthetase                 
Yes: 
ser-like specificity  
 
 
3.4 – Confirmation of pyoverdine NRPS identity by gene knockout 
 
In order to confirm that the candidates identified in 3.3 were in fact the pyoverdine 
biosynthetic NRPS genes of Ps1448a, an in-frame deletion of each gene was created and the 
phenotypes of the resulting mutant strains characterised.  
 
3.4.1 – Construction of pyoverdine NRPS mutant strains 
In-frame deletion of target NRPS genes from the chromosome of Ps1448a was achieved using 
a rapid overlap PCR-based method [141], a schematic overview of the deletion procedure is 
shown in Figure 3.3.  A detailed description of the procedure for knockout generation is given 
in Section 2.7.3.  
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Figure 3.3 – Strategy for in-frame deletion of siderophore biosynthetic genes 
A- Overlap PCR was used to generate 800 base pair mutagenic fragments; these fragments were designed so as to 
maintain the original reading frame of the gene 
B-Mutagenic fragments were cloned into the vector pDM4 which is unable to replicate in P. syringae. The 
resulting mutagenic plasmids were delivered to cells by electroporation and homologous recombination events 
selected on chloramphenicol plates. Selection of cells in which a second recombination event had mediated loss 
of plasmid sequence from the chromosome were then selected using sucrose containing medium and the identity 
of double recombinants confirmed by PCR and/or Southern blot, as well as phenotypic analysis. 
 
 
3.4.1.1 – Confirmation of knockouts by PCR and southern blot 
 
In order to detect and confirm the identity of putative mutant strains a two step PCR screen 
was employed. In order to detect candidate gene deletion events, colonies isolated following 
growth on sucrose medium were screened directly by PCR (Figure 3.4a) using the protocol 
described in 2.7.2.3. In this initial screen primers flanking the gene of interest were used and 
the amplification conditions set such that colonies containing a truncated version of the gene 
would result in amplification of an 800 bp product, whereas WT colonies would result in no 
amplification. Genomic DNA was then prepared from clones positive for the 800 bp truncated 
gene and subjected to a second PCR screen using primers specific for the putative deleted 
region of the gene (Figure 3.4b). Clones found testing positive for the truncated gene and 
negative for intervening sequence were taken to be knockouts and subjected to phenotypic 
analysis. For ∆1926 and ∆1924 confirmation by southern blot was also carried out. Figure 3.4 
shows a representative example of knockout confirmation by PCR and southern blot. 
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Figure 3.4 – Confirmation of pspph1926 deletion by PCR and Southern blot 
A – Putative knockouts were screened by colony PCR using primers that flank the gene of interest. Colonies one 
and eight are positive for 800 b.p truncated gene. Lane 9 is a no template control reaction. 
B – Confirmation of gene deletion by PCR. Primers targeted to the deleted region of pspph1926 amplified the 
expected 3.5 kb product when chromosomal DNA from the WT bacterium (lane 2) was used. This product could 
be amplified when genomic DNA from ∆1926 (lane 1) was used. Lane three is a no template control reaction 
C – Confirmation by Southern blot. Luminescent probe targeted toward a 6.7 kb genomic DNA EcoRI fragment 
predicted to be absent in the mutant strain was used. The probe hybridized to WT but not ∆1926 genomic DNA 
that had been digested with EcoRI.   
 
3.4.2 – Initial phenotypic characterisation of NRPS knockout strains 
Following confirmation by PCR and/or Southern blot, each of the five pyoverdine NRPS 
knockout strains was subjected to three basic phenotypic tests to assess the capacity of the 
strain for pyoverdine production. The first of these was growth on iron-limiting King’s B (KB) 
medium [142], a medium known to stimulate pyoverdine production in fluorescent 
pseudomonads. When grown on KB plates, each NRPS gene deletion strain lacked the UV 
fluorescence of WT (Figure 3.5A), indicating that pyoverdine was no longer being produced. 
Siderophore secretion and the iron uptake capacity of mutant strains was also assessed using 
chromeazurol S (CAS) agar plates. CAS plates contain a dye which is blue-green when 
complexed with iron and yellow when iron is absent, such that when a siderophore producing 
organism is grown on CAS agar a yellow halo is observed around colonies as a result of 
secreted siderophore wresting iron from the dye. Secondary assessment on CAS agar was 
necessary to confirm the absence of pyoverdine production as pyoverdine fluorescence is pH 
dependent. As such, mutations that alter intracellular pH without reducing pyoverdine 
production would also abrogate fluorescence. Following 24 h growth on CAS agar at 28 ˚C 
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each of the five NRPS mutant strains lacked the characteristic orange halo of the wild type 
strain (Fig 3.5B). This result confirmed that the lack of fluorescence observed for the mutant 
strains was indeed due to pyoverdine deficiency. In order to assess growth under severe iron 
limitation each mutant strain, along with a wild type control was streaked on KB media 
containing 200 µg/mL EDDHA (an iron chelating agent which restricts passive iron uptake). 
Unlike wild type Ps1448a, the mutant strains were unable to grow under severe iron limitation. 
Taken together, the phenotypes described above confirmed that none of the gene deletion 
strains were able to produce pyoverdine.  
 
Figure 3.5 –  Characterisation of Ps1448a pyoverdine NRPS knockouts 
A – Wild type (WT) and pyoverdine NRPS knockouts (∆1911, ∆1923-1926) on iron-limiting KB agar viewed 
under UV light. Only the wild type is able to synthesise fluorescent pyoverdine.  
B – Wild type and pyoverdine null strain (∆1925) inoculated into KB agar containing CAS dye and incubated for 
24 h at 28 °C. Only the wild type strain scavenged discernible levels of iron as evidenced by the orange halo 
surrounding this inoculum. All pyoverdine NRPS knockouts exhibited indistinguishable iron transport deficient 
phenotypes.  
C – Wild type, ∆1925 and ∆1925 complemented by pSX:1925 on iron-restricted KB agar containing 200 µg/mL 
EDDHA. Complementation by a functional gene copy in trans restored pyoverdine synthesis to near wild type 
levels in each of the NRPS knockout strains. 
 
3.4.3 – Complementation of a pyoverdine NRPS deletion in trans 
To ensure that the gene deletion strategy produced non-polar mutations it was necessary to 
complement a pyoverdine NRPS mutant in trans using a plasmid encoded copy of the wild 
type gene. To this end the entire sequence of the gene Pspph1925 was cloned into the 
Pseudomonas expression vector pSX to generate the complementation plasmid pSX:1925. 
This plasmid was then delivered to Ps∆1925 by electroporation. Introduction of the 
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complementation plasmid into the mutant cells resulted in a restoration of fluorescence and 
also allowed growth on KB agar containing 200 µg/mL EDDA (Figure 3.4C). This successful 
restoration of pyoverdine production by complementation in trans indicated that the mutant 
phenotypes described in Section 3.3.2 did not result from polar effects. Expression from 
pSX:1925 is under the control of the IPTG inducible tac promoter, interestingly 
complementation by this plasmid was only observed when bacteria were grown at 18 °C in the 
absence of IPTG. This indicated that high expression levels or temperature were resulting in 
the production of inactive protein from pSX:1925. This result is consistent with previous 
observations that over-expression or elevated temperatures result in misfolded, inactive NRPS 
proteins [37, 85, 143]. 
 
3.5 – Identification and genetic characterisation of achromobactin 
as a secondary siderophore of Ps1448a 
 
Although the pyoverdine deficient (Pvd-) strains were unable to discernibly alter the colour of 
the CAS dye during 24 h growth on agar at 28 ˚C (Figure 3.5b), i.e. no active iron transport 
was apparent within this timeframe, some colour change was observed when these plates were 
subsequently left at room temperature or maintained at 28 ˚C for an extended duration. These 
observations suggested that the pvd- strains were employing an alternative siderophore. 
Production of this presumed secondary siderophore appeared to be temperature dependent, 
with the pvd- strains exhibiting greater iron uptake at 22 °C than at 28 °C (the latter being the 
optimal laboratory temperature for growth of Ps1448a [144] (Figure 3.6a,b). However, none of 
the pvd- strains were able to grow during 72 h incubation at either temperature on solid media 
containing 200 µg/mL EDDHA, indicating that this secondary siderophore had a much lower 
affinity for iron than pyoverdine.  
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Figure 3.6 – Temperature-dependent production of a secondary siderophore by 
pyoverdine null Ps1448a 
Wild type and pyoverdine null Ps1448a colonies were inoculated into identical Kings B plates containing CAS 
dye. Both plates were incubated at 28 °C for 24 h, following which plate B was removed to 22 °C for the 
remainder of the experiment while plate A was maintained at 28 °C. For each plate, wild type is on the left, and 
the pyoverdine null strain is on the right. 
 
3.5.1 – In silico characterisation of the Ps1448a achromobactin 
biosynthetic locus 
To identify candidate genes governing synthesis of this secondary siderophore, some known 
siderophore synthetase sequences from other phytopathogenic bacteria were aligned by 
BLASTP against the Ps1448a genome [138, 145]. This search revealed that Ps1448a contains 
orthologs of the D. dadantii achromobactin synthetase genes. Figure 3.7 compares the 
achromobactin gene locus of Ps1448a with that of D. dadantii [134], and presents a simplified 
scheme for achromobactin synthesis based on previous studies. In both D. dadantii and 
Ps1448a achromobactin appears to be synthesised by six proteins, AcsA-F. D. dadantii AcsD, 
a type A NRPS-independent synthetase, has been characterised both biochemically and 
structurally and found to catalyse the condensation of citric acid with L-ser [131, 133]. Roles 
for D. dadantii AcsACEF have also been proposed on the basis of protein homology studies 
and the known structure of achromobactin, but no clear role for AcsB has yet been identified 
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[132, 134]. The predicted functions of the corresponding Ps1448a orthologs are summarised in 
Table 3.3.  
 
In addition to the acsA-F genes, the Ps1448a locus also contains an ortholog of yhcA, 
proposed to be involved in export of achromobactin [134]; acr, a TonB dependent siderophore 
receptor; and the four genes cbrABCD, the products of which form a permease complex for 
ATP-dependent import of ferric achromobactin [146]. Immediately adjacent to the Ps1448a 
achromobactin gene cluster are five genes (Pspph2742-2746) predicted (COG prediction) to 
encode proteins comprising an ABC-type dipeptide/oligopeptide/nickel transport system (not 
shown). 
 
After the completion of the work described in this chapter, a paper was published in which the 
locus for achromobactin biosynthesis in P. syringae p.v syringae B728a (PssB728a) was 
characterised [104]. It was found that PssB728a contains an achromobactin locus identical to 
that of Ps1448a. The function of the biosynthetic enzymes of this locus was determined and 
agrees with the in silico characterisation described in this chapter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7 – Comparison of the achromobactin gene loci of D. dadantii and Ps1448a 
Genes are colour coded according to function, as described in the key. The achromobactin structure is also colour 
coded to indicate the distinct constituent groups of this molecule that are hypothesised to be joined by the various 
achromobactin synthetase enzymes as summarised in Table 3. 
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Table 3.3 – Summary of D. dadantii and Ps1448a achromobactin gene alignment results 
 
D. dadantii  
gene name 
Ps1448a gene 
number 
Putative function of Ps1448a ortholog† 
acr 2749 TonB-dependent outer membrane ferric siderophore receptor (30%) 
acsF 2750 Diaminobutyrate--2-oxoglutarate transaminase (74%). Makes L-DABA 
and α-ketoglutarates from aspartate semialdehyde and glutamate 
acsD 2751 Type A NRPS-independent synthetase [131] (65%). Condenses L-serine 
with citric acid 
acsE 2752 Pyridoxal-dependent decarboxylase (71%). Decarboxylates serine group 
of achromobactin to yield ethanolamine 
yhcA 2753 Major Facilitator Family efflux pump YhcA (70%). Proposed to be 
involved in achromobactin export from cell 
acsC 2754 Type C NRPS-independent synthetase (55%). Condenses L-DABA with 
product of AcsD reaction 
acsB 2755 Aldolase/citrate lyase family protein (72%) 
acsA 2756 Type B NRPS-independent synthetase (64%). Condenses two α-
ketoglutarates with product of AcsC reaction 
cbrA 2757 Ferric achromobactin-binding periplasmic protein precursor (70%) 
cbrB 2758 Achromobactin inner membrane permease component (72%) 
cbrC 2759 Achromobactin inner membrane permease component (70%) 
cbrD 2760 ATP binding protein from the ferric achromobactin permease (80%) 
†Based on D. dadantii alignment; numbers in brackets indicate aa identity with corresponding D. dadantii 
ortholog. 
 
 
 
 
3.5.2 – Generation and characterisation of achromobactin deficient 
Ps1448a strains 
In order to confirm the role of the proposed achromobactin biosynthetic locus the Ps1448a 
acsA homolog was deleted from both WT and pvd- strains of Ps1448a using the same 
procedure described for generation of pyoverdine NRPS mutants. On solid media the 
achromobactin deficient (acr-) single mutant was indistinguishable in phenotype from wild 
type, growing effectively in the presence of 200 µg/mL EDDHA and rapidly taking up iron on 
CAS agar. In contrast, not only could the pvd-/acr- double mutant not grow in the presence of 
200 µg/mL EDDHA, it was also unable to take up any discernible amounts of iron on CAS 
agar irrespective of the duration or temperature of incubation (after 72 h at either 22 or 28 °C 
pvd-/acr- colonies on CAS agar appeared identical to the 24 h pvd- mutant pictured in Figure 
3.5b.  
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Figure 3.8 – Liquid CAS assay  
96 well plate wells containing 200 µl unamended King’s B liquid media were inoculated in triplicate from 
synchronised overnight cultures of the following strains: WT (■), Acr- (○), Pvd- (●), and Pvd-/Acr- (♦). A 
triplicate media-only control (▲) was also included. Plates were incubated with shaking at either 22 °C (A) or 28 
°C (B) for 48 h. Cells were then pelleted and 150 µl supernatant removed to fresh wells. CAS dye (30 µl) was 
added to each well and the rate at which iron was removed from the dye by secreted factors in the supernatant 
was followed at OD 655 (monitoring loss of blue coloration). Error bars are presented as ± 1 standard deviation. 
 
 
Similar phenotypes were observed for each of the WT, pvd-, acr-, and pvd-/acr- strains grown 
in liquid media, using a modified CAS assay that we developed to measure iron acquisition by 
factors secreted into the culture supernatant (Figure 3.8). In this assay strains were grown in 
quadruplicate in a 96 well plate for 48 h at either 22 or 28 °C. Following growth, cells were 
pelleted by centrifugation and supernatant removed to fresh wells. CAS dye was then added to 
the media and the rate at which iron was removed from the dye by secreted factors in the 
supernatant measured by tracking decrease in OD 650 (Absorbance maximum for CAS in the 
presence of iron). This assay showed that WT and acr- strains were indistinguishable with 
regard to siderophore activity in the culture supernatant. Pvd- strains had reduced siderophore 
activity compared to wild type, but this difference was less marked at 22 °C, indicating that 
Ps1448a is able to employ achromobactin as a temperature-regulated secondary siderophore 
that is secreted into the extracellular environment for active uptake of iron. The supernatant 
from the pvd-/acr- strain appeared identical to a media-only control indicating that no 
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siderophores were being secreted by this strain, a result consistent with those obtained from 
the agar based assay (Figure 3.6). It is interesting to note that Ps1448a appears to have the 
genetic capacity to produce a third siderophore, yersiniabactin (Ybt) but we were unable to 
detect any evidence of Ybt production in any of the phenotypic assays we employed.  
 
 
3.6 – Assessment of relative fitness of mutant stains under iron 
starvation conditions 
 
In order to more precisely quantify the contribution of each siderophore under varying degrees 
of iron starvation, a serial dilution experiment was performed, employing EDDHA 
concentrations diluted 1:2 from 800 µg/mL down to 0.2 µg/mL in KB media in a 96 well 
plate. The WT, pvd-, acr-, and pvd-/acr- strains were replica-inoculated into each well and 
incubated with shaking at 22 °C for 24 h, following which culture turbidity was measured. 
IC50 values (indicating the concentration of EDDHA that yielded only 50% turbidity relative 
to the unchallenged control) were calculated for each of the strains using Sigma Plot. The IC50 
for the WT (260 ± 50 µg/mL) and Acr- (220 ± 70 µg/mL) strains were approximately equal, 
confirming that pyoverdine is able to compensate for achromobactin deficiency. In contrast, 
the Pvd- strain was sensitive to almost three orders of magnitude less EDDHA, with an IC50 of 
only 0.57 ± 0.02 µg/mL, demonstrating that achromobactin cannot completely compensate for 
the absence of pyoverdine. However, the IC50 for the Pvd-/Acr- double mutant strain (0.31 ± 
0.01 µg/mL) was reproducibly lower yet, verifying that in the absence of pyoverdine 
achromobactin still makes a small contribution to fitness during iron starvation. At 28 °C the 
IC50 for WT and Acr- strains were essentially unchanged, but the difference between the pvd- 
mutant (0.38 ± 0.01) and pvd-/acr- double mutant (0.26 ± 0.01) was less marked. Figure 3.89 
gives a graphical representation of the results of this assay. 
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Figure 3.9 – Growth of WT and siderophore deficient strains during iron starvation 
Quadruplicate cultures were set up for each strain at each concentration of EDDHA in a 96 well plate. Following 
24 h growth at 22 °C, growth was assessed by measuring turbidity at 600 nm using a microplate reader. 
Increasing concentration of EDDHA results in greater restriction of iron availability. WT = Wild type Ps1448a, 
Pyo = pyoverdine null strain, Ach = achromobactin null strain, Doub = pyoverdine/achromobactin null strain. 
Data from two independent experiments are shown; error bars are presented as +/- one standard deviation 
 
 
3.7 – Assessment of pathogenicity of mutant strains in Phaseolus 
vulgaris 
 
In order to assess the pathogenicity in the natural host of Ps1448a, each of the mutant strains 
was subjected to the standard ‘bean prick’ pathogenicity test using bean pods [147]. All single 
and double mutant strains were still able to cause characteristic water soaked lesions after 
inoculation and incubation in bean pods, irrespective of temperature and whether or not the 
beans were picked or still attached to the parental plant. This indicates that neither pyoverdine 
nor achromobactin is essential in enabling Ps1448a to cause halo blight in the bean plant 
Phaseolus vulgaris. Although no evidence for Ybt production was observed in any of our 
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phenotypic assays, we wanted to investigate the possibility that this siderophore was still 
contributing in some manner to virulence in Phaseolus vulgaris. A pvd-/acr-/ybt- strain was 
created by deletion of the proposed ybt biosynthetic NRPS irp1 from a pvd-/acr- background, 
this triple mutant was also assessed by the standard pathogenicity test and was also able to 
cause characteristic water-soaked lesions. Figure 3.10 shows a bean pod with water soaked 
lesions caused by each of the mutant strains and a wild type control.  
 
 
Figure 3.10 – Assessment of WT and mutant strains using standard pathogenicity test 
Each of the indicated replicates contains, in order, WT, pvd-, acr/pvd- and acr-/pvd-/ybt- strains. Each strain was 
inoculated into a bean pod from a single colony, using a hypodermic needle. The pod was then incubated in a 
humid chamber at room temperature for 48 hr. All strains display characteristic water-soaked lesions indicating 
pathogenicity in Phaseolus vulgaris. Assay was repeated in triplicate, the photograph is representative of results 
from all repeats. 
 
3.8 – Mass spectrometric analysis of pyoverdine and achromobactin 
purified from Ps1448a 
  
In order to validate the in silico predictions of the structures of pyoverdine and achromobactin 
from Ps1448a, each siderophore was purified (by silica chromatography and amberlite bead 
purification methods for achromobactin and pyoverdine, respectively, as described in Sections 
2.8.4 .1and 2.8.4.2) and subjected to analysis by mass spectrometry. Fractions were collected 
and analysed for siderophore activity using CAS dye, and those with the highest activity were 
sent to the Centre for Protein Research at the University of Otago for analysis. Each of the 
samples was subjected to MALDI TOF analysis to identify the mass of the primary 
constituents. The major peaks of the pyoverdine sample were also fragmented by MS/MS in 
order to discern the aa composition of the peptide side chain.  
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Figure 3.11 – MS analysis of pyoverdine purified from Ps1448a  
Structures previously elucidated for pyoverdine from P. syringae have shown the molecule can either be in linear 
(A) or cyclic (B) form. The cyclic form results from the formation of an ester bond between the C-terminal 
carboxyl group and the sidechain of the second internal L-threonine residue (Figure 3.2b). Both of these forms of 
pyoverdine were identified in the MALDI TOF spectra (C) of pyoverdine purified from Ps1448a. A third peak 
not consistent with previously solved structures was also observed. 
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As shown in Figure 3.11, analysis of purified pyoverdine by MALDI TOF revealed the 
presence of three major positive ion peaks. Two of these peaks agree with the published 
masses of pyoverdines isolated from other P. syringae strains [136], the third peak does not. 
The peak at 1123 corresponds to cyclic pyoverdine, in which an ester bond between the C-
terminal carboxyl and the side chain of an internal threonine residue results in a lactonic 
structure. The peak 18 mass units higher than this, at 1141, corresponds with linear pyoverdine 
in which this ester bond has either been hydrolysed or was never formed; pyoverdine in this 
form has not undergone a water loss due to ester bond formation and as a result is 18 mass 
units heavier than the cyclic form. The peak at 1212, 71 mass units higher than that of linear 
pyoverdine, can not be accounted for based on the structures previously elucidated for other P. 
syringae strains. In order to investigate the identity and order of the aas present, the peaks at 
1141 and 1212 were subjected to MS/MS analysis. Analysis of peptides in this fashion is 
facilitated by fragmentation at amide bonds, the result of this is two characteristic ions. These 
ions are known as Y ions and B ions. As outlined in Figure 3.12 and Table 3.4, fragmentation 
of the peak at m/z= 1141 resulted in the formation of a set of B ions that corresponded exactly 
to the order and identity of aas that been predicted by in silico analysis of the pyoverdine 
NRPS of Ps1448a and that have previously been observed for pyoverdine from other P. 
syringae strains [136]. Fragmentation of the peak at m/z = 1212, results in an identical spacing 
and intensity, except all peaks are shifted 71 mass units higher. Possible explanations for this 
result are discussed in Section 3.9. 
 
For achromobactin a major peak was present at 590.2, consistent with the published mass for 
achromobactin of 590.15 [104]; however the largest peak observed was at m/z 572.2, 
corresponding to a water loss (-18). For achromobactin, which had been evaporated to dryness 
then resuspended in solvent prior to analysis, the relative intensity of the peak at 572.2 was 
increased and the peak at 590.2 decreased, indicating that water was being lost as a result of 
heating during the purification procedure.   
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Figure 3.12 – Ions arising from MS/MS analysis of pyoverdines isolated from Ps1448a 
A – Fragmentation of the peak found at 1141 mass units produces a set of molecular ions consistent with the 
predicted structure of Ps1448a pyoverdine. The masses of the labelled peaks and the ions they represent  are 
given in Table 3.4. 
B – Fragmentation of the peak at 1212 mass units produces a set of ions with identical spacing and intensity, 
shifted right by 71 mass units.  
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Peak 
number 
Mass Composition of  ion 
1 357.13 B ion: CH 
2 458.24 A ion: CH_K 
3 616.28 B ion: CH_K_OH-D 
4 718.32 B ion: CH_K_OH-D_T 
5 818.39 B ion: CH_K_OH-D_T_T 
6 905.42 B ion: CH_K_OH-D_T_T_S 
7 1036.41 B ion: CH_K_OH-D_T_T_S_OH-D 
Y1 1067.48 Y ion resulting from loss of chromophore 
acyl group 
 
Table 3.4 – Diagnostic ions arising from MS/MS analysis of the m/z = 1141 pyoverdine species  
Fragmentation of the m/z = 1141 pyoverdine species resulted in identification of the following negative ions as 
shown in Figure 6.11. Peaks 1-7 match the expected pattern of A and B-ions previously reported for 
fragmentation of other P. syringae linear pyoverdine molecules[136]. Y1 has the correct mass for the Y ion 
resulting from loss of the acyl group of the chromophore.  CH = chromophore, OH-D = hydroxyaspartate, all 
other aas indicated by standard one letter code. 
 
 
3.9 – Discussion 
 
This study constitutes the first experimental characterisation of pyoverdine NRPS genes in 
Pseudomonas syringae. The results of the bioinformatic, mutational and mass spectrometric 
analyses are consistent with the structure that has previously been proposed for the P. syringae 
pyoverdine molecule [136, 137], and support the mechanisms of synthesis that are outlined in 
Figure 3.2. As per previous pyoverdine NRPS gene knockouts in fluorescent pseudomonads 
[85], in-frame deletion of any of the chromophore or side chain NRPS genes in Ps1448a 
resulted in complete abolition of pyoverdine synthesis. Analysis of these mutants under iron-
limiting conditions revealed the presence of a secondary siderophore, production of which was 
temperature sensitive. Temperature regulation of siderophore production has been observed 
for other bacterial species [148-150] and has been known to govern expression of other P. 
syringae genes, especially those implicated in causing disease [151]. Additional bioinformatic 
and mutational analyses identified achromobactin as the secondary siderophore. 
Achromobactin is known to contribute to virulence in D. dadantii [134], and these 
observations prompted us to test whether it is a virulence factor in Ps1448a also.  
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The contribution of both achromobactin and pyoverdine to virulence of Ps1448a during 
infection of Phaseolus vulgaris was assessed by inoculation of mutant strains and wild type 
controls into the bean pods. All single and double mutants were still able to cause lesions in 
this standardised pathogenicity test, indicating that neither siderophore is required for Ps1448a 
to cause halo blight in Phaseolus vulgaris. These results were surprising given that: iron is 
essential for core metabolic processes; is believed to be severely restricted in the plant 
extracellular environment [152]; and that siderophores are generally regarded as important for 
microbial pathogenesis of both plant and animal hosts [127, 134]. However, although the 
assumption is frequently made that pyoverdines are able to act as virulence factors in both 
animal and plant hosts, there is little experimental evidence for the latter. Indeed, pyoverdine 
from P. syringae pv. syringae has likewise been shown not to have a determinative role in 
pathogenesis of sweet cherry fruit [153]. It may be that phytotoxins render siderophores 
obsolete during the disease process by releasing iron from damaged plant cells into the extra-
cellular environment. It should also be noted that the standard bean inoculation assay for 
Ps1448a virulence monitors only the ability to cause lesions, which is dependent primarily on 
toxin release and may not accurately report on the full progression of disease. Irrespective, it 
must be considered that any plant protection strategy which aims to target pyoverdine and/or 
achromobactin in P. syringae pv. Phaseolicola will not prevent the appearance of 
economically-damaging halo blight lesions in bean crops. 
 
Despite no evidence for an active role in lesion formation, our phenotypic analyses of iron 
uptake and growth under iron limiting conditions confirmed that siderophores are indeed 
important for fitness of Ps1448a during iron starvation. Although P. syringae has traditionally 
been defined as a phytopathogen, it is unclear how important pathogenicity really is to the 
survival of this bacterium in the wild [154], and it may be that the Ps1448a siderophores are 
more important for epiphytic survival on leaf surfaces, in soil or water than during infection. 
However, given the clear superiority of pyoverdine as a siderophore, it is unclear why Ps1448a 
makes achromobactin also. All of the fluorescent Pseudomonas species known synthesise at 
least one secondary siderophore and there is presumably some fitness benefit to be derived 
from this investment. There is evidence that secondary siderophores can have affinity for 
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metals other than iron [155], and the presence of orthologs of known nickel-transport genes 
immediately adjacent to the Ps1448a achromobactin cluster may be indicative of a similar role 
in this bacterium (although there was no discernable phenotypic effect of nickel addition or 
exclusion on achromobactin synthesis in the pvd mutant; not shown). It has also been 
suggested that secondary siderophores can be involved in signalling pathways, or can have 
antimicrobial activities that are distinct from their iron scavenging properties [114, 156]. 
 
Alternatively, Dominique Expert and co-workers have demonstrated that achromobactin in the 
phytopathogen D. dadantii is synthesised temporally before the primary NRPS-derived 
siderophore chrysobactin [134]; and have proposed that achromobactin in this bacterium may 
function as a provisional measure, enabling cells to respond more rapidly to fluctuations in 
iron availability while the slower chrysobactin system is established [134, 152]. We suggest 
that a likely explanation for this scenario lies with the high energy investment required for 
activating NRPS mechanisms of siderophore synthesis. NRPS enzymes are amongst the 
largest known, with single proteins routinely exceeding 200 kDa [157]. The energy 
requirements for a cell to synthesise such large proteins are significant, and when already 
stressed this may represent an impassable barrier. However, once the NRPS enzymatic 
template is in place it is an extremely efficient method for synthesising short peptides, 
consuming significantly less ATP per peptide bond formed than ribosomal mechanisms [29]. 
It might therefore be useful to have a backup siderophore in place which is constitutively 
produced at low levels and can be rapidly up regulated in response to iron starvation. Such a 
system would provide the cell with small amounts of iron while the NRPS template for the 
more efficient primary siderophore is established. As the phenotypes of Ps1448a mutant 
strains indicate that achromobactin is only important when pyoverdine is not available, it is 
possible that achromobactin likewise serves as a ‘first response’ siderophore to cope with a 
sudden onset of iron starvation in Ps1448a.  
 
The results of in silico and mass spectral analyses indicate that Ps1448a synthesises 
achromobactin which has the same structure as that of PssB728a [104]. MS analysis of 
pyoverdine purified from Ps1448a unexpectedly revealed the presence of three distinct 
pyoverdine molecules. Fragmentation by ms/ms suggested that the lighter two of these were 
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identical to the structures already elucidated for other P. syringae strains [136, 137]. The 
heavier species isolated was 71 Da larger. Three possibilities were considered in the 
determination of the identity of this molecule.  
 
It was initially thought that this cryptic peak might be due to a pyoverdine molecule that had 
the same structure as previously published, with the exception of a larger acyl substituent 
attached to the chromophore or that it was a contaminant which had co-purified with 
pyoverdine. Fragmentation analysis conclusively refuted both of these this possibilities. As 
shown in Figure 3.12, fragmentation of the 1212 Da species resulted in a set of peaks identical 
in spacing and relative intensity, to those seen for fragmentation of the 1141 Da species. The 
only difference between the two sets of peaks is that each peak arising from fragmentation of 
the heavier species is 71 Da larger. In both fragmentation sets, there is a peak at m/z =357 
which is the predicted mass of the chromophore of pyoverdine in which the attached acyl 
group is derived from succinic acid. In both spectra there are also intense peaks that 
correspond a Y-ion formed as a result of loss of the acyl group from the chromophore; these 
peaks also differ by 71 Da. An alternative acyl group therefore seems an unlikely explanation 
for the cryptic pyoverdine species isolated. An alternative explanation for the spectrum 
obtained upon fragmentation of the larger pyoverdine species is that an extra monomer is 
incorporated into the side chain of pyoverdine. The B-ion pattern suggests that this monomer 
is the first residue of the sidechain, falling between the chromophore and L-lysine, increasing 
the mass by 71 Da. The only aa which could give this mass increase is alanine with a 
molecular weight of 89 which, following loss of water as a result of the condensation reaction 
would increase mass by 71. However, in silico analysis of the pyoverdine locus of Ps1448a 
did not reveal any NRPS modules specifying alanine, and likewise analysis of all annotated 
NRPS genes domains in the genome of Ps1448a also failed to reveal any A-domains predicted 
to specify alanine. Thus, the exact structure and mechanism of synthesis of the cryptic 1212 
Da pyoverdine species remain unknown. 
 
 
 96 
Chapter 4 – Techniques for purification and 
characterisation of NRPS A-domains 
 
4.1 Introduction  
 
The initial aim of this work was to biochemically determine the substrate specificity of each of 
the seven modules that synthesise the aa side-chain of pyoverdine in Pseudomonas syringae 
pv. phaseolicola 1448a. Modules characterised in this chapter were to be subsequently used in 
domain swapping experiments to generate novel pyoverdine derivatives and probe C-domain 
selectivity at the donor site (Chapter 5 of this thesis). As a first step toward achieving this 
goal, bioinformatic analyses were conducted to predict the preferred substrate for each 
synthetase module in silico (described in Chapter 3) and plasmid based constructs for the 
expression and purification of an AT bi-domain from each module were designed and 
constructed. Following optimisation of expression conditions in E. coli, soluble recombinant 
AT bi-domain was obtained for each module and subjected to a substrate binding assay. 
However, each of the proteins was inactive with all substrates tested. A number of approaches 
to generate active protein were subsequently undertaken, but despite exhaustive investigation, 
active protein could not be obtained for any of the seven modules.  
 
This chapter describes techniques for production and purification of recombinant A-domains 
as well as new methods for assessment of their substrate specificity that were developed as a 
result of this work. While determination of substrate specificity for the seven P. syringae 
NRPS was ultimately unsuccessful, the techniques developed will be a valuable reference for 
future characterisation attempts. 
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4.2 General strategy for determination of substrate specificity 
 
In order to biochemically determine the substrate specificity on a given NRPS module, it is 
necessary to first purify the A-domain of that module, either alone or in combination with 
other domains. One of the most convenient methods for doing this is to clone the nucleotide 
sequence encoding the desired domain or domains into a plasmid vector, allowing production 
of recombinant proteins in E. coli with a C or N terminal tag of six consecutive histidine 
residues. his6-tagged proteins produced in this fashion can be easily isolated from crude cell 
lysate by virtue of the affinity of histidine residues for nickel ions immobilised on an agarose 
matrix [158, 159]. To allow for the production of his6-tagged derivatives of Pspph pyoverdine 
synthetase modules in E. coli, the commercially available pET 28a+ (Figure 4.1) was chosen 
as an expression vector. pET 28a+ contains a multiple cloning site into which desired open 
reading frames (ORFs) can be introduced to yield either a C or N terminal his6-tag. A search 
of the literature revealed only one published example where the substrate specificity of a P. 
syringae NRPS enzyme had successfully been determined [160], this paper assayed an AT bi-
domain rather than an A-domain in isolation. In light of this, it was decided that AT bi-
domains rather than A-domains would be purified for assessment of substrate specificity of 
each pyoverdine side-chain NRPS module.  
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Figure 4.1 – pET28a+ map and features 
A – A map of the vector showing important features: of particular note, the pBR 322 origin of replication (ori) 
allows plasmid replication in E. coli, Kan encodes a kanamycin resistance selectable marker, and lacI encodes the 
lac repressor protein. 
B – Detail of the expression region and multiple cloning site: Expression is driven by the T7 promoter, in the 
absence of IPTG the lac repressor protein binds to the lac operator preventing transcription initiation. Addition of 
IPTG to the culture media causes dissociation of the lac repressor and initiation of transcription and subsequent 
translation of plasmid encoded ORFs. Location of the N-terminal his6-tag region is also indicated. The T7 
promoter is only recognised by T7 polymerase, hence expression from this plasmid is only possible in E. coli 
strains that have a chromosomal or plasmid encoded copy of T7 polymerase. BL21(DE3) is the best known 
example of such a strain. Panel A is taken from the Novagen pET28a+ manual. 
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4.2.1 Design and construction of AT bi-domain expression vectors 
 
The genes for production of the Pspph pyoverdine side-chain synthetases were identified in 
silico, as described in Section 3.3. The AT domain boundaries were approximated using the 
TIGR NRPS server (http://nrps.igs.umaryland.edu/nrps/) and primers were designed to 
amplify the AT bi-domain from each module. Henceforth, each AT bi-domain will be referred 
to by a number designation, according to the last two digits of its gene number and the number 
of the module from which it was derived. For example the AT bi-domain from the second 
module of the gene Pspph1925 is designated 252. Primer pairs were picked using the “amplify 
selection” function in Vector NTI and restriction sites for directional cloning of AT bi-
domains into pET 28a+ were introduced at the 5’ end of the forward and reverse primer for 
each construct.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 – Construction of AT bi-domain expression vectors 
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The upstream restriction site was NdeI and the downstream restriction site was Hind III for all 
constructs except 231 and 251, which had an XhoI and an EcoRI site respectively on the 
downstream primer (Refer to Table 2.5 for sequences). Amplification of domains, cloning and 
screening for recombinants were carried out following standard molecular biology protocols 
as described in Section 2.7; Figure 4.2 gives an overview of design and construction of the 
expression vectors. Following confirmation by colony PCR and restriction digest, the identity 
of the AT bi-domain insert in recombinant plasmids was verified by sequencing. 
 
4.2.2 – Preliminary expression testing 
After verification at the nucleotide level, each construct was transformed into the E. coli 
expression host strain BL21(DE3), and tested to determine whether or not the correct sized 
protein was expressed. Typically, expression was tested by growing a small-scale culture to an 
appropriate density, taking an uninduced sample, adding IPTG to induce protein expression 
and then taking aliquots of the culture 1, 2 and 3 h after induction. Cells from the aliquots 
were then pelleted and lysed and total cellular protein analysed by SDS PAGE. In each case it 
was possible to see clear induction of expression of the AT bi-domain.  
 
4.2.3 – Optimisation of expression conditions to achieve soluble 
recombinant proteins 
In order to purify an active his6-tagged derivative of a protein, it is necessary that the protein 
is not only expressed to high levels but is also present in a soluble form [161]. In order to 
determine whether each recombinant AT bi-domain was soluble under standard expression 
conditions (37 °C, 0.5 mM final concentration IPTG), cells from a 50 mL culture were 
harvested 3-6 h after induction, lysed by French-press and the resulting lysate separated into 
soluble and insoluble fractions by centrifugation. The insoluble fraction was then re-
solubilised in a denaturant, and samples of each fraction analysed by SDS PAGE. For each of 
the constructs, analysis of this type revealed no discernable target protein in the soluble 
fraction (Figure 4.3a), it was therefore necessary to optimise expression conditions so that 
recombinant protein was present in a soluble form.  
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It is well known that over-expression of proteins in E. coli can lead to the formation of 
insoluble aggregates of misfolded proteins known as inclusion bodies; in part, this is thought 
to be due to excessive production overwhelming the molecular chaperones that guide folding 
of nascent proteins [161-163]. NRPS proteins are particularly difficult to work with in this 
regard and expression conditions generally have to be optimised to obtain soluble protein [37, 
80, 160, 164, 165]. Two established methods for increasing the solubility of recombinant 
proteins in E. coli are expression at low temperatures and reduction of induction levels; the 
former is believed to increase protein stability, the latter to prevent protein folding machinery 
being overwhelmed [161]. Both of these factors were investigated in small-scale (50 mL) 
cultures, however expression at 25 °C – with final concentrations of IPTG as low as 0.0625 
mM – failed to yield any soluble protein as assessed by SDS PAGE (not shown). 
 
 
 
Following the failure of low temperature and reduced expression rate to yield any soluble 
recombinant protein, it was decided to carry out expression at low temperatures in the 
presence of 1 M D-sorbitol and 2.5 mM glycine betaine [166]. Under these conditions 
Ackerley et al. were previously successful in purifying a functional his6-tagged AT bi-domain 
Figure 4.3 – Obtaining soluble 
protein by expression at low 
temperatures with 1M D-sorbitol 
and 2.5 mM glycine betaine 
A – Soluble (S) and insoluble (I) fractions 
for 251 and 231 expression strains 
following expression for 3 h under 
standard conditions (37 °C, LB medium). 
The target protein is located exclusively in 
the insoluble fraction in both cases. 
B – Soluble and insoluble fractions from 
the same strains following expression at 18 
°C for 24 h in LB medium amended with 1 
M D-sorbitol and 2.5 mM glycine betaine. 
There is now a significant amount of each 
target protein in the soluble fraction.  
Molecular weight marker used for this and 
all subsequent gels are described in Section 
2.9.3.1  
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from a P. aeruginosa pyoverdine NRPS [37]. The rationale behind the media composition is 
first, that the high concentration of D-sorbitol induces osmotic shock and expression of 
associated chaperone proteins; and second, that uptake of glycine betaine is promoted by 
osmotic shock, and once internalised is believed to assist in the folding of nascent proteins 
[10, 14]. Initially a small-scale (50 mL) trial of this technique was run using the 231 and 251 
expression strains and found in both instances to yield large amount of soluble recombinant 
AT bi-domain (Figure 4.3b). 
 
The betaine/sorbitol expression procedure was subsequently scaled up to 500 mL and then 
used to purify soluble his6-tagged AT bi-domain from each of the seven modules. In each case 
cell lysis was carried out by French press and removal of insoluble debris by centrifugation. 
Target protein was purified from the resulting soluble fraction by Ni-NTA affinity 
chromatography using a Novagen® Hisbind kit, following the manufacturer’s directions. 
Figure 4.4a shows SDS PAGE analysis of such purification, Figure 4.4b shows SDS PAGE 
analysis of all purified AT bi-domains. After purification desalting and quantification, proteins 
were ready for use in a substrate specificity assay. 
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Figure 4.4 – Ni-NTA purification of AT bi-domains 
Soluble his6-tagged AT bi-domain was purified from each of the seven over-expression strains using a 
Novagen® Hisbind® column containing 1.5 mL of settled resin. Protein binding, wash steps and elution were 
carried out according to the manufacturer’s directions. Eluted protein was captured in 1 mL fractions for analysis 
by SDS PAGE, a sample of column flow through from washing steps was also retained for analysis.  
A – SDS PAGE analysis of one such purification (that of 231); 1-8 = 1 mL fractions of eluted protein in the order 
they came of the column; S = soluble fraction; I = insoluble fraction; W = flow through from washing steps.  
B – SDS PAGE analysis of each AT bi-domain following purification and buffer exchange. This panel is a 
compilation of various gels and shows each purified protein immediately after buffer exchange.  
 
4.2.4 – Assessment of substrate specificity by ATP/32PPi exchange assay 
After soluble recombinant AT bi-domain had been purified for each module, it was assessed 
for substrate specificity using the ATP/32PPi exchange assay. This assay was the first to be 
developed for assessment of A-domain specificity and has since become the accepted standard 
for substrate specificity determination [1, 4, 167]. Many variants of this assay protocol have 
been published [1, 3, 10, 12, 18, 19], all of which operate on the same basic principle. The 
assay relies on the fact that the production of aa adenylates by an A-domain is an equilibrium 
reaction. Activation of a cognate aa substrate (S) by the enzyme (E) consumes one molecule 
of ATP and generates enzyme-bound aa adenylate (E-S-AMP) and free pyrophosphate (PPi); 
whereas the reverse process yields ATP and free substrate. The equilibrium situation can thus 
be represented by the equation E+S+ATP ↔[ES-AMP] + PPi [143]. If radiolabeled 32PPi is 
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present in a reaction it will be incorporated into AMP to yield 32P-ATP, but only if a substrate 
that is recognised and activated by the enzyme is present. Two versions of this assay were 
employed for assessment of substrate specificity, both of which were validated using positive 
and negative control reactions prior to use with the purified AT bi-domains described above.  
 
4.2.4.1 –Validation of ATP/32PPi exchange assay version 1 
The first version of the ATP/32PPi exchange assay used (EA1) followed the protocol of 
Ackerley and Lamont [37, 143]. In this assay exchange reactions containing enzyme, buffer, 
essential cofactors, 32PPi and individual aa substrate candidates were set up in triplicate in 1.5 
mL microfuge tubes and incubated for 30 min at 28 °C. Following incubation, a suspension of 
activated charcoal in perchloric acid solution was added to terminate the reaction and bind 
ATP. The charcoal was then applied to a 0.22 µM filter and washing steps carried out to 
remove free 32PPi. After washing, ATP was eluted from the filter and transferred into 
scintillation vials containing distilled water. Cerenkov counts were then taken to assess the 
amount of 32P-ATP that had been formed in the presence of each substrate.  
 
To test this protocol a control experiment was run, using soluble fractions from E. coli or P. 
syringae crude cell lysate in the place of purified enzyme. Cell lysate contains a mixture of all 
soluble enzymes, including those that carry out reversible aa adenylation reactions such as 
NRPS enzymes and tRNA synthetases. It was found that inclusion of E. coli lysate resulted in 
a 31.6-fold increase in radioactivity recovered from activated charcoal when compared to 
reactions without any lysate. Inclusion of P. syringae lysate resulted in 6.4-fold increase in 
radioactivity. The results of this experiment are shown graphically in Figure 4.5. These results 
indicated that the assay was effective for recovering and quantifying 32P-ATP formed as a 
result of an enzymatic reaction and therefore suitable for the assessment NRPS A-domain 
substrate specificity.  
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4.2.4.2 – Validation of exchange assay version 2 
Although shown to be effective for recovering and quantifying 32P-ATP, EA1 proved time-
consuming and cumbersome, owing mainly to the need for immobilisation of charcoal from 
each reaction on a separate filter followed by washing and elution steps. During the course of 
this study an alternative version of the assay (EA2) was tested, employing a micro-centrifuge-
based protocol that has been used in a number of published characterisation reports [10, 16-
19]. Exchange reactions were set up, incubated and terminated by charcoal/perchloric acid 
addition as for EA1, except a 10-fold increase of 32PPi was included to improve sensitivity. 
Following reaction termination, charcoal was pelleted by centrifugation and washing steps 
carried out in 1.5 mL microfuge tubes. The charcoal was then suspended in distilled water and 
transferred to a scintillation vial for direct measurement of Cerenkov counts. Total processing 
time from termination to measurement of Cerenkov counts for EA2 was about 1/3 of that for 
EA1.  
 
A positive control experiment was also run for EA2. In this experiment a previously 
characterised serine activating A-domain, that of the E. coli siderophore synthetase EntF [20, 
Figure 4.5 – Validation of 
exchange assay EA1 using cell 
lysate positive controls 
Assays were performed in triplicate as 
described in Section 2.10.1, error bars 
represent +/- one standard deviation. 
Lysate positive controls contained 10 
µL of filter sterilised cell lysate 
soluble fraction from either E. coli or 
P. syringae. In the case of the no-
lysate reactions, 10 µL lysis solution 
was included in the place of cell 
lysate.  
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21], was employed. EntF A-domain protein was expressed from pET28a+ in a BL21 
background at 18 °C in LB medium (without betaine and sorbitol addition being required) and 
subsequently purified. Exchange reactions were set up in triplicate, testing four different aas 
(L-ser, L-asp, L-lys and L-thr) and a no substrate control. Following washing and transfer to 
scintillation vials, the amount of 32P-ATP formed in each reaction was assessed by Cerenkov 
counting. The first attempt of this assay showed weak but reproducible ATP/32PPi exchange 
activity for recombinant EntF in the presence of lysine only (Figure 4.6A) – an unexpected 
result given that EntF is a known activator of serine. A second batch of recombinant EntF was 
subsequently prepared, this time following the betaine/sorbitol expression procedure used with 
the P. syringae AT bi-domains. The results of this second experiment, shown in Figure 4.6B, 
are clearly consistent with EntF being an activator of L-serine. The EA2 assay procedure, as 
well as prior enzyme purification steps, was therefore deemed suitable for determination of 
NRPS A-domain specificity. The difference in activity between the two preparations of EntF 
indicate that NRPS A-domains are capable of adopting soluble but inactive conformations in 
solution and also demonstrates the utility of the betaine/sorbitol expression method (Section 
4.2.3) for promoting correct folding of recombinant proteins. 
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4.6 – Validation of exchange assay EA2 using EntF A-domain positive control 
A – Exchange activity of his6-tagged EntF A-domain preparation 2 in the presence of 10 mM of the indicated aa 
substrate.  
B – Exchange activity of his6-tagged EntF preparation 1 showing weak activation of L-lysine.  
C – Comparison of unexpected activity of preparation 1 with that seen for the subsequent preparation 
highlighting the difference between weak activation of L-lysine and true exchange activity in the presence of L-
serine. Assays were performed in triplicate as described in section 2.10.1, error bars represent +/- one standard 
deviation. NENS= no enzyme or aa substrate, NS= no aa substrate. 
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4.2.4.3 – Assessment of substrate specificity of P. syringae pyoverdine side-chain NRPS 
by ATP/32PPi exchange assay 
Each of the seven AT bi-domains purified, except 261, was subjected to either EA1 or EA2 in 
order to determine substrate specificity. In each assay reactions were set up in triplicate with 
either L-serine, L-lysine, L-aspartic acid or L-threonine as a substrate. Triplicate no-substrate 
controls and no-enzyme controls were also included. It was not deemed necessary to include 
any additional aa substrates, as each of the modules had already been confirmed as a 
pyoverdine synthetase by gene knockout (See section 3.10.2) and the side-chain of P. syringae 
pyoverdine has been shown to contain only the four aas that were tested in all substrate 
specificity assays [22, 23]. None of the AT bi-domains displayed the expected ATP/32PPi 
exchange activity with their expected substrate, however in some instances unexpected low 
levels of activity were seen in the presence of L-lysine. Table 4.1 gives a summary of assays 
conducted and results for each bi-domain. Figure 4.7 shows representative assay results. A 
control assay was also run with L-lysine in the presence of no enzyme and no significant 
difference was seen between reactions containing L-lysine and those without (not shown). 
One possible explanation for the lack of exchange activity seen was that the enzymes were co-
4.7 – Representative assay 
results for EA1 and EA2 
A- Substrate specificity assessment of 
his-tagged 231 AT bi-domain using 
EA1. Assays were preformed in 
triplicate as described in section 210.1, 
error bars represent +/- one standard 
deviation. 
B- Substrate specificity assessment of 
his tagged 242 AT bi-domain using 
EA2 showing weak exchange activity 
in the presence of L-lysine only.  
Assays were preformed in triplicate as 
described in section 210.1, error bars 
represent +/- one standard deviation. 
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purifying with small amounts of the molecular chaperone DnaK; this phenomenon was 
previously observed during purification of the pyoverdine NRPS PvdD AT bi-domain from P. 
aeruginosa, and appeared to inhibit exchange activity [37]. To test this possibility, DnaK 
contamination was removed from two Pspph enzyme preparations (251 and 252) as per the 
previous PvdD study, by incubation at 37 °C in the presence of 2 mM ATP and 10 mM 
MgSO4, followed by a second passage of Ni-NTA affinity chromatography [37, 143]. The re-
purified proteins were then assayed for exchange activity as before, and were once again 
found to be inactive. Interestingly 252, which previously showed reproducible low levels of 
activity with lysine, no longer exhibited this activity following ATP treatment (Figure 4.8), 
indicating that such activity may be symptomatic of DnaK contamination. Since DnaK is 
known to associate with improperly folded or aggregated proteins [4, 24, 25] it follows that 
the unexpected lysine activation observed was a result of the protein in the assay being 
improperly folded.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 – Effect of ATP/Mg2+ treatment on ATP/32PPi exchange activity of 252 
his6-tagged 252 AT bi-domain (blue bars) was assessed for substrate specificity using EA1 and found to have 
weak exchange activity in the presence of L-lysine. The remainder of the purified protein was incubated at 37 °C 
with 2 mM ATP and 10 mM MgCl2, then subjected to an additional passage of Ni-NTA affinity chromatography. 
Following ATP/Mg2+ treatment exchange activity was no longer observed in the presence of L-lysine (yellow 
bars). 
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4.3 – Exploring alternative protein expression strategies 
 
Following the failure of E. coli based expression to yield active his6-tagged AT bi-domain, 
five additional strategies for expression and subsequent purification were investigated. The 
rationale behind these, as discussed at length in Section 4.4 of this chapter, was that the 
protein initially obtained, though soluble, may have been inactive due to partial or improper 
folding. Additional measures were therefore tested in an attempt to purify properly folded 
protein for subsequent assays.  
 
Two new assay procedures, which did not require the use of radioactive isotopes, were also 
implemented. The impetus for developing new, non-radioactive assays was decreasing the 
time between production and assessment of proteins. Since EA1 and EA2 relied on having 
access to a short-lived stock of 32PPi, it had previously been necessary to purify all proteins 
prior to substrate specificity assessment, in order to allow all proteins to be assessed without 
the need for ordering multiple, costly batches of  radioisotope. Development of the new assays 
allowed assessment of proteins immediately following purification, decreasing the likelihood 
of stocks becoming denatured while in storage. 
 
 4.3.1- Pseudomonas species as an expression host 
It stands to reason that the environment most conducive to correct folding of a protein is the 
protein’s native environment, since this is where it has resided and evolved into its present 
state. Differences in osmolarity, translational machinery, pH and molecular chaperone 
function are all possible reasons that have been attributed for failure of a protein to fold 
correctly in a heterologus host [161, 163]. With this in mind it was decided to attempt 
overexpression of AT bi-domains in Pseudomonas hosts. 
 
4.3.1.1 – Development of a plasmid based system for expression and purification of his6-
tagged proteins from Pseudomonas species 
Initial attempts at expression in Pseudomonas were carried out using the previously developed 
broad host range vector pMMB67EH [168]. For testing, the 231 bi-domain was sub-cloned 
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into this vector and initial expression and purification trials run using both P. syringae and P. 
putida as hosts. It was determined from these trials that pMMB67EH was not a good vector 
for expression and purification in these hosts for a number of reasons. The expression levels 
observed from this plasmid were very low, especially in P. syringae, making it difficult to 
obtain sufficient protein for characterisation assays. Furthermore, we have observed that the 
ampicillin resistance marker of pMMB67EH functions poorly in Pseudomonas species leading 
to difficulty in plasmid selection and maintenance. Possibly due to unusual supercoiling, this 
plasmid is also extremely resistant to cleavage with restriction endonucleases and difficult to 
purify in large amounts owing to its low copy number in E. coli. It was therefore decided to 
develop a new expression plasmid that allowed higher levels of protein expression in 
Pseudomonas species, had a higher copy number in E. coli and was more amenable to genetic 
manipulation.  
 
4.3.1.1.1 Construction of pSX, a novel Pseudomonas expression vector  
The plasmid constructed to address the shortcomings of pMMB67EH was based on the 
existing broad host range vector pUCP22 [98]. Primers were designed to amplify the backbone 
of pUCP22 such that the resulting PCR product lacked only the original multiple cloning site 
and contained terminal AgeI and SpeI restriction sites. A second set of primers was designed 
to amplify lacIQ, the tac promoter and MCS from the E. coli expression vector pUCX [99], 
flanked by the same restriction sites. The two PCR products were then digested, ligated 
together and transformed following standard molecular biological protocols. The resulting 
plasmid, designated pSX, was found to be suitable for IPTG-regulated expression of 
recombinant proteins in Pseudomonas species, had a high copy number in E. coli and was 
readily cleaved by restriction endonucleases. The gentamycin resistance marker of pSX 
allowed reliable selection and maintenance of the plasmid in Pseudomonas species.  
 
4.3.1.1.2 – Optimisation of pSX-based expression of his6-tagged proteins in Pseudomonas 
species 
For the purpose of initial expression trials, the 251 AT bi-domain was sub-cloned from 
pET28a+ into the newly developed pSX plasmid. The resulting construct was transformed into 
P. syringae, P. putida and P. aeruginosa by electroporation and protein induction profiles 
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were run for each of these hosts. Initial trials using a final concentration of 0.5 mM IPTG 
resulted in no visible expression of recombinant protein. For subsequent expression profiles in 
each host, 50 mL cultures were grown to an appropriate density (OD 600 = 0.5-1.0) and 
protein expression induced by addition of IPTG to a final concentration of 1, 2.5, 5 or 10 mM. 
Cultures were incubated for an additional 12-16 h after which analysis of total cellular protein 
by SDS PAGE was conducted. For each strain an uninduced control was also included. 
Results of these experiments (Figure 4.9) showed that higher levels of IPTG were required for 
induction of protein expression in Pseudomonas hosts than E. coli and that even when a final 
concentration of 10 mM IPTG was used, expression was still much lower than that seen in E. 
coli at a final concentration of 0.5 mM IPTG.   
 
 
 
 
Figure 4.9 – Expression tests for pSX:251 in P. syringae, P. putida, P. aeruginosa and E. 
coli 
50 mL cultures were grown to an OD 600 of 0.5-1.0 prior to induction of protein expression by 
addition of IPTG. Cultures were incubated for a further 12-16 h before analysis of total cellular protein 
by SDS PAGE. The final concentration of IPTG in mM is indicated above each lane. MW = Molecular 
weight marker. 
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4.3.1.2- Purification of his6-tagged proteins from Pseudomonas expression hosts 
Following expression trials, AT bi-domains for 231 and 252 were sub-cloned from pET28a+ 
into pSX to give the plasmids pSX:231 and pSX:252. A new construct was also created for 
expression of the A-domain of Pspph1923 without any additional domains, this construct was 
designated pSX:23a. Plasmids were introduced into P. syringae and P. putida by 
electroporation and their expression tested using a final concentration of 5 mM IPTG, with 
results comparable to those described above (not shown). For purification of these domains 
from P. syringae and P. putida, 500 mL cultures were grown at 28 °C to an OD 600 of 0.5-1.0 
mM. Protein expression was then induced by  addition of IPTG to a final concentration of 5 
mM and cultures were incubated for an additional 16-24 h. Cell harvest, lysis by French press, 
removal of insoluble debris and purification of his6-tagged protein was then conducted as 
previously described for E. coli. Purification of each of the proteins for which a pSX construct 
was available was attempted from both P. syringae and P. putida. Figure 4.10 shows SDS 
PAGE analysis of the successfully purified proteins. From P. syringae only 252 and 23a had 
sufficient yield for analysis by SDS PAGE. Greater yields of 231 and 251 were obtained from 
P. putida, but in each case contaminating protein species were present in the final preparation 
of desalted protein. 
 
 
 
 
 
 
 
Figure 4.10 – His6-tagged A and AT 
proteins purified from P. syringae and P. 
putida 
1) Molecular weight marker. 2) 231 purified from P. 
putida. 3) 23a purified from P. putida. 4) 251 
purified from P. putida. 5) 252 purified from P. 
putida. 6) 252 purified from P. syringae. 7) 23a 
purified from P. syringae. Where contaminating 
species are present, the band corresponding to the 
expected size of the target protein is indicated with 
an arrow.  
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4.3.1.3 – Development of a non radioactive assay for assessment of A-domain substrate 
specificity  
In order that purified proteins might be rapidly assessed for substrate specificity, without the 
need for radioisotope, an absorbance based 96 well plate assay for A-domain specificity was 
developed. The assay was based on the Enzcheck® pyrophosphate assay kit, which is 
commercially available from Invitrogen. This assay, known as the PPi release assay, has 
previously been used to determine substrate-dependent release of PPi from ATP by A-domains 
in a 1 mL cuvette format [78, 160, 169, 170]. This assay relies on the fact that aa adenylate 
formation by an A-domain in the presence of a cognate aa results in the release of PPi, levels 
of which are indicative of substrate preference [111]. PPi levels cannot be measured directly 
however inclusion of two additional enzymatic steps and one additional substrate in the 
reaction results in the formation of a compound which can be assayed spectrophotometrically. 
The first enzyme is inorganic pyrophosphatase (IP), which cleaves PPi into two units of 
inorganic phosphate (Pi). These Pi intermediates are then covalently linked to the nucleotide 
analogue 2-amino-6-mercapto-7-methylpurine ribonucleoside by the action of a second 
enzyme, purine nucleoside phosphorylase, resulting in a shift of absorbance maximum from 
330 to 360 nM proportional to the original levels of PPi in a sample. 
 
To ascertain whether or not the Enzcheck® assay was suitable for quantification of PPi in a 96 
well plate format, reactions were scaled down from 1 mL to 200 µL and a PPi standard curve 
set up with final concentrations ranging from 0-40 µM PPi (sodium pyrophosphate). It was 
found that in a 96 well plate format, the assay produced a linear relationship between [PPi] 
and A360 for concentrations ranging from 0 to 20 µM PPi (Figure 4.11A). To determine 
whether the assay was suitable for determination of A-domain substrate specificity, a positive 
control experiment was run using the EntF A-domain. In this experiment A-domain reactions 
with one of four substrates, as well as a no-substrate negative control, were set up in triplicate 
in a final volume of 125 µL. These reactions were allowed to proceed for 60 min before 
addition of Enzcheck® assay components. The results of this end-point assay were consistent 
with the previously characterised role of EntF as a serine activator (Figure 4.11B), thus 
validating the assay (henceforth referred to as RA1) for assessment of A-domains substrate 
specificity.   
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Figure 4.11 – Validation of absorbance-based PPi release assay RA1 for determination of 
A-domain substrate specificity. 
A- RA1  standard curve for reactions incubated and quantified in a 96 well plate. Reactions for each PPi 
concentration were set up in triplicate, in a final volume of 200 µl as described in Section 2.10.2. Following 
incubation at room temperature for 20 min, absorbance at 360 nM was measured using a microplate reader. Error 
bars represent +/- one standard deviation. 
B- Assessment of EntF substrate specificity using RA1. RA1 measures substrate preference by determining levels 
of PPi released in the presence of a particular aa substrate candidate. A-domain reactions for each substrate were 
set up in triplicate in a 96 well plate as described in Section 2.10.2; NS= no substrate. Error bars are presented as 
+/- one standard deviation. Absorbance values are given relative to control reaction containing no enzyme or 
substrate control. 
 
 
A second, continuous, version of this assay was tested by adding the components of the A-
domain and Enzcheck® reactions to wells simultaneously. These reactions were initiated by 
addition of the EntF A-domain and the change in A360 was measured continuously for 60 min, 
followed by a final reading at 220 min. In this continuous assay, two substrates (L-ser and L-
thr) as well as a no substrate control were assessed in parallel, with the preferred substrate 
serine included at two concentrations (10 mM and 100 mM) . Reactions including 200 µM PPi 
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were also included. The purpose of this experiment was to ascertain whether the reaction was 
reaching saturation before the endpoint of 60 min and also to determine whether increasing 
substrate concentration would increase reaction rate. As shown in Figure 4.12, reactions were 
not reaching saturation point (as defined by the 200 µM PPi control reactions) and increasing 
the concentration of the aa substrate 10-fold had little effect on the overall reaction rate. Taken 
together, the results summarised in Figures 4.11 and 4.12 indicated that the absorbance-based 
PPi release assay adapted for 96 well plate use was suitable for determination of A-domain 
substrate specificity.  
 
Figure 4.12 – Monitoring continuous release of PPi by EntF A-domain 
Reactions were set up in a 96 well plate as for the PPi release RA1 (2.10.2), except Enzcheck® components were 
added prior to initiation of reactions. Immediately following addition of EntF A-domain the plate was transferred 
to a microplate reader set to measure Abs 360 every 60 s; for clarity only every fifth point is shown. Neg = no A-
domain or aa substrate, NS = no substrate, PPi = 200 µM PPi saturation control, 10 x L-ser = L-serine at 20 mM, 
L-ser/L-thr = aa substrates at 2 mM.  
 
 
4.3.1.3.1 – Design and testing of an alternative PPi release assay not based on a commercially 
available kit 
While RA1 was a convenient method for rapidly assessing substrate specificity of A-domains, 
it relied on reagents supplied in the Enzcheck® kit, making the assay relatively expensive to 
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run. To reduce the cost associated with running multiple assays, an alternative version, RA2 
was developed. This assay was effectively the same as the malachite green reagent assay for 
A-domain assessment described by McQuade et. al [111], except with modifications to the 
malachite green reagent [171] as described in 2.10.2. For RA2, PPi release by an A-domain 
proceeds as for RA1 and, as before, PPi is cleaved into two equivalents of Pi by IP. RA2 
differs from RA1 only in the means of detection of Pi levels. In RA2, reactions are terminated 
by addition of acidic ammonium molybdate solution to each well, followed by addition of 
malachite, or brilliant green dye. A green complex between the dye, molybdate ions and free 
Pi is then formed. The intensity of green colouration is dependent on the concentration of free 
Pi and can be measured via absorbance at 650 nM. The effective range of RA2 was 
determined to be 0.2-25 µM free PPi (Figure 4.13A). The suitability of RA2 for assessment of 
A-domain specificity was assessed, using the previously characterised NRPS protein 
BpsA[80] as a positive control. Results of BPSA assessment with RA2 ( Figure 4.13B) were 
consistent with previous experimental results showing BPSA to be an activator of L-gln [80]. 
A detailed description of BPSA is given in Section 6.1. 
 
4.3.1.4 – Substrate specificity assessment of domains purified from Pseudomonas species 
Each of the his6-tagged domains purified from P. syringae and P. putida was assessed for 
substrate specificity using RA1 or RA2. Each purified protein was assessed for PPi release 
activity in the presence of L-lysine, L-serine, L-aspartic, L-threonine and no aa substrate, as 
described in Sections 2.10.2 and 2.10.3. In no case was there any significant increase in 
activity in the presence of any aa substrate, suggesting that purification from Pseudomonas 
species had not produced active protein. 
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Figure 4.13 – Validation of A-domain specificity assay RA2 
A – A two-fold dilution series from 0.2-50 µM PPi, in 1 x RA2 reaction buffer, was set up in triplicate in a 96 
well plate. Following incubation at RT for 5 min to allow the pyrophosphatase reaction to proceed, RA2 
detection reagents were added and absorbance at 650 nM measured using a microplate reader. 
B – Purified BpsA, a characterised L-gln specific NRPS, was incubated with 10 mM of each of the indicated aa 
substrates in 1 x RA2 reaction buffer for 30 min at 28 °C. RA2 detection reagents were then added and 
absorbance at 650 nM measured using a microplate reader. Reactions were set up in triplicate for each substrate. 
For both A and B, error bars represent +/- one standard deviation. NS = no aa substrate.   
 
 
4.3.2 – Purification and assessment of proteins produced in E. coli co-
expressing molecular chaperone proteins 
The most common cause of protein inactivity following over-expression and purification is 
incorrect folding [5, 6, 28], a process dependent on not only the primary sequence of the over-
expressed protein but also on the action of various chaperone proteins that guide the folding of 
a nascent protein into its correct, active conformation [29, 34-36]. One recently developed 
strategy for improving the conformational quality of proteins over-expressed in E. coli is the 
co-expression of the molecular chaperone proteins DnaK, DnaJ, GroESL and GrpE; this 
process has been shown to be effective in a number of instances for improving both the 
solubility and activity of recombinant proteins [25, 29-32]. In order to investigate the 
possibility that co-expression of molecular chaperone proteins might promote correct folding 
of recombinant Pspph A- and AT-domains in E. coli, four chaperone co-expression strains 
(CH1-4) were used as expression hosts. As outlined in Table 2.7, the chaperone co-expression 
strains harbour plasmids, allowing IPTG regulated co-expression of different combinations of 
the chaperone proteins DnaK, DnaJ, GroESL, ClpB and GrpE in BL21(DE3) cells. The use of 
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these strains for improving solubility of recombinant proteins over-expressed in E. coli has 
been well studied [106, 172, 173], although not previously for NRPS protein expression. 
 
4.3.2.1-Assessment of chaperone strains for improvement of NRPS solubility in E. coli  
An initial trial using the A-domain of Pspph1923 (23a) was conducted to assess the suitability 
of CH1-4 for improving yield of soluble recombinant NRPS proteins. Expression of 23a was 
carried out in each of the four chaperone expression strains as described in Section 2.9.1.4. 
Following expression soluble fractions were separated (Section 2.9.2.1) then analysed by SDS 
PAGE and the amount of soluble 23a, relative to total 23a protein, was determined by 
volumetric analysis using the programme Imagequant®. The results of the solubility trial, 
shown graphically in Figure 4.14, indicated that expression using CH4 as a host resulted in the 
highest levels of soluble 23a, with CH2 a distant second. For Pspph1923 it was necessary to 
use the A-domain without its cognate T-domain in solubility trials, as the recombinant AT bi-
domain protein was found to run at the same location as DnaK on SDS PAGE gels (DnaK 
being expressed at high levels in chaperone strains).   
 
 
 
 
Figure 4.14 – Solubility trial 
using Chaperone strains 1-4 
23a was expressed in each chaperone 
strain under identical conditions. Soluble 
and insoluble fractions were then 
analysed by SDS PAGE and % solubility 
of 23a determined by volumetric 
analysis.  
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4.3.2.2- Substrate specificity assessment of 23a and 251 purified from chaperone strains 
two and four 
Following initial trials to assess the suitability of each chaperone co-expression host, 23a and 
251 were purified from both CH2 and CH4. Expression and purification was conducted as 
described in Section 2.9 and purified domains were assessed for substrate specificity using 
RA1. No activity was seen in the presence of any substrate for either 23a or 251 purified from 
CH2. For both 23a and 251 purified from CH4, weak activity in the presence of L-lys was 
observed. Although lysine is the predicted substrate of 23a, the activity seen was extremely 
weak compared to that of recombinant EntF with serine (included as a positive control) so is 
not likely to represent true adenylation activity, rather the non-specific activation that had 
previously been observed with putative inactive A-domains in the presence of L-lys.  
 
4.3.3- Refolding of a denatured AT bi-domain isolated from inclusion 
bodies 
When isolating recombinant proteins prone to inclusion body formation, an alternative to 
purification of soluble protein is to denature insoluble proteins trapped in inclusion bodies and 
subject them to refolding treatment [38, 39]. There are a number of methods for refolding of 
denatured proteins isolated from inclusion bodies, all of which operate on the same basic 
principle[174]. Inclusion bodies are first solubilised in a harsh denaturant, such as SDS, 
guanidium HCl or urea, and the concentration of this denaturant is then gradually decreased. 
As the denaturant concentration is reduced, denatured proteins are forced to adopt a soluble 
conformation in order to remain in solution. For any globular cytoplasmic protein, refolding 
has (at least theoretically) the potential to regenerate the native conformation of a protein, 
which should be the most energetically favourable state in solution [172, 175]. A particularly 
convenient protocol for refolding of affinity tagged recombinant proteins purified by column 
chromatography is on column refolding [176, 177]. In this process denatured, affinity-tagged 
proteins are bound to a column in the presence of denaturant and a decreasing concentration 
gradient of denaturant is applied to the column. Protein bound to the column is refolded as the 
concentration of denaturant is slowly decreased to zero. The process is thought to be assisted 
by immobilisation on the column matrix, which prevents the formation of aggregates [174]. 
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4.3.3.1 – Isolation, denaturation and on-column refolding of recombinant NRPS domains 
sequestered in inclusion bodies 
A detailed description of the refolding process is given in Section 2.9.2.3, briefly; a 500 mL 
expression culture was set up for 252 under standard conditions (induction at 37 °C with 0.5 
mM IPTG) in order to bring about inclusion body formation. Following lysis, inclusion bodies 
containing the target proteins were collected by centrifugation, dissolved in binding buffer 
containing 8 M urea and applied to a Ni-NTA column. Washing steps were then carried out 
using standard buffers with urea added to a final concentration of 8 M. Following washing, a 
linear gradient of urea from 8 to 0 M in binding buffer was applied to the protein bound to the 
column over a period of 24 h. Any soluble protein remaining on the column was eluted with 
standard elution buffer that did not contain urea. A schematic representation of the refolding 
process and apparatus is given in Figure 4.15. Using this process it was possible to regenerate 
soluble recombinant protein for 252 (Figure 4.16). Refolded 252 was assessed using both RA1 
and EA2, but did not show any adenylation activity, indicating that it had not been refolded 
into an active conformation.  
 
 
 
 
 
Figure 4.15 – 
Apparatus for on 
column refolding of 
denatured proteins 
The column was connected 
to a peristaltic pump, so that 
as buffer flowed from 
chamber 1 to chamber 2 the 
urea concentration decreased 
in a linear fashion. Flow rate 
was adjusted such that 
concentration of urea on the 
column decreased from 8 to 
0 M over 24 h. Any refolded 
protein remaining on the 
column was then eluted as 
before. 
 
 
 
1 2
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Figure 4.16 – SDS Page analysis of soluble 252 recovered from denatured inclusion 
bodies 
MW = Molecular weight marker. 1-6 = 10 µl from 1.5 mL fractions of refolded 252 in the order they were eluted 
from the column. Fractions were subsequently pooled and, following buffer exchange, assessed for substrate 
specificity using RA1 and EA2. 
 
 
4.3.4 – Exploration of alternative domain boundaries and constructs for 
substrate specificity assessment 
As outlined in the previous sections, active AT bi-domain protein was not recovered for any of 
the seven P. syringae pyoverdine side-chain synthetase modules. A construct expressing only 
the A-domain of Pspph1923 (23a) also failed to produce active protein. In order to investigate 
the possibility that this lack of activity was due to inappropriate domain boundary definition in 
the original constructs, new constructs were produced in which the domain boundaries were 
altered. Two different domain expression platforms were constructed and tested as outlined in 
the following sections. 
 
 
 
 
 
 123 
4.3.4.1 – Expression and purification of entire NRPS side-chain synthetase proteins for 
substrate specificity assessment 
The entire gene for Pspph1925 was cloned into both pET28a+ and pSX. Initially the pSX 
construct was transformed into the corresponding side-chain synthetase knockout strain of P. 
syringae to determine whether functional protein was being produced. As described in Section 
3.3.3, pSX:1925 was found to restore pyoverdine synthesis in Pspph∆1925, establishing that 
functional Pspph1925 protein was being produced. A particularly interesting feature of 
complementation of Pspph∆1925 by pSX:1925 (Section 3.3.3), was that restoration of 
pyoverdine synthesis was only achieved on agar plates grown at 18 °C when ITPG was absent 
from the growth medium, suggesting that when expressed at high levels from pSX, Pspph1925 
was not being produced in an active conformation.  
 
Purification of the entire side-chain synthetase for both Pspph1923 and Pspph1925 was 
attempted from both E. coli and P. syringae. For E. coli purification, expression at 18 °C in 
betaine/sorbitol media was used, as previously described. For purification from P. syringae, in 
addition to the expression protocol described for this organism (Section 2.9.1.3), a plate based 
purification protocol was also attempted. For the plate-based protocol, four iron-limited media 
plates were streaked to confluency with Pspph∆1925::pSX:1925 and grown at 18 °C for five 
days. After five day’s growth there was clear evidence of pyoverdine production (See Figure 
3.4c for representation), indicating that functional his6-tagged Pspph1925 protein was being 
produced. For purification, cells were scraped from the plates, resuspended in binding buffer 
and subjected to the usual lysis and purification steps. However, purification attempts from 
both P. syringae and E. coli did not yield discernable amounts of recombinant NRPS protein, 
as assessed by SDS PAGE and Biorad DC assay, so substrate specificity assessment was not 
possible. 
 
4.3.4.2- Alternative constructs for production and purification of AT bi-domains 
After it was determined that purification of entire NRPS proteins from E. coli or P. syringae 
could not be achieved, alternative strategies were considered for production of AT bi-domains. 
These were guided by the recent publication of a paper in which the substrate specificity of an 
AT bi-domain from the P. syringae NRPS protein syrE was determined [78]. The new 
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constructs were modelled on the AT bi-domain overexpression construct described in this 
paper. These constructs, and the proteins they expressed are henceforth indicated using the 
prefix xAT. For example, the construct pXAT:252 contains the first module from the gene 
pspph1925 with new domain boundaries defined as described below. The protein expressed 
form this construct is referred to as xAT251. 
 
4.3.4.2.1- Design and construction of pXAT expression vectors 
In order to define the new domain boundaries for pXAT constructs, the protein sequence of 
the SyrE AT bi-domain successfully characterised in [78] was aligned against each of the P. 
syringae pyoverdine side-chain NRPS sequences using the alignment function of Vector 
NTI®. Primers were then designed to amplify the corresponding nucleotide sequence and 
domains were cloned into pET28a+ as previously described. In all cases the downstream 
restriction site used for cloning was NdeI and the upstream site was HindIII. Confirmation of 
constructs by sequence and testing protein expression testing was performed as previously 
described.  
 
4.3.4.2.2- Purification and substrate specificity assessment of XAT bi-domains 
An alternative expression protocol to those previously described in this chapter was used for 
the purification of xAT bidomains. This expression protocol, which is described in detail in 
Section 2.9.1.5, made use of auto-induction media [178], with growth conducted at 16 °C for 
36-48 h. Using this auto-induction protocol, good yields of soluble xAT251 and 241 were 
obtained with the resulting protein preparations being of better purity than those for the 
original AT bi-domain constructs using betaine/sorbitol expression. The substrate specificities 
for xAT-domains purified for 251 and 241 were assessed using RA2 and in each case no 
specificity for any of the aas tested was observed. For x251, weak activation of lysine was 
again observed. It has been noted previously by structural biology groups that inclusion of low 
concentrations of a mild denaturant in protein assays can increase activity, possibly by 
prevention of protein aggregate formation (Dr TT Caradoc-Davies, pers. comm.). Given that 
weak activity in the presence of L-lysine was repeatedly observed for otherwise inactive 
NRPS modules, it is possible that lysine was promoting enzyme activity by acting as a weak 
denaturant. The possibility that L-lysine was promoting activity of purified recombinant A-
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domains was investigated by repeating Assays for x251 in the presence of various 
concentrations of L-lys, with either L-ser or L-thr as a co-substrate. As illustrated in Figure 
4.17, addition of L-lys to reactions did not promote activation of either L-ser or L-thr by x251 
(the latter being the predicted substrate for this construct), although it did result in elevated PPi 
release by xAT 251 independent of any co-incubated aa substrate. Table 4.1 gives a summary 
of all purification procedures described in this chapter and subsequent assay results.  
 
 
Figure 4.17 – Assessment of L- lysine concentration on PPi release activity of x251 
Purified x251 was incubated with 10 mM of indicated aa substrates in 1 x RA2 reaction buffer for 30 min at 28 
°C. RA2 detection reagents were then added, with absorbance at 650 nM measured using a microplate reader. 
Reactions were set up in triplicate for each substrate, for no-enzyme controls one reaction was set up for each L-
lys concentration. Error bars represent +/- one standard deviation. NS = no aa substrate, NENS= no x251 or 
substrate. Key indicates the final L-lys concentration present in a given reaction.  
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Protein and expected 
substate 
Purification 
procedure(s) 
Assay procedure(s) used  Results 
231: L-lysine BS, PP, PS EA1 No activity with any substrate 
23a: L- lysine PS, PP,  
CH 
RA1(PS, PP) 
RA1 (CH) 
No activity with any substrate 
Weak activity with L-lysine 
241: L-aspartic acid BS, CH, 
xAT 
EA2 (BS, CH) 
RA2(xAT) 
No activity with any substrate 
No activity with any substrate 
242: L-threonine BS EA2 Weak activity with L-lysine 
251: L-threonine BS, BS-ATP 
PS, PP, CH 
xAT 
EA1 (BS) 
EA1 (BS-ATP)  
RA1 (PS, PP, CH) 
RA2(xAT) 
No activity with any substrate 
No activity with any substrate 
No activity with any substrate 
Weak activity with L-lysine 
252:L-serine BS, PS, PP, 
CH, RF 
EA1(BS) 
EA1(BS-ATP) 
RA1 (CH) 
EA2 (RF) 
Weak activity with L-lysine 
No activity with any substrate 
Weak activity with L-lysine 
No activity with any substrate 
261: L-aspartic acid BS Not assessed - 
262 L-serine BS EA1 Weak activity with L-lysine 
 
Table 4.1 – Summary of purification procedures and assay results 
For purification procedures: BS = betaine sorbitol, BS-ATP = Betaine sorbitol followed my ATP/Mg treatment 
and a second passage of Ni-NTA affinity chromatography; CH = purified from chaperone strains 2 and 4; PP = 
purified from P. putida; PS = purified from P. syringae; RF = Refolded from denatured inclusion bodies; xAT = 
Alternative domain boundaries investigated, autoinduction protocol used for expression. For Assay procedures: 
EA = ATP/32PPi exchange assay; RA = PPi release assay. Bracketed letters after assay procedure indicate which 
purification/ assay combination gave a particular result.  
 
4.4 – Discussion 
 
This chapter describes intensive efforts to biochemically determine the substrate specificities 
of seven A-domains derived from the five NRPS enzymes proposed to synthesise the aa side-
chain of pyoverdine in the bacterium Pseudomonas syringae pv phaseolicola 1448a. In spite 
of rigorous and systematic investigation, it was not possible to derive active protein for 
substrate specificity assessment for any of the seven domains investigated. There are a number 
of possible reasons for the failure to derive active protein, the feasibility of which is now 
discussed. 
 
Before any conclusions can be drawn regarding the activity or inactivity of the proteins 
assessed in this chapter, it is necessary to ensure that the assays employed were suitable for 
determination of substrate specificity. There were four assay procedures used to determine 
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substrate specificity: two ATP/32PPi exchange assays (EA1 and EA2) and two PPi release 
assays (RA1 and RA2). Variant forms of each of these assays have been previously described 
for the determination of A-domain specificities [78, 80, 111, 160], and validation experiments 
were carried out to identify potential problems that may have resulted from reagents, 
equipment and procedures specific to our laboratory. EA1 was validated using a cell lysate 
positive control experiment, the results of which demonstrated that this assay was effectively 
recovering and measuring 32P-ATP formed as a result of enzymatic reactions. For EA2, RA1 
and RA2, positive control experiments went a step further and employed a previously 
characterised NRPS protein as a positive control. For each assay, the results of the positive 
control experiments were consistent with the previously described results. These data suggest 
that the failure to detect any activity stemmed from inactivity of the purified proteins, and not 
from deficiencies in the various assay procedures.  
 
A possible reason for the inactivity of purified proteins is the presence of a small molecule 
inhibitor, either in the protein preparation itself or in one of the components of the subsequent 
assay. All examples of NRPS A-domain inhibitors thus far characterised are aminoacyl-AMP 
analogs that are thought to possess inhibitory activity by virtue of their similarity to the native 
adenylated substrate of an A-domain. Such inhibitors are generally specific to a particular A-
domain or set of A-domains with similar specificity [179, 180]. The likelihood that inhibitors 
specific to all six modules tested – but not to either the recombinant BpsA or EntF positive 
controls – seems remote, especially given that expression and purification were performed in 
three different host organisms (E. coli, P. putida and P. syringae). The activity of the EntF 
positive control is especially relevant to the putative serine activating domains 252 and 262, as 
any inhibitors specific to serine activating A-domains would be expected to inhibit the EntF 
A-domain also.  
 
Another possible factor to consider is the definition of domains used to derive over-expression 
constructs. Initially, domain boundaries were defined using the TIGR online NRPS analysis 
tool. AT bi-domains and A-domains defined in this fashion were used for construction of P. 
syringae and EntF over-expression constructs. In order to verify that all structural elements 
were present, aa sequence alignment of A-domains, as defined for use in over-expression 
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constructs, was performed against the A-domain of GrsA (pdb:1AMU) [25]. Visualisation of 
the resulting sequence alignments using DeepView [181] revealed that in each case all of the 
structural elements believed to be necessary for function of the A-domain were present in the 
final over-expression construct. Although the recombinant EntF construct was active, the 
domain boundaries selected might not have been optimal for the Pspph enzymes; and so an 
alternative set of AT bi-domain over-expression constructs was also designed and tested. 
Domain boundaries for these constructs were defined by protein sequence alignment against 
an AT bi-domain from P. syringae, which has successfully been used in substrate specificity 
determination experiments [78]. The AT-domains used for this second set of constructs were 
still inactive, despite good solubility.  
 
While there are no immediately obvious reasons why the domain boundaries chosen should 
have precluded production of active recombinant A- or AT-domain proteins, the possibility 
can not be completely discounted. Even if an exhaustive set of domain boundaries were tested, 
the possibility that the A-domains in question are incapable of functioning outside of their 
native setting would remain. While the domains of NRPS are certainly autonomous in some 
instances [1, 30, 169], there is no way of knowing if this dogma holds true for all, or even the 
majority of NRPS A-domains. The number of published examples in which A-domain 
specificity has been successfully determined biochemically is very small, and the specificity of 
the majority of A-domains assigned in public data bases is based on in silico prediction and/or 
determination of product structure. As failed attempts at A-domain characterisation are seldom 
published ([182] being a rare example of this), it is difficult to know how prevalent a 
phenomenon A-domain inactivity in vitro actually is.  
 
What is particularly surprising about the characterisation attempts reported here is that purified 
recombinant domains were inactive, in spite of having good solubility. Up until recently, the 
accepted paradigm for purification of recombinant proteins has been that solubility is a good 
indicator of activity, and that – especially for cytoplasmic proteins such as NRPS – proteins 
present in the soluble fraction of cell lysate are expected to be in their native, active 
conformation [161, 172, 183, 184]. However, increasing evidence suggests that solubility is 
not always a good indicator of conformational quality, and that for a given protein many 
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misfolded but soluble conformations may exist [185-187]. Since the native conformation of a 
protein should represent the lowest energy arrangement of all constituent atoms in a particular 
solution [175], inactive soluble conformations can be thought of as local energy minima that a 
polypeptide can become trapped in, if a cell’s protein folding machinery is overwhelmed 
[188]. A graphical representation of this principle is given in Figure 4.22.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 – The relationship between energy and conformation of proteins in the 
cytoplasm 
The native, active conformation of a protein is presumed to be at its lowest energy state in solution; however, 
there are thought to be a number of alternative, inactive soluble conformations which a protein can adopt. These 
conformations are represented as local energy minima in which a protein can become trapped without proper 
guidance from molecular chaperone proteins. Figure reproduced from [188]. 
 
 
It is possible that the P. syringae NRPS proteins described in this chapter are only able to 
adopt their active conformation when expressed at low levels in a cell. Evidence for this can 
be found in the complementation experiments described in Sections 4.3.4.1 and 3.3.3. In these 
experiments the entire Pspph1925 gene was cloned into pSX and the resulting construct used 
to successfully complement the corresponding P. syringae NRPS knockout strain, as 
 130
evidenced by restoration of fluorescence and ability to survive severe iron starvation. 
However, when IPTG was present in the medium – even under severe iron starvation, when 
survival of the bacterium depended on production of active 1925 protein – no enzyme activity 
was apparent. This suggests that elevation in expression levels as a consequence of IPTG 
addition may have resulted in excessive levels of nascent protein exceeding the folding 
capacity of molecular chaperone proteins. Even low levels of functional 1925 would 
presumably have allowed the bacterium to survive iron starvation, and the evidence suggests 
that once the cell’s capacity for folding has been exceeded, all of the protein produced ended 
up in an inactive conformation. If this hypothesis is correct then it is likely that the Pspph 
NRPS domains are particularly prone to misfolding when over-expressed at high levels.  
 
In light of this evidence, the most feasible explanation for the consistent inactivity of proteins 
observed in this chapter is that the expression levels exceeded folding capacity, even though 
numerous steps were taken to avoid these phenomena. Consequently, any soluble proteins that 
were expressed and purified were likely in an inactive conformation, and therefore unusable 
for substrate specificity determination.     
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Chapter 5 – Probing C-domain specificity using the 
pyoverdine biosynthetic NRPS of Pseudomonas aeruginosa 
as a model system. 
 
5.1 – Introduction 
 
Pyoverdine biosynthesis in pseudomonads provides a unique model system for conducting 
module swapping experiments with the aim of developing successful strategies for NRPS 
manipulation. This chapter describes the use of this model to investigate the specificity of 
NRPS C-domains. The majority of hands-on bench work was conducted by Honours student 
Mark Calcott following my research design and under my supervision, based on an original 
concept provided by Dr David Ackerley. However, with the exception of acknowledged 
Figures, the presentation and analysis of data in this chapter is my own. 
 
5.1.1 – Pyoverdine synthesis as a model system for module swapping 
experiments 
As described in Chapter 3, pyoverdine is a siderophore synthesised by NRPS enzymes in 
fluorescent Pseudomonas species. There are three features of pyoverdine synthesis that are 
particularly well suited for studying NRPS manipulation. First, pyoverdine is fluorescent and 
coloured. This fluorescence and colour is a property of the chromophore group of pyoverdine, 
and, as evidenced by the diversity of pyoverdine structures in nature, is independent of the 
composition of the aa side chain [119, 121, 127]. Thus, the NRPS responsible for synthesis of 
the side chain can be manipulated without destroying the fluorescence of the final product, 
providing a rapid and unambiguous means for assessment of the function of modified NRPS 
genes. Second, the diverse array of side chain structures in nature is evidence that the number, 
order and specificity of modules in the synthesising NRPS enzymes can be varied without 
destroying function [124]. Nature has evidently already conducted a wide range of module 
swapping experiments, with a great deal of success. Third, the fluorescent pseudomonads are 
genetically tractable, allowing them to be readily transformed with plasmid encoded copies of 
modified NRPS genes. This study uses Pseudomonas aeruginosa as a host for module 
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swapping experiments. A previously established system in our lab allows complementation of 
pvdD mutant P. aeruginosa strain with plasmid encoded genes, either modified or wild type 
[85]. This system has already been used to assess C-domain specificity, as described below.  
 
5.1.2 – A description of previous module swapping experiments 
conducted using the P. aeruginosa pyoverdine biosynthetic system. 
The experiments described in this chapter build on earlier work conducted by Dr Ackerley in 
which module swapping was carried out using the pyoverdine NRPS of P. aeruginosa in an 
attempt to generate modified pyoverdine molecules (Figure 5.1) [85, 143]. In this previous 
work, the penultimate A-domain of the pyoverdine NRPS system was substituted by foreign 
A-domains. This was achieved by manipulation of the first module of the pvdD gene, which in 
its native state contains two L-threonine specifying modules [37]. It was found that 
substitution of the first pvdD A-domain by an A-domain specifying an aa other than L-thr 
completely abolished pyoverdine biosynthesis. This result was consistent with other 
experimental data showing that C-domains exhibit selectivity for both the chirality and 
sidechain of downstream (acceptor) aa residues in a condensation reaction [48, 49]. 
 
 In order to test the hypothesis that C-domain specificity for the acceptor residue during the 
condensation reaction was preventing incorporation of novel aas, additional module swapping 
experiments were conducted. In these experiments A-domains were swapped along with their 
cognate C-domain partners. However, this strategy of swapping CA bi-domains also failed to 
generate pyoverdine containing a new aa at the penultimate position. Furthermore, the foreign 
CA domains present in one of the non-functional recombinant genes were taken from a 
module in which L-thr was the native acceptor substrate. One possible explanation put forward 
to explain these data was that C-domains exhibit specificity not only for the aa acceptor in a 
condensation reaction, but also for the side chain of residues present in the peptide donor.   
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Figure 5.1 – Summary of previous domain swapping strategies using pvdD 
In previous experiments [85] the A-domain from the penultimate module of pvdD was substituted by foreign 
domains, either alone or in combination with a cognate C-domain. Pyoverdine synthesis was only restored if the 
substitute A-domain specified L-thr. In the case of non-thr swaps generated using strategy 1, loss of function 
could be attributed to the acceptor specificity of the native C-domain (Blue). Non-thr swaps created using 
strategy 2 are not restricted by their acceptor specificity, but were still non functional suggesting that donor 
specificity of the upstream (orange) or downstream (Pink) C-domain may also have been a barrier to 
manipulation. 
 
5.1.3 – Aims and overview 
The aim of this work was to more rigorously assess the specificity of C-domains for the 
peptide donor in a condensation reaction using the pyoverdine NRPS model system. To this 
end a set of modified derivatives of the P. aeruginosa pvdD gene was created in which the CA 
domains of the final module were substituted for alternative CA domains from both P. 
aeruginosa and P. syringae pyoverdine NRPS genes. These modified genes were designed 
specifically to test the ability of substituted C-domains to utilise L-threonine at the C-terminus 
of a peptide donor chain during a condensation reaction. Based on the previous work 
described it was expected that only C-domains excised from a setting in which they originally 
utilised an L-threonine at this position would be able to fulfil this role. Assessment of one of 
these genes revealed that a C-domain, whose native role was to use L-N5-formyl-N5-
hydroxyornithine (L-FHorn) at the C-terminal of the peptide donor, was able to efficiently use 
L-thr and restore pyoverdine synthesis to a pvdD knockout (∆pvdD) strain of P. aeruginosa. 
This provided direct evidence against the initial theory of C-domain donor specificity, 
suggesting this was not the cause of inactivity in previous pyoverdine module swapping 
experiments.  
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5.2 – Design and construction of recombinant pvdD genes 
 
PvdD is the final NRPS protein involved in the biosynthesis of pyoverdine and contains two 
modules, both of which specify L-thr. The final module, which contains a thioesterase domain, 
was chosen for CA-domain swapping. In contrast to previous experiments, which had used the 
first module, the experiments described in this chapter replaced the CA-domains in the second 
module. Because this is the terminal pyoverdine module, there are no additional C-domains 
downstream that will be affected if the aa substrate for this module is changed. This new 
strategy therefore isolates donor site selectivity to a single module. Acceptor site specificity is 
also avoided because all swaps were conducted using a C-domain along with its cognate A-
domain. The novel C-domain introduced would therefore always be utilising its native aa 
substrate as an acceptor and the ability of said C-domain to use L-thr as a donor could be 
unambiguously assessed via the ability or inability of a recombinant gene to restore 
pyoverdine synthesis in a ∆pvdD P. aeruginosa.  
 
In order to facilitate expression of recombinant genes in ∆pvdD P. aeruginosa, the plasmid 
pSW196 was employed. This vector was chosen for two reasons. First, it is an integrative 
vector, which can be inserted into the chromosome of any bacteria containing an attB site in 
its chromosome [189]. This feature was important as it had previously been determined that 
complementation of the pvdD mutation using a high copy number plasmid resulted in a 
reduction in pyoverdine synthesis efficiency, most likely due to expression levels of plasmid 
encoded pvdD being too high [37, 85, 143]. Insertion into the chromosome would ensure that 
only a single copy of a recombinant gene was present in each cell, leading to more appropriate 
expression levels. Second, pSW196 contains an arabinose inducible promoter that drives 
expression of cloned genes. This promoter system is known to allow very fine regulation of 
expression levels by altering arabinose concentration in culture medium or agar plates [97]. 
The combination of these features means that pSW196 allows fine regulation of expression 
levels, allowing recombinant genes to be expressed at levels optimal for function. 
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Figure 5.2 – Outline of pSMC staging vector 
The Staging vector contains the pvdD gene, lacking the C and 
A domain of the second module. Restriction sites allow 
introduction of desired CA domains into pSMC in order to 
create recombinant pvdD genes in which the native CA- 
domains of module 2 have been replaced with foreign CA-
domains. The recombinant genes can then be integrated into 
the chromosome of P. aeruginosa and their expression 
controlled by adjusting arabinose concentration. The plasmid 
contains a tetracycline resistance marker (Tet) allowing 
selection of integrants on tetracycline containing medium.    
 
 
 
In order to allow introduction of foreign CA-domains, in place of the final CA-domain of 
pvdD, the regions up and downstream of the swap region were cloned into pSW 196 with 
restriction sites introduced on primers to allow introduction of foreign domains. As illustrated 
in Figure 5.2 the result was a plasmid with the domain order CAT-SpeI NotI-TTE. SpeI and NotI 
are unique restriction sites that allow introduction of foreign domains with flanked by 
appropriate restriction sites as follows: XbaI-CA-NotI. Cutting DNA with XbaI produces sticky 
ends compatible to those of DNA cut with SpeI. It was necessary to use XbaI as the upstream 
site on CA domains, as some of the domains to be swapped contained internal SpeI sites. The 
identity and location of restriction sites was chosen based on restriction sites previously used 
for construction of recombinant pvdD genes, which were known to preserve function [85, 
143]. The staging vector created for substitution of CA-domains into the last module of pvdD 
is henceforth referred to as pSMC. Before creation of genes harbouring non-native CA 
domains, a positive control was created to assess the impact of introduced restriction sites on 
the function of PvdD. In this control the native CA domains of pvdD were in introduced into 
pSMC. The resulting plasmid was integrated into the attB site of P. aeruginosa::∆pvdD and 
was found to restore pyoverdine synthesis to this strain to levels comparable to those observed 
in wild type. This was an improvement over previous work in which the pvdD mutation was 
complemented by the wild type gene on a multi-copy plasmid, where pvdD overexpression 
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was observed to reduce overall levels of pyoverdine production by 2-3 fold relative to wild 
type.  
 
Having demonstrated that the introduction of restriction sites had not destroyed function, five 
recombinant genes were created. Table 1 outlines the genes created, and gives the specificity 
of the substitute A-domain as well as the donor residue that the C-domain processes in its 
native setting. A graphical representation of recombinant genes is given in Figure 5.3. 
 
 
 
Figure 5.3 – Recombinant genes pvdD created in this study 
The left panel shows the origin of the domains introduced into pSMC, the right panel shows the domain 
composition of the resulting recombinant pvdD gene. The donor substrate utilised by a C-domain in its native 
setting is shown in parentheses followed by A-domain specificity. Ps = P. syringae, Pa = P. aeruginosa. Figure 
produced by Mark Calcott. 
 
5.2.1 – Nomenclature for describing modified genes and strains created 
in this study 
Modified genes will henceforth be described as outlined in Figure 5.3. For each modified 
PvdD gene harbouring introduced CA-domains in the last module, a descriptor of the 
 137 
organism from which these genes were derived is first given (Pa for P. aeruginosa, and Ps for 
P. syringae). This is followed in parentheses by the donor aa that is recognised by the 
introduced C-domain in its native setting. Finally, the substrate specificity of the introduced 
A-domain is given. For example, the modified pvdD gene in which the native CA-domains of 
the last module have been replaced with the CA-domains from the second module of the P. 
syringae gene pspph1924 is referred to as Ps(Thr)Ser, as the introduced C-domain receives a 
thr residue at its donor site in its native setting, and the substrate specificity of the introduced 
A-domain is serine. Unless otherwise noted, all strains harbouring modified genes lack a 
chromosomal copy of the native pvdD gene and are named according to the recombinant pvdD 
gene integrated into their chromosomal attB site. 
 
5.3 – Assessment of function of recombinant genes 
 
Each of the plasmids harbouring the recombinant pvdD derivatives indicated in Figure 5.3 was 
delivered to P. aeruginosa::∆pvdD by electroporation, with plasmid integrants selected on LB 
agar containing tetracycline and their identity confirmed by colony PCR. These strains were 
then subjected to a series of phenotypic analyses to characterise the activity of the recombinant 
genes. To maximise pyoverdine production, a plasmid encoding the sigma factor PvdS was 
transformed into two of the recombinant gene expression strains, Pa(Thr)Thr and Ps(Thr)Ser, 
together with a wild type P. aeruginosa control, to generate pvdS over-expression derivatives 
of these strains. As PvdS is a sigma factor known to stimulate production of the pyoverdine 
biosynthetic genes in P. aeruginosa [121], it was expected that increased levels of this protein 
would promote pyoverdine production even if the final product was not able to transport ferric 
iron into the recombinant strains.  
 
5.3.1 – Pyoverdine production on solid media 
The first phenotypic characterisation to which these strains were subjected was assessment of 
pyoverdine production on Kings B (KB) agar (2.8.6). KB is an iron limited medium known to 
stimulate production of pyoverdine in fluorescent Pseudomonas species. Duplicate plates were 
streaked with strains harbouring each of the recombinant genes, as well as the WT and ∆pvdD 
controls and the pvdS overexpression strains. Arabinose was present at a final concentration of 
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0.4% in one of the plates and absent in the other. After incubation at 37 °C for 16 h the strains 
were assessed for pyoverdine production by visualisation of green pigmentation and UV-
fluorescence. As shown in Figure 5.4, there was no evidence of pyoverdine production for 
∆pvdD, Ps(Asp)Thr, Ps(Thr)Thr or Ps (Thr)Ser in either the presence or absence of arabinose. 
In contrast, strong colouration and fluorescence were evident for WT regardless of arabinose 
inclusion. Pa(Thr)Thr and Pa(Orn)Thr were also strongly coloured and fluorescent, but only 
when arabinose was included in the medium. By eye, inclusion of the pvdS over-expression 
plasmid made no apparent difference to pyoverdine production in any of the strains tested.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 – Assessment of pyoverdine production strains on KB agar 
Two separate plates are shown, the plate in the top panel is unamended KB agar, the plate in the bottom panel 
contains 0.4 % arabinose to induce expression of recombinant genes under the contol of the aribinose regulated 
pSMC promoter. Plates were photographed under natural lighting (left) and UV light (right) after 24 h growth at 
37 °C. Strain identity is as follows: a) WT, b) WT pvdS overexpression, c) PvdD Pa(fOHOrn)Thr, d) PvdD 
Pa(Thr)Thr, e) PvdD Pa (Thr)Thr pvdS overexpression, f) PvdD Ps(Asp)Thr, g) PvdD Ps(Thr)Thr, h) PvdD 
Ps(Thr)Ser, i) PvdD Ps(Thr)Ser pvdS overexpression, and j) pvdD deletion mutant. Strains c-i contain modified 
pvdD genes integrated into the chromosomal attB site and lack the native pvdD gene. Figure produced by Mark 
Calcott. PvdS overexpression refers to strains harbouring a plasmid borne copy of the pvdS gene of P. 
aeruiginosa (Plasmid pucP22::pvdS, table 2.4)  
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5.3.2 – Pyoverdine production in liquid media 
In order to more quantitatively assess the level of pyoverdine production in strains bearing 
recombinant pvdD genes, growth in liquid media, followed by measurement of pyoverdine 
levels in culture supernatant was carried out as described in Section 2.8.6. The chromophore 
pyoverdine absorbs maximally at a wavelength of 400 nm, so absorbance at this wavelength is 
proportional to the concentration of pyoverdine in a particular solution [190, 191]. Pyoverdine 
levels in culture supernatant were measured following 24 h growth in KB broth in a 96 well 
plate. Three cultures were assessed for each strain in both the presence and absence of 
arabinose. As shown in Figure 5.5, pyoverdine was not detected in the culture supernatant of 
Ps(Thr)Thr or Ps(Thr)Asp, consistent with the results of assessment on KB agar. Of particular 
interest, pyoverdine was detectable in the culture supernatant of Ps(Thr)Ser, suggesting that 
this strain was successfully producing a modified pyoverdine. Furthermore, Pa(Orn)Thr was 
functional, but Ps(Thr)Thr was not, challenging the donor site hypothesis. The highest levels 
of pyoverdine were observed for WT followed by Pa(Thr)Thr and then Pa(Orn)Thr. For WT, 
Pa(Thr)Thr, Pa(Orn)Thr and Ps(Thr)Ser, pvdS over-expression strains were also assessed and 
in all cases found to produce higher levels of pyoverdine than the corresponding strain not 
harbouring a pvdS over-expression plasmid.  
 
An additional experiment was run in which ∆pvdD, Pa(Thr)Thr and Ps(Thr)Ser were assessed 
for pyoverdine production following growth at various concentrations of arabinose. In this 
experiment, pyoverdine levels were assessed by measuring emission at 450 nm following 
excitation at 403 nm – the characteristic excitation and emission wavelengths of the 
chromophore of pyoverdine [190, 191]. The results of this experiment, represented graphically 
in Figure 5.6, showed that up until a final concentration of 0.4 % w/v, higher arabinose 
concentration resulted in more pyoverdine being produced for both Ps(Thr)Ser and 
Pa(Thr)Thr; with concentrations above 0.4 % reducing pyoverdine levels. 
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Figure 5.5 – Quantitative assessment of pyoverdine production in KB broth 
The indicated strains were grown in KB for 24 hr with or without 0.4% arabinose. Cultures were set up in 
triplicate for each condition/strain in a 96 well plate. Following growth, cells were pelleted and pyoverdine levels 
in culture supernatant determined by measuring absorbance at 400 nm using a microplate reader. The suffix + 
indicates a strain harbouring a pvdS overexpression plasmid. Error bars are presented as +/- one standard 
deviation. Figure produced by Mark Calcott. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6  – Effect of arabinose concentration on pyoverdine production 
Triplicate cultures for the indicated strains were inoculated for each arabinose concentration in a 96 well plate. 
The base medium used was KB broth. Following 24 hr growth at 37 °C, pyoverdine levels in culture supernatant 
were determined by measuring emission at 450 nm following excitation at 403 nm. Error bars are presented as +/- 
one standard deviation. Figure produced by Mark Calcott. 
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5.3.3 – Assessment of pyoverdine function for strain harbouring modified 
pvdD genes 
Having established that a subset of strains harbouring modified pvdD genes were capable of 
producing pyoverdine, the ability of these strains to utilise the pyoverdine they produced for 
iron uptake was assessed. This was achieved by streaking on to KB agar containing 200 
µg/mL EDDHA. EDDHA is an iron chelator that prevents passive uptake of iron, and it has 
previously been demonstrated that P. aeruginosa cannot grow in the presence of 200 µg/mL 
EDDHA unless functional pyoverdine is being produced [37, 85, 143]. As illustrated in Figure 
5.7, it was found that only WT, Pa(Thr)Thr and Pa(Orn)Thr were producing a pyoverdine 
species that enabled them to grow in the presence of 200 µg/mL EDDHA. The fact that the 
pyoverdine species produced by Ps(Thr)Ser was not functional was consistent with this 
molecule having an alternative aa installed at the final position, resulting in a loss of function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 Growth of mutant strains under iron starvation. 
Strains were generously streaked onto KB agar containing 200 µg/mL EDDHA. Under these conditions passive 
uptake of iron is completely restricted. After 18 h incubation at 37 °C the plate was photographed under natural 
(left) and UV (right) light. Strain identity is as follows: a) WT, b) Pa(fOHOrn)Thr, c) Pa(Thr)Thr, d) Ps(Asp)Thr, 
e) Ps(Thr)Thr, f) Ps(Thr)Ser, and g) pvdD deletion mutant. Figure produced by Mark Calcott. 
 
5.3.4 – Analysis of intracellular pyoverdine levels in modified strains 
using flow cytometry 
The results outlined thus far suggested that the Ps(Thr)Ser was producing a modified 
pyoverdine derivative harbouring ser instead of thr as its terminal aa. This modified species 
was produced at levels much below those of WT and was not able to effectively function as a 
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siderophore. These results presented the possibility that the modified pyoverdine produced by 
Ps(Thr)Ser was not being effectively exported from the cell. In order to assess the levels of 
intracellular pyoverdine present in Ps(Thr)Ser, WT, ∆pvdD and Pa(Thr)Thr strains, washed 
cells from iron starved cultures were subjected to flow cytometric analysis using the Pacific 
Blue™ channel (ex 410/em455). The results of this analysis, in which 5,000 events were 
collected for each strain, are shown in Figure 5.8. As expected, ∆pvdD had lower mean 
fluorescence levels than WT. Unexpectedly, both Ps(Thr)Ser and Pa(Thr)Thr had higher mean 
fluorescence than wild type. This result suggests that these strains were accumulating 
pyoverdine in their periplasm. In the case of Ps(Thr)Ser, this is supporting evidence for the 
proposition that a modified pyoverdine was being produced, but was unable to be effectively 
exported from the cell. The increased intracellular flourescence of Pa(Thr)Thr may be a 
symptom of a disruption of the correct molar ratio of NRPS modules involved in pyoverdine 
biosynthesis. The reduced export levels seen in Ps(Thr)Ser prevented purification of the 
putative modified pyoverdine for MS analysis, however this goal is being persued by Mark 
Calcott as part of his doctoral research. 
 
Figure 5.8 – Determination of intracellular pyoverdine levels by flow cytometry 
The fluorescence of individual cells was assessed by measuring emission at 455 nm following excitation at 410 
nm. 5000 events were recorded for each strain; the frequency of events giving a particular fluorescence level is 
presented as a histogram. Figure produced by Mark Calcott. 
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5.4 – Discussion 
The aim of the experiments described in this chapter was to assess C-domain specificity for 
the upstream (donor) aa during a condensation reaction. Based on previous experiments [85, 
143], it was hypothesised that donor site specificity would prevent modified pvdD genes 
restoring fluorescence to P. aeruginosa::∆pvdD cells unless the terminal C-domain in such 
genes was able to recognise an L-thr donor. However, the results of the experiments described 
are not consistent with this hypothesis. 
 
Of the five modified pvdD genes created and tested, two contained terminal C-domains that do 
not receive L-thr as a donor substrate in their native setting. These were Ps(Asp)Thr and 
Pa(Orn)Thr, both of which contained foreign A-domains specifying thr. Whereas Ps(Asp)Thr 
was not able to restore fluorescence to P. aeruginosa::∆pvdD under any of the conditions 
tested, Pa(Orn)Thr was not only functional, but actually restored fluorescence to levels 
comparable to those seen for WT P. aeruginosa. The pyoverdine produced by Pa(Orn)Thr 
cells was able to scavenge iron from the environment under conditions of severe iron 
limitation, indicating that it was identical to the native pyoverdine. The substituted C-domain 
in Pa(Orn)Thr must therefore be able to receive both L-fhorn and L-thr residues at the donor 
site. As shown in Figure 5.9, the side chain of these two substrates is vastly different in terms 
of both size and chemical composition, providing evidence that the terminal C-domain in 
Pa(Orn)Thr does not discriminate between donor substrates based on the sidechain of the C-
terminal residue. Investigation of the generality of this result is one of the aims of the doctoral 
research of Mark Calcott and will require synthesis of additional recombinant genes, coupled 
with purification and MS analysis of products. 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 – Comparison of L-thr and L-fhorn 
structure 
Boxes indicate the sidechain of each amino acid. 
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It is more difficult to draw definitive conclusions from negative results, as there may have 
been multiple reasons for the failure of recombinant pvdD constructs to yield a pyoverdine 
product. However, that the Ps(Asp)Thr construct did not yield a pyoverdine product is 
consistent with the C-domain not being able to receive L-thr as a donor substrate from module 
1 of pvdD. In its native setting, this C-domain utilises D-asp as a donor substrate, and previous 
in vitro characterisation experiments have indicated that C-domains do possess specificity for 
the chirality of donor substrates in a condensation reaction [48, 49].  
 
More surprisingly, the gene Ps(Thr)Thr was not able to function in place of pvdD. This result 
cannot be explained by C-domain specificity constraints since the substitute C-domain in 
Ps(Thr)Thr uses the same donor and acceptor substrates in its native setting as those required 
in its new setting. This demonstrates that there can be additional barriers, independent of C-
domain specificity, which prevent optimal function of recombinant NRPS proteins. One 
possible explanation for the lack of function of Ps(Thr)Thr is that the introduced C and A-
domains are unable to correctly interact with the native T-domains of pvdD. As discussed at 
length in Chapter 6 of this thesis, there is good evidence that T-domains enter into specific 
interactions with partner domains in NRPS enzymes and that disruption of optimal T-domain 
interactions can contribute to loss of function in modified NRPS enzymes [15, 53, 92-94, 192, 
193]. There are three possible interactions that could break down as a result of substituting 
foreign CA-domains into the last module of pvdD. As illustrated in Figure 5.10, the substituted 
C-domain is required to interact with both up and downstream T-domains during the 
condensation whereas the substituted A-domain is required to interact only with its 
downstream T-domain during substrate transfer.  
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Figure 5.10 – Interaction of substituted CA domains with T-domains in PvdD 
In order to function correctly in PvdD, substituted A-domains (Green) and C-domains (Red) must interact 
correctly with the native T-domains of PvdD. In the case of the substituted A-domain, this interaction occurs 
exclusively with the downstream T-domain during substrate transfer (box A). In the case of the substituted C-
domain, interaction with both the upstream and downstream T-domains is required during peptide bond 
formation (box B). 
 
 
Evidence for the lack of function of Ps(Thr)Thr being a consequence of breakdown in T-
domain interactions was found by in silico analysis. The bioinformatic and directed evolution 
studies described in Chapter 6, as well as existing structural [53, 119, 192] and biochemical 
data [92-94], identify specific sequence elements in T-domains that may be important for 
correct interaction with downstream domains. One such residue is found at position +4 relative 
to the conserved ser 4’-PP attachment site (S+4) (Figure 5.11). In the bioinformatic analysis 
described in Appendix 1 it was found that, in T-domains that are immediately adjacent to a 
downstream C-domain, this residue can be either thr, ser, val, ala or met; whereas in T-
domains that are adjacent to a downstream E or TE-domain this position is always occupied 
by a hydrophobic residue. The first T-domain of PvdD has a thr at position S+4; and for each 
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of the functional recombinant pvdD constructs the native upstream T-domain partner of the 
introduced C-domain also has a thr in this position. Conversely, neither of the inactive 
recombinant C-domains is partnered with a T-domain that has a thr at position S+4 in its 
native setting (Figure 5.11). However, the hypothesis that the position S+4 threonine in the T-
domain of the first pvdD module may have been a primary cause of inactivity for the 
Ps(Thr)Thr and Ps(Asp)Thr constructs is yet to be tested experimentally. 
 
                                                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One possible avenue for such investigation is to perform site-directed mutagenesis and/or 
directed evolution of the T-domain immediately upstream of the substituted C-domain in 
Ps(Thr)Thr. Directed evolution could be achieved using a system similar to that described in 
Chapter 6, in which T-domains are randomly mutated by error prone PCR and variations 
resulting in improved interaction with partner domains are selected based on improvements in 
product synthesis. In the case of Ps(Thr)Thr, the natural function of pyoverdine provides the 
basis for a screen even more powerful than that described in Chapter 6. Functional pyoverdine 
is essential for survival on plates containing 200 µg/mL EDDHA, and consequently T-domain 
mutations resulting in functional Ps(Thr)Thr could be categorically selected in a single step by 
plating error prone libraries on this medium. For a more quantitative assessment of function in 
vivo, surviving clones could then be assessed for level of fluorescence. A system similar to 
this has been successfully implemented for the directed evolution of the aryl carrier protein of 
Figure 5.11 – Alignment of 
T-domains found upstream 
of swapped C-domains in 
nature 
The top sequence is the first T-
domain of PvdD, which is the 
upstream interaction partner for all 
C-domains in the recombinant pvdD 
constructs. Below this are the 
sequences of the T-domains that 
occur immediately upstream of the 
introduced C-domains in their native 
setting. The activity of each 
recombinant construct is 
summarised on the right. For clarity 
only part of the sequence alignment 
is shown here, the full alignment can 
be found in Appendix 1. 
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the enzyme EntB, involved in production of the siderophore enterobactin in E. coli [92]. 
However, the selection step in this system relied on assessment of relative growth rate rather 
than absolute selection of viable clones, and subsequent quantitative analysis was arduous as 
enterobactin does not possess any inherently quantifiable properties akin to the fluorescence of 
pyoverdine.     
 
The modified pvdD derivative Ps(Thr)Ser created in this study was able to restore 
fluorescence to cells lacking the native pvdD gene. This result is particularly exciting as based 
on the specificity of the new A-domain in Ps(Thr)Ser, the pyoverdine species produced is 
likely to possess ser instead of thr at the last position. The fact that the pyoverdine produced 
by Ps(Thr)Ser is not functional is strong evidence that it differs in structure from the native 
pyoverdine species produced by P. aeruginosa. Additional evidence that the pyoverdine 
produced by Ps(Thr)Ser contains an alternative aa is found in the results of the flow 
cytometric analysis described in Section 5.3.4. In this analysis it was found that Ps(Thr)Ser 
cells accumulate higher levels of pyoverdine intracellularly than WT P. aeruginosa. This 
result is consistent with production of a modified pyoverdine that is less efficiently recognised 
and exported from the cell. Confirmation of the identity of the pyoverdine species produced by 
Ps(Thr)Ser cells could be confirmed by purification followed with MS analysis as described in 
Section 3.7. Or if purification is not possible owing to the impaired export of this compound, 
whole cell mass spectrometry (WSMS) could be used. There are a number of WSMS 
techniques, including whole cell MALDI TOF that allow identification of the products [194, 
195]  and intermediates [196, 197] of NRPS pathways in bacteria. These techniques have 
proven effective for detecting molecules of similar size to pyoverdine with good resolution, 
and could potentially be used to accurately determine the mass difference between the 
pyoverdine species produced by Ps(Thr)Ser and wild type PAO1, without the need for prior 
purification steps.  
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Chapter 6 – Probing T-domain interactions using BpsA as a 
reporter system 
 
6.1 – Introduction 
 
This chapter describes development and implementation of a directed evolution platform, the 
purpose of which was to identify key residues involved in the interaction between T-domains 
and other domains in an NRPS enzyme. The system described was based on the recently 
characterised Blue Pigment Synthetase A (BpsA), from Streptomyces lavendulae. The native 
T-domain of BpsA was substituted by foreign T-domains using three different schemes and 
the resulting hybrid proteins assessed for activity in vivo. In all cases, substitution of the native 
T-domain caused severe reduction or complete ablation of pigment synthesis, presumably due 
to inability of the substituted T-domain to correctly interact with other domains in BpsA. A 
high throughput screening system was developed which allowed hybrid synthetases with 
reduced function to be improved by random mutagenesis of the substituted T-domain, 
followed by selection of improved variants using a multi-tiered screening process. By 
sequencing improved variants and determining changes that consistently led to improved 
function it was possible to identify key residues likely to be involved in interaction between 
the T-domain of BpsA and other domains in the NRPS. Based on these results, a model for T-
domain interaction with the thioesterase domain of BpsA is presented. 
 
Blue Pigment Synthetase A (bpsA) is a single module NRPS gene from Streptomyces 
lavendulae that was recently genetically and functionally characterised [80]. BpsA catalyses 
the formation of the blue pigment indigoidine from two molecules of L-gln. A proposed 
mechanism for this reaction [80, 198] is outlined in Figure 6.1B; it should be noted that this 
mechanism has not been experimentally verified and there is some uncertainty over the order 
of the condensation and oxidation steps. Indigoidine is synthesised by an array of 
phylogenetically diverse bacteria [80], is believed to play a role in quorum sensing, and is 
necessary for virulence in Erwinia chrysanthemi [198]. BpsA has unusual domain 
organisation, containing an oxidation domain integrated into its single A-domain between 
conserved motifs 8 and 9. In addition to its single Ox and A-domain, the protein contains a T-
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domain and a TE-domain. The modular architecture of BpsA is outlined in Figure 6.1A. BpsA 
is the only known example of a single NRPS module that is capable of synthesising an easily 
detectable, coloured product, without the requirement of additional enzymatic steps [80]. This 
factor, coupled with its ability to function in E. coli, make BpsA a particularly attractive model 
for conducting domain swapping experiment to examine domain interactions in NRPS. 
 
 
Figure 6.1 – BpsA 
A – BpsA is an NRPS enzyme with unusual domain organisation, it contains a single A, T and TE-domain with 
an Ox-domain integrated into the A-domain. 
B – BpsA synthesises the blue pigment indigoidine from two molecules of L-gln. The function of each of the 
domains is shown. It is unknown if the oxidation reaction occurs before or after cyclisation. The mechanism of 
dimerisation is also unknown. The proposed synthesis mechanism is as described in [198], structures for substrate 
intermediates and product were reproduced from this reference. 
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Recent biochemical and structural data indicate that NRPS T-domains play an essential role in 
the coordination of enzymatic steps during product synthesis by NRPS via specific temporal 
and spatial interactions with other synthetase domains [15, 44, 47, 53, 93, 94, 192, 193]. It is 
not presently clear exactly how T-domains interact with other domains, however what is clear 
is that the T-domain can no longer be thought of simply as a passive tether, to which substrates 
and intermediates are attached. As outlined in Section 1.4, T-domains are known to adopt at 
least three distinct conformations in solution, one of which is exclusive to apo-domains, 
another exclusive to holo-domains and the third an intermediate between the two [44]. There 
is evidence that switching between these conformations alters the affinity of the T-domain for 
other proteins and domains, suggesting that conformational switching modulates T-domain 
interactions [3, 44]. One possible interpretation of the available data is a cycle of T-domain 
conformational switches. In this model conformational changes modulate interaction with the 
appropriate partner domain, as illustrated in Figure 6.2.  Elucidation of the crystal [47, 53] and 
solution [192] structures of multi-domain NRPS subunits in which a T-domain is present, has 
supported the hypothesis that T-domains interact specifically with partner domains, and that 
this interaction is involved in correct positioning of substrates and intermediates of the 
biosynthetic process. However, one limitation of structural data in the context of proteins such 
as NRPS that exhibit considerable conformational plasticity, is that a particular structure may 
represent only one of many conformational states. Interestingly, in the case of multi-domain 
crystal structures, generation of diffraction quality crystals has required that the T-domain be 
exclusively in its inactive apo-state (without attachment of 4’-PP), a situation achieved either 
by mutation of the active site serine [53] or repression of PPTase activity in culture medium 
[47]. Having the T-domain present in its apo-state presumably allows crystal formation by 
locking the protein in one conformation. 
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6.1.1 – T-domain structure and function 
All NRPS T-domains perform essentially the same function, carrying aa substrates and peptide 
intermediates during synthesis. Aside from the difference in substrates and intermediates, this 
function can be extended to other carrier proteins found in PKS and fatty acid (FAS) 
biosynthetic pathways [1, 3, 11]. This common function is evident in structural data which has 
revealed that different NRPS T-domains as well as the carrier proteins of FAS and PKS have 
Figure 6.2 – A model for T-domain conformational switching and domain interactions. Statements 
in bold have been experimentally verified; others are hypothetical 
 
The Apo (T-A) state is exclusive to T-domains prior to 4’-PP attachment and might promote interaction 
with a PPTase. 4’-PP attachment allows access to the Holo (T-H) state. Switching to the H-state alters 
affinity for other domains and might promote interaction with an A-domain leading to attachment of an 
amino acid substrate. Once amino acylated (T-aa), the T-domain may again undergo a conformational 
switch, allowing it to interact with the upstream C-domain. Following transfer of the growing peptide chain 
to the T-domain (T-pept) additional conformational switching might facilitate interaction with a downstream 
C or TE-domain. Interaction with this downstream domain would result in peptide removal, resetting the T-
domain to its H state. The T-A and T-H states have been experimentally detected along with an intermediate 
T-A/H state. T-aa and T-pept structures have not been investigated, so the existence of distinct 
conformations is hypothetical. An alternative possibility is that there is not a distinct conformation in these 
states and that interaction with the correct partner domain occurs out of necessity, since no other domain is 
capable of correctly processing the T-linked intermediate.   
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the same basic 3-4 helical (depending on conformation) structure, in spite of having low 
sequence identity [43, 53, 192]. Secondly, it should be noted that there is a high level of 
diversity in the aa sequence of T-domains, even within a single species. If this sequence 
diversity reflects purpose, e.g.  specialisation to interact with a particular domain or set of 
domains in a synthetase enzyme, T-domains from NRPS enzymes may be viewed not only as 
carriers of aas and peptides, but also of information [92-94, 193, 199-201].  
 
6.1.2 – Aims 
The aim of the work described in this chapter was to identify key residues involved in 
interaction between the T-domain and other NRPS domains in the protein BpsA by using 
directed evolution to improve the function of BpsA enzymes harbouring foreign T-domains.  
 
6.2 – Examination of T-domain interactions in silico 
 
As a guide for the design and interpretation of the experiments described in this chapter two in 
silico analyses of T-domains were carried out. The first of these was an alignment based 
analysis, the second an examination of existing T-domain structural data. 
 
6.2.1 – Alignment based analysis of T-domain interactions 
The vast majority of NRPS T-domains are required to interact with both an A-domain and a C-
domain located upstream in a synthetase complex. The interaction with downstream partners 
is more varied, with three distinct possibilities existing for the downstream interaction partners 
of a T-domain. These possibilities are a C-domain only, an E-domain and a C-domain or a TE-
domain only. It was theorised that if T-domains are specialised for interaction with particular 
partner domains, this would be reflected by the presence of specific sequence elements 
common to T-domains interacting with a particular downstream domain. In order to test this 
theory a simple bioinformatic analysis was carried out. This analysis is described in detail in 
Appendix 1 of this thesis and the key findings are summarised here: 
1) T-domains exhibit very high sequence diversity compared to carrier proteins that interact 
with a limited set of partner proteins such as the carrier protein of type II fatty acid synthases ( 
refer to Figure A1.1 in appendix one). 
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2) The analysis of multiple T-domain sequences interacting with a C, E or TE-domain 
downstream revealed that specific sequence elements are common to T-domains that have to 
interact with the same downstream domain ( refer to Figure A1.2 and table A1.1 in appendix 
one).  
3) Analysis of sequences arising from a whole-module (CAT) duplication upstream of a TE-
domain showed that the sequence of duplicated T-domain diverges much more quickly than 
that of the A or C-domain. This accelerated divergence presumably reflects adaptation of the 
duplicated T-domain for optimal interaction with its new downstream partner.  
4) T-domains that have TE-domains as downstream interaction partners have the highest 
sequence diversity; this suggests that there are multiple ways that a T-domain can interact with 
a downstream TE-domain. By contrast, T-domains that have an E-domain as a downstream 
interaction partner have the lowest sequence diversity suggesting a less variable mode of 
interaction. 
The overall conclusion from the bioinformatic analysis was that T-domains have specific 
genetic features that provide a structural basis for their interactions with specific partner 
domains. Alignment of multiple T-domain sequences revealed key residues likely to play key 
roles in interaction with downstream domains.  
 
6.2.2 – Structural insights into T-TE interaction 
Existing biochemical data, as well as the alignment analysis described, suggests that the native 
interaction between a T-domain and a downstream domain is specialised and that interaction 
with a TE-domain is particularly sensitive to disruption in manipulation experiments [15, 92, 
93, 192]. To provide a structural foundation for assessing which mutations may have 
improved function by restoring interaction between a substituted T-domain and the TE-
domain of BpsA, the solution structure solved for the EntF T-TE bi-domain [192] was 
examined in detail. The PDB file for this structure, 2roqA, was downloaded and visualised 
using Deep View, this PDB file contains 20 conformers, the first of which is thought to be the 
best representation of the average structure. In this structure the T-domain is in close 
association with the TE-domain in a conformation that is believed to represent productive 
interaction between the two domains [192].  
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The structure of the T-domain in 2roqA, henceforth referred to as the TE-state, differs 
considerably from previously solved structures for T-domains in isolation. It is most similar to 
the H-state observed for the TycC3 T-domain however differs considerably even from this 
structure. The relative size and orientation of helices differs between the H and TE-states, and 
there is an additional single turn helix (αT1’) present in the TE-state [192]. αT1’occurs at the 
site of two consecutive phe (F41 and F42) residues, which are absolutely conserved in all T-
domains. The presence of αT1’ results in a drastic alteration in the orientation of these phe 
residues, as shown in Figure 6.3. In the H-state the side chains of both phe residues are pointed 
toward the hydrophobic core of the T-domain, in the TE-state however, the F41 is embedded 
in the core of the T-domain while F42 is found in the core of the adjacent TE-domain. F42 lies 
at the heart of a predominantly hydrophobic interface between the T and TE-domains during 
their interaction in EntF which is now examined. 
 
 
 
 
 
 
Figure 6.3 – Comparison of T-domain H and TE-states 
The relative length and orientation of the helices in the two structures differs and there is an additional single turn 
helix (αT1’) present in the TE state. Two consecutive F residues which are absolutely conserved in all T-domains 
are shown. In the H-state, the side chain of both of these residues points toward the hydrophobic core of the T-
domain. In the TE-state, the side chain of the second F residue (blue) extends into the hydrophobic core of the 
adjacent TE-domain (not shown). 
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Visualisation of all residues within 5Å of the side chain of F42 (Figure 6.4) reveals a cluster of 
hydrophobic residues from both the T and TE-domains of EntF that form the interface 
between the two domains. Analysis of TycC3 in the H state shows the equivalent residues are 
all buried in the core of the T-domain. Transition from the H-state to productive interaction 
with a TE-domain therefore requires that the sidechains of residues previously buried in the 
core of the T-domain now extend into the hydrophobic core of the TE-domain.  
 
 
Figure 6.4 – Hydrophobic interface of the T and TE-domains of EntF 
A – Detail of the interaction region of the T and TE-domains of EntF showing hydrophobic residues which are 
found at the interface of the two domains. Residues from the T domains are coloured yellow, residues from the 
TE-domain are red. F42 (Blue) from the T domain is found at the heart of this cluster. 
B – Addition of van der Waals radii to the side chains forming the hydrophobic interface emphasises the 
formation of a tightly packed hydrophobic core.     
 
 
The analysis of the structure 2roq suggests that the interface between the T and TE-domain of 
EntF is stabilised by hydrophobic interactions. In order to assess whether a similar situation is 
likely for the interaction of the T and TE-domains of BpsA, a model for the structure of these 
domains was generated using the Swissprot server. The T and TE-domains of BpsA were 
aligned against those of EntF and a set of preliminary structural models generated using Deep 
View. These models were then submitted to the online server for refinement and the quality of 
refined models assessed as described in 2.16.2. The best quality model was then visualised in 
Deep View and the interface between the T and TE-domains in this model was examined. This 
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structural model, which is presented and discussed in Sections 6.11.3-6.11.5, predicted a 
similar hydrophobic interface between the T and TE-domains of BpsA. 
 
 Two additional models for T-TE-domain interfaces were generated using 2roqA as a 
template. The T-TE bidomains for which models were generated were taken from the terminal 
modules of the P. syringae NRPS Pspph1926 and an uncharacterised NRPS from Vibro 
angularium which shared 29 and 46 % sequence identity with EntF respectively. For both of 
these structural models, a hydrophobic interface between the T and TE-domains was again 
predicted.  
 
 
6.3 – Cloning of BpsA and determination of compatibility with 
Pseudomonas PPTases 
 
BpsA is non-functional when expressed in otherwise unmodified E. coli, due to the inability of 
native PPTase enzymes to recognise and activate its T-domain [80]. Before moving on to 
manipulation experiments using BpsA, it was therefore necessary to develop protocols for co-
expression of this protein with a cognate PPTase in E. coli. Since the sequence for the native 
PPTase of S. lavendulae is not available, it was decided to test the competency of PPTase 
enzymes from other bacterial strains in our laboratory for activation of BpsA in vivo. In their 
characterisation of BpsA, Takashi et al. used the PPTase of the genome sequenced organism 
S. lividans to activate BpsA; however gDNA from this organism was not available to us. 
Prompted by published reports describing the broad substrate specificity of various 
Pseudomonas PPTases [69, 202, 203], it was decided to express BpsA in P. putida KT2440, 
P. aeruginosa PAO1 and P. syringae pv phaseololicola 1448a, in order to ascertain whether 
the endogenous PPTases of these organisms were able to recognise the T-domain of BpsA. 
 
6.3.1 – Construction of plasmids for expression of BpsA in E. coli and 
Pseudomonas species 
For initial expression trials of BpsA in E. coli and Pseudomonas, it was decided to use the 
broad host range expression vector pSX (Section 4.2.1.1.1) The entire 3.9 kb BpsA gene was 
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amplified by PCR using Phusion® high fidelity polymerase using primers with an upstream 
NdeI site and downstream HindIII site incorporated. The PCR product was ligated into pSX, 
giving the final BpsA expression construct pSX:BpsA. The identity of this construct was 
verified by sequencing and expression tests were conducted in E. coli under standard growth 
conditions (37 °C, 200 rpm) with a final concentration of 0.5 mM IPTG used to induce protein 
expression. Strong induction of a band of ~140 kDa in response to IPTG was identified by 
SDS-PAGE, indicating that BpsA was being expressed. However, no pigmentation was 
observed for these cells, consistent with previous observations that the endogenous PPTases of 
E. coli are unable to activate BpsA. 
 
6.3.2 – Assessment of BpsA activity in Pseudomonas species 
pSX:BpsA was delivered to P. aeruginosa, P. syringae and P. putida by electroporation. As 
colonies developed, there was clear evidence of blue pigmentation for P. putida harbouring 
pSX:BpsA even though IPTG was absent from the medium. For P. syringae and P. 
aeruginosa there was no evidence of blue pigmentation, with or without IPTG addition. Figure 
6.5A shows P. putida harbouring the plasmid pSX:BpsA. At the time it was assumed that the 
above result was due to the fact that only P. putida possessed a PPTase capable of recognising 
BpsA, however later co-expression studies in E. coli (6.3.1) showed that PcpS, the PPTase of 
P. aeruginosa [69] was also capable of activating BpsA. The lack of pigment production in P. 
aeruginosa was most likely due to recombination mediated loss of plasmid sequence. In P. 
putida, it was also observed that expression of BpsA was unstable. Cells that had been grown 
in the presence of IPTG, once sub cultured or streaked onto a fresh plate, lost the ability to 
express BpsA but retained gentamycin resistance. Repeated re-streaking or sub-culturing, in 
the absence of IPTG, also led to the loss of BpsA expression. This instability was taken as a 
sign that the product of BpsA, indigoidine, was toxic to the cells leading to selection of cells in 
which recombination mediated loss of part of the plasmid sequence had occurred. This theory 
was supported by the fact that plasmid DNA isolated from cells that had lost the ability to 
express BpsA contained a truncated version of the bpsA gene. 
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Figure 6.5 – Expression of BpsA in P. putida 
A- P. putida expressing BpsA from the plasmid pSX:BpsA.  
B- P. putida transformed with empty pSX plasmid.  
C- Close up of the boxed region in panel A, it can clearly be seen that the actively replicating bacteria toward the 
edge of the patch have stopped producing indigoidine. Isolation of plasmid DNA from such cells showed that the 
bpsA gene was truncated. 
 
 
6.4 – Development of plasmid based platforms for the co-expression 
of BpsA and an activating PPTase in E. coli  
 
An important consideration when developing an E. coli BpsA expression system was tightly 
regulating control of BpsA expression. Although pSX:BpsA was suitable for IPTG regulated 
expression in E. coli, this plasmid was prone to leaky expression which, coupled with the 
toxicity of BpsA expression, was a potential source of plasmid instability. To circumvent this 
problem, the bpsA gene was sub-cloned into pET28a+, where it would be under the control of 
the tightly regulated T7 promoter [204, 205]. Use of pET28a+ had the additional advantage of 
adding an N-terminal 6his tag that would enable Ni-NTA purification of BpsA and any 
modified variants generated.  Plasmids for IPTG regulated co-expression of three PPTases 
were also created. These PPTases were PcpS from P. aeruginosa, Sfp from B. subtilis and 
PP1183 from P. putida. The gene for each PPTase was cloned into both pET28a+ and 
pCDFduet1 expression vectors. PPTase and BpsA expression constructs were verified by 
sequencing and assessed for protein expression by SDS PAGE. A co-expression strain for 
BpsA with each PPTase was then constructed and it was found that expression of any one of 
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the three PPTases in E. coli resulted in activation of BpsA, as evidenced by strong blue 
colouration of cells grown on solid media and supernatant from liquid culture. 
 
 
6.5 – Development and testing of T-domain swapping platforms 
 
Once it had been established that co-expression of BpsA and an activating PPTase in E. coli 
was possible, construction and testing of plasmids for substitution of foreign T-domains into 
BpsA was undertaken. Three different substitution vectors (pBPSA1-3) were created, each 
differing in the up and downstream T-domain splice points.  
 
6.5.1 – Substitution scheme one 
For the first attempt at swapping foreign T-domains into BpsA, the definition of T-domain 
boundaries was set according to the prediction of the TIGR NRPS analysis server. The 
sequence either side of the T-domain was cloned into the expression vector pET28a+, such 
that the resulting construct contained the bpsA gene without its native T-domain and 
incorporated two unique restriction sites to enable introduction of foreign T-domains (Figure 
6.6). Initially a positive control was created in which the native bpsA gene was recreated, with 
a NheI site introduced upstream of the T-domain and a KpnI site introduced downstream. The 
purpose of this control was to determine whether introduction of the two restriction sites, each 
of which added two foreign aas to the protein, would impair enzyme function. As described in 
6.6, the resulting modified BpsA was still functional, although in vivo pigment synthesis 
efficiency was reduced. Once it had been established that introduction of restriction sites did 
not totally destroy function, foreign T-domains were substituted in place of the native domain. 
A summary of in vivo pigment synthesis efficiency for all modified BpsA enzymes is given in 
Table 6.2. A graphical overview of all swapping schemes is given in Figure 6.6. 
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6.5.2 – Substitution scheme two 
Substitution scheme two was designed to address an inherent flaw in the first scheme. This 
flaw was not detected until a more detailed analysis of the splice points used in the first 
scheme. Alignment of the T-domain of BpsA against that of TycC3, a T-domain with solved 
structure, revealed that splice points had been inappropriately predicted by the TIGR NRPS 
analysis server, with the up and downstream points falling within the first and last α-helix of 
the domain respectively. Results from previous NRPS modification experiments have 
suggested that splice points should be introduced in the disordered linker regions that connect 
adjacent domains [13, 15, 16], a requirement that was addressed in the design of substitution 
scheme two. A positive control, consisting of the native gene with introduced restriction sites 
was again created and assessed for pigment synthesis efficiency. Surprisingly, the efficiency 
of this protein was lower than that created using scheme one. Four foreign T-domain 
substitutions were also carried out using scheme two, and in each case the modified protein 
was found to have equal or lower efficiency than the equivalent protein created using scheme 
one.  Based on this result it was decided that substitution scheme two should not be used for 
any subsequent directed evolution experiments.      
 
6.5.3 – Substitution scheme three 
The third T-domain substitution scheme was created after successful directed evolution 
experiments had already been conducted using scheme one. The third scheme also aimed to 
address a specific problem that had been identified with scheme one. This problem was the 
presence of foreign aas as a result of restriction site introduction. In the third scheme, 
restriction sites were designed such that once a foreign domain had been introduced, there 
would be a seamless transition between native BpsA sequence and the foreign domain 
introduced. This was achieved by introducing silent restriction sites that did not alter the 
sequence of the translated protein. The design and construction of recombinant genes using 
substitution scheme three is outlined in 2.15.1. This method allows splicing of NRPS domains 
without the introduction of additional foreign protein sequence, a potentially valuable 
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technique for future modification experiments. Elimination of additional coding sequence 
introduced via restriction sites was important for interpretation of directed evolution results. 
Since there were no additional foreign aas present in constructs created using scheme three, it 
can be assumed that any improved variants from directed evolution experiments using this 
scheme represented adaptation of a foreign T-domain to interact with other BpsA domains, 
rather than adaptation to deleterious aas introduced via restriction sites.  Swapping scheme 
three utilised pCDFduet1 as an expression vector for modified BpsA variants due to a lack of 
appropriate restriction sites in pET28a+.  
 
6.5.4 – System for description of modified BpsA variants.  
A total of fifteen different modified bpsA genes were created using swapping schemes 1-3, as 
outlined in table 6.1. Substitutions created using scheme one are denoted with the prefix “o”, 
those created using scheme 2 have the prefix “n” , those created using scheme three have the 
prefix “sl”. The prefix is followed by an identifier of the T-domain substitution. For example 
oBpsA was created using swapping scheme 1 and contains the native BpsA T-domain, nPvdD 
was created using swapping scheme 2 and contains the T-domain from the first module of 
PvdD. The protein expressed from the construct slBpsA is as identical aa sequence to WT 
BpsA.  
 
 
 
 
 
 
 
 
Table 6.1 – system for describing modified BpsA genes/proteins.  
BpsAT= native BpsA T-domain, PvdD = T-domain from module one of P. aeruginosa PvdD, EntF = T-domain 
from E. coli EntF, DhbF= T-domain from second module of B. subtilis DhbF, EntB= Aryl carrier protein from E. 
coli EntB, PsT = T-domain from second module P. syringae Pspph1926. Prefix o, n or sl denotes swapping 
scheme used in generation of modified BpsA variant. Substitutions not tested in this study are denoted with an X.   
 
 
                                         Origin of substitute T-domain 
 BpsA PvdD EntF DhbF EntB PsT 
1 oBpsA oPvdD oEntF oDhbF oEntB oPsT 
2 nBpsA nPvdD nEntF X X nPsT 
 
Swapping 
scheme 
used 3 slBpsA slPvdD slEntF slDhbF slEntB X 
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Figure 6.6 – Splice points for T-domain substitution schemes 1-3. 
Substitution scheme one uses a KpnI site at (2) and an NheI site at (3), substitution scheme two uses a KpnI site 
at (1) and an NheI site at (4). For both schemes one and two, restriction sites resulted in insertion of aas between 
the residues indicated with an arrow. KpnI inserts GT, NheI inserts AS. For substitution scheme three, there were 
no insertions or alterations in aa sequence other than the substituted T-domain, which was inserted between (1) 
and (4). This was achieved by introducing silent restriction sites that did not alter the aas encoded in the bpsA 
gene. These sites were located up stream of (1) and down stream of (4). The intervening sequence between the 
silent restriction sites and splice points (1) and (4) was added to the primers used to amplify substitute T-domains 
resulting in a seamless transition between BpsA sequence and substituted T-domain sequences at points (1) and 
(4). The blue panel shows the location of splice points 1-4 on a structural model of the BpsA T-domain; note that 
splice points (2) and (3) disrupt α-helices. 
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6.6 – Assessment of modified BpsA variants created using 
swapping schemes 1-3 
 
Each of the modified BpsA derivatives was assessed for pigment synthesis in E. coli. 
Conditions optimal for pigment synthesis were determined by systematically varying 
concentrations of L-glutamine (BpsA substrate) and IPTG (for induction of expression of both 
BpsA and the co-expressed PPTase) in culture medium. The effect of temperature on pigment 
production was also investigated. The reporter used for this experiment was oBpsA co-
expressed in E. coli with PcpS. As illustrated in Figure 6.7 the optimal composition of media 
was LB supplemented with 100 mM L-gln, 0.5-1.0 mM IPTG and appropriate antibiotics. 
Growth at 18 °C resulted in markedly elevated pigment production compared to growth at 30 
°C. Growth at 37 °C was not assessed in this experiment, as previous observation suggested no 
pigment production occurred at this temperature. Following this experiment, all future 
assessment of pigment production was carried out at 18 °C in LB supplemented with 100 mM 
L-gln, 0.5 mM IPTG and appropriate antibiotics, this medium is hence forth referred to as 
pigment development medium, used as both broth and agar.  
 
Following optimisation of growth conditions, all modified BpsA proteins were assessed for 
pigment production capacity in E. coli. For each BpsA variant, the activating PPTase used was 
PcpS. Table 6.2 summarises the pigment production capacity of modified BpsA proteins 
expressed in E. coli. Quantification of pigment production was achieved by measuring 
absorbance at 590 nM, this being the previously determined absorbance maximum for 
indigoidine [80]. The method used for calculating in-vitro pigment synthesis capacity is 
outlined in 2.13. In some cases, pigment production was not detected using broth but was 
apparent after extended incubation in pigment development agar, in such cases the 
recombinant BpsA was presumed to have lower activity than any variant found to produce 
pigment in broth. In cases where pigmentation would not develop in broth or on agar, 
recombinant genes were deemed completely inactive. 
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Table 6.2 – In vivo pigment synthesis capacity of recombinant BpsA genes. 
In vivo pigment synthesis activity of all recombinant BpsA genes relative to wild type (set at 100%) as 
determined by measuring OD 590 of supernatant from cultures grown in pigment development medium at 18 °C. 
Error values are given as +/- one standard deviation. For a detailed description of how these values were 
determined refer to section 2.13. Substitutions not made are denoted with an X. Instances where activity was too 
low to be detected by OD 590 measurement, but apparent after extended incubation on plates, are denoted with 
an L  
                                      Origin of substitute T-domain 
 BpsA PvdD EntF DhbF EntB PsT 
1 21.7 +/- 2.7% 0% L L 0% 0.773 +/-0.278% 
2 1.62+/-0.14% 0% 0% X 0% 0% 
 
Swapping 
scheme 
used 3 100% 0% 5.14+/- 0.28% 0% 0% X 
 
 
Figure 6.7 – Determination of 
optimal conditions for pigment 
synthesis  
 
Columns 1-6 contain a two-fold serial 
dilution series from 2.0 to 0.0625 mM 
IPTG, with L-gln concentration fixed at 
100 mM. Columns 7-12 contain a two-
fold serial dilution series from 100 to 
3.13 mM L-gln with IPTG concentration 
fixed at 0.5 mM. Each well contains a 
final volume of 100 µL inoculated to a 
uniform density with an overnight 
culture of E. coli harboring plasmids for 
the expression of oBpsA and P. 
aeruginosa PPTase. All wells contain 50 
µg/mL Kanamycin and 100 µg/mL 
ampicillin. Plate A was grown for 16 h 
at 18 °C, plate B was grown for 16 h at 
30 °C. Base medium was LB.  
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6.7 – Development of a high throughput screening process for 
directed evolution of recombinant bpsA genes 
 
As outlined in Table 6.2, substitution of the native T-domain of BpsA for a foreign domain, 
consistently reduced the efficiency of pigment synthesis in vivo. This result agrees with 
published structural and biochemical data which suggests that T-domains undergo specific 
interactions with other NRPS domains during the biosynthetic process [15, 44, 47, 53, 93, 94, 
192, 193]. Having established and tested a T-domain swapping platform, directed evolution 
experiments were conducted with the aim of identifying key residues involved in T-domain 
interaction with other BpsA domains. In these experiments the activity of recombinant BpsA 
variants created using swapping schemes one and three, that had impaired function, was 
improved. To achieve this, the substituted T-domains of these variants were randomly mutated 
using error prone (ep) PCR.  The resulting products were then cloned into the corresponding 
BpsA T-domain swapping construct, to give a mutant library varying only in the sequence of 
the T-domain. Development of a robust, high throughput first tier screening procedure allowed 
qualitative identification of variants with improved T-domain function in BpsA. Improved 
variants were then subjected to a second tier screen to quantitatively assess pigment synthesis 
capacity in vivo.  Based on the results of the second tier screen, selected improved clones were 
sequenced and the mutations responsible for improved function were determined.    
 
6.7.1 – Development of a first tier agar plate based screening system. 
To develop a first tier screen for improved pigment synthesis capacity, priority was given to 
screening as many clones as possible, as quickly as possible and with a minimum of manual 
input. Avoidance of false positives and quantitative assessment of activity were given low 
priority as these issues could be addressed in a second, lower throughput screen. At this stage 
it had already been established that pigment production was readily detectable in BpsA 
expressing E. coli patched on to agar plates, and that even weak activity (<0.7% of WT) could 
be detected following 24-48 h incubation on pigment development agar. To facilitate 
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screening however, pigmentation would have to be visible in single colonies immediately 
following transformation. This was now assessed. 
 
Initial trials were run using E. coli harbouring a PP1183 expression plasmid. A plasmid for the 
expression of oBpsA was transformed into this background and plated on agar containing 100 
mM L-gln and 0.5 mM IPTG. Under these conditions, it was consistently found that no 
transformants could be recovered. If, however, IPTG was omitted from the plates, 
transformation with high efficiency was achieved. This result suggested that toxicity arising 
from indigoidine production was rendering transformants inviable in the presence of IPTG.  
 
To circumvent this problem, a novel system for on-plate induction was developed. 
Transformed cells were plated on media containing antibiotics and L-gln only, and incubated 
overnight to allow colonies to develop. Following colony development the entire agar slab was 
scooped from the plate and rested on the sterile lid. IPTG solution was then spread on the 
bottom of the empty plate and the agar slab replaced on top of the solution. Diffusion of ITPG 
into the medium then resulted in induction of protein synthesis in colonies on the top surface 
of the agar and development of strong pigmentation in individual colonies.  
 
6.7.2 – Optimisation of library generation for directed evolution 
 An important consideration for directed evolution is the development of a reliable system for 
library generation. In this case libraries were generated by first conducting epPCR using a 
particular T-domain as template. The resulting PCR product was then introduced, via 
compatible restriction sites, into a plasmid borne copy of the bpsA gene, resulting in a library 
of bpsA genes with variant T-domain sequence. The most critical factor in this process is 
generation of high quality, restriction digested linear vector into which a digested PCR product 
can be introduced by ligation. In order to ensure that vector preparations for directed evolution 
were of consistently of high quality, a standardised protocol for preparation and quality 
assessment of digested linear vector was developed. This allowed consistent generation of 
libraries in which greater than 70 % of plasmids contained the desired insert. Library 
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generation protocols were progressively refined throughout the course of this study, eventually 
resulting in optimised protocol given in 2.11.1.  
 
6.8 – Adaptation of a T-domain from DhbF to function in BpsA using 
directed evolution  
 
The first directed evolution experiment conducted aimed to improve the function of oDhbF 
(i.e. the modified derivative of BpsA, in which the native T-domain had been replaced by a T-
domain from the B. subtilis enzyme DhbF using substitution scheme 1). Assessment of the 
activity of oDhbF revealed initial activity was lower than 0.7% (Table 6.2). To improve the 
function of oDhbF, a T-domain variant library of approximately 25,000 insert containing 
clones was screened on pigment development agar plates, resulting in the recovery of 12 
putative improved clones. Figure 6.8 gives an overview of the screening process and shows a 
typical improved clone on a pigment development agar plate. The 12 clones recovered from 
the plate base tier of screening were then subjected to a second tier screening procedure, to 
quantitatively assess pigment production during planktonic growth in a 96 well plate. Eleven 
of the initial hits were confirmed as having improved activity in this second tier screen. These 
were sent for sequence analysis, which revealed four different single aa changes, two of which 
were recovered multiple times. The procedure for library generation, screening and the 
controls employed for this and subsequent experiments, is described in detail in 2.11. A 
summary of all sequence analysis from all experiments is given in the discussion section 
(tables 6.3 and 6.4), complete annotated sequence alignments can be found in Appendix 1. In 
the second tier screens for all directed evolution experiments two controls were included. The 
un-improved enzyme is included as a negative control in each case and either oBpsA or WT 
BpsA as a positive control. It is important to note that although in some instances the activity 
of improved clones appears to approach or exceed that of the positive control, this is an 
artefact of the screening process. This artefact arises due to saturation of pigment production. 
This saturation is likely to be a result of indigoidine toxicity inhibiting cell growth at higher 
concentrations. 
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Figure 6.8 – Overview of directed evolution procedure 
A) A schematic representation of the directed evolution protocol. (1) T-domain is amplified by error prone PCR 
and amplicon is ligated into plasmid borne copy of BpsA gene. (2) The resulting library of T-domain variants is 
transformed into cells harbouring an activating PPTase. (3) Transformed cells are plated on pigment development 
agar and improved clones are recovered. (4) Improved clones are subjected to a second, quantitative screen for 
activity in a 96 well plate format 
B) Photograph of a pigment development plate on which an improved variant of oDhbF can be seen.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9 – Quantitative assessment of activity of improved variants of oDhbF 
In vivo activity of improved clones was determined by measuring OD 590 of supernatant for triplicate cultures of 
each clone grown in a 96 well plate as described in 2.11.3. The yellow bar is unimproved oDhbF included as a 
negative control. The dark blue bar is oBpsA included as a positive control. Sequence of all variants except 1s11 
was determined. Error bars are presented as +/- one standard deviation.   
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6.9 – Adaptation of a T-domain from PvdD to function in BpsA 
 
The native T-domain of BpsA was replaced with the first T-domain from the P. aeruginosa 
NRPS PvdD using all three substitution schemes described in 6.4. In all cases this substitution 
was found to result in completely inactive BpsA. E. coli harbouring these modified BpsA 
variants and an activating PPTase were unable to produce any discernable blue pigment on 
pigment development agar or in pigment development broth regardless of incubation time, 
activating PPTase or temperature. Both oPvdD (swapping scheme 1) and slPvdD (swapping 
scheme 3) were improved using directed evolution. The cloning and transformation protocol 
used for evolution were modified from those used for oDhbF. This allowed generation of 
much larger variant libraries and an estimated 5-6 x 105 clones were screened for both oPvdD 
and slPvdD. 
6.9.2 – Recovery and assessment of hits 
For each hit recovered from the agar based screen, the time for pigmentation to develop was 
noted and only the fastest developing hits from each library were chosen for further 
assessment. A total of 44 putative improved variants of slPvdD and 14 putative improved 
variants of oPvdD recovered from the first tier screen were subjected to second tier screening 
(Figures 6.10 A and B).  The sequence of all 14 oPvdD clones was determined. For hits 
derived from slPvdD, the 8 clones indicated were analysed. The most active clone recovered 
from improvement of slPvdD, designated 3kF0, was chosen for further improvement by a 
second round of epPCR and selection.  
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Figure 6.10A – Quantitative assessment of activity of improved variants of slPvdD 
In vivo activity of improved clones was determined by measuring OD 590 of supernatant for quadruplicate 
cultures of each clone grown in a 96 well plate as described in 2.11.3. The yellow bar is unimproved slPvdD 
included as a negative control. The dark blue bars is WT BpsA included as a positive control. Clones for which 
sequence was determined are indicated by red bars. Selection aimed to determine sequence for clones with a wide 
variety of pigment synthesis activity. Error bars are presented as +/- one standard deviation.   
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Figure 6.10B – Quantitative assessment of activity of improved variants of oPvdD 
In vivo activity of improved clones was determined by measuring OD 590 of supernatant for quadruplicate 
cultures of each clone grown in a 96 well plate as described in 2.11.3. The yellow bar is unimproved oPvdD 
included as a negative control. The dark blue bar is oBpsA included as a positive control. Sequence of all variants 
was determined. Error bars are presented as +/- one standard deviation.   
 
 
6.9.3 – Second round evolution  
For second round evolution the T-domain of clone 3kF0 was used as template for the epPCR 
reaction instead of wt PvdD T-domain. Transformation and screening were conducted as for 
the first round of evolution, and 22 hits were recovered from an estimated total of 600,000 
clones screened. Screening proved more difficult than for the first round of evolution due to 
the higher levels of pigmentation of unimproved clones. Selection of improved clones required 
qualitative appraisal of relative pigmentation by naked eye, including subjective assessment of 
local variations in induction, presumably arising due to uneven diffusion of IPTG. 
Nonetheless, the number of false positives recovered proved to be low with 14 of the 22 hits 
recovered showing a clear improvement in function in the second tier of the screen (Figure 
6.11). 
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Figure 6.11 – Quantitative assessment of activity of improved variants of 3KFO 
In vivo activity of improved clones was determined by measuring OD 590 of supernatant for quadruplicate 
cultures of each clone grown in a 96 well plate as described in 2.11.3. The yellow bar is the best hit from round 
one, 3kf0, included as a negative control. The T-domain of 3kF0 was the starting template for error prone library 
generation in this experiment. The dark blue bar is WT BpsA included as a positive control. False positives are 
indicated by black bars, sequence was not determined for these clones. Error bars are presented as +/- one 
standard deviation.   
 
 
6.10 – Adaptation of the T-domain of EntF to function in BpsA 
 
Of all the domain substitutions created, slEntF had the highest in vivo pigment synthesis 
capacity prior to directed evolution. This may be a consequence of the T-domain of EntF 
being the only substitute T-domain employed in swapping scheme three that is required to 
interact with a TE-domain in its native setting. slEntF was also improved by directed 
evolution, following the same protocols used for the first round evolution of oPvdD and 
slPvdD. Libraries were transformed into electrocompetent cells harbouring the PPTase of P. 
putida and approximately 500,000 clones were assessed in the first tier of screening.  As for 
the second round evolution of slPvdD, the fact that unimproved slEntF exhibited strong 
pigmentation on pigment development agar made selection of improved clones more difficult 
than for the other first round evolution experiments described in this chapter. Nonetheless, the 
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screening procedure again proved to be robust, with 39 of the 46 hits recovered from the first 
tier showing elevated pigment synthesis in the second tier (Figure 6.12). Of the 39 improved 
clones recovered, the sequence of 8 was determined. Sequence analysis of plasmid DNA from 
an additional 12 clones failed due to poor sample quality. It was decided not to reassess these 
clones owing to the large data set already accumulated from the various directed evolution 
experiments. 
 
 
Figure 6.12 – Quantitative assessment of activity of improved variants of slEntf 
In vivo activity of improved clones was determined by measuring OD 590 of supernatant for quadruplicate 
cultures of each clone grown in a 96 well plate as described in 2.11.3. The yellow bar is unimproved slEntF and 
is included as a negative control. The dark blue bar is WT BpsA included as a positive control. Clones for which 
sequence was determined are indicated by red bars. Error bars are presented as +/- one standard deviation.   
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6.11 – Summary of sequence data from directed evolution 
experiments 
 
The total number of improved clones analysed from all directed evolution experiments was 59. 
In this set of improved clones there were a total of 26 different mutations occurring at 22 
different positions. Five of these mutations had a neutral or deleterious effect on activity and 
were only recovered by association with a second, beneficial mutation. These were discounted 
from analysis. The remaining mutations all contributed positively to function of BpsA, as 
evidenced by improving in vivo pigment synthesis activity when present as a single mutation, 
or by additively improving activity when in combination with a second mutation previously 
shown to increase pigment synthesis. 
 
These mutations were viewed as falling into one of two categories.  The first category (type I) 
comprises mutations in which the sequence of the substituted domain had become more 
similar to the original sequence of BpsA, by reverting to a residue identical or more similar (as 
assessed by BLOSUM 62 matrix) to that originally found at the same location in BpsA. The 
second category (type II) consists of mutations which resulted in no change in similarity or the 
sequence of the substitute domain becoming less similar. In interpreting this data, it was 
assumed that the native sequence of the BpsA T-domain has evolved for optimal interaction 
with other BpsA domains, an assumption consistent with the observation that all substituted T-
domain constructs exhibited impaired activity in this study. Bearing this assumption in mind, 
type I mutations would appear to highlight positions at which a specific residue is required for 
optimal interaction. Conversely, type II mutations may either represent optimisation of generic 
T-domain functions that are independent of interaction with other domains; or else provide an 
alternative mode of domain interaction to that which originally evolved in BpsA. A summary 
of the mutations recovered from first and second round directed evolution experiments is 
given in Tables 6.2 and 6.3 respectively.  
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Type I mutations 
 
 
Type II mutations 
 
Table 6.3 – Type I and II mutations recovered from first round directed evolution experiments 
The location of mutations is given in the top row with the residue present in the native T-domain of BpsA 
indicated in parentheses. The left hand column indicates the directed evolution experiment for which mutations 
were recovered. Text in bold indicates mutations which occurred in a substitute T-domain and the number of 
times it was recovered. Instances where a mutation was not recovered are indicated with a dash, followed by the 
residue present in the substitute domain. 
 
 
Type I mutations 
Type II mutations 
 
 
 
Table 6.4 – Type I and II mutations recovered from second round evolution of 3kF0 
Clone 3kF0 is an improved variant of slPvdD. This clone had two mutations, +4T→I and +24 F→I. The 
mutations recovered from a second round of mutagenesis and selection using 3kF0 as a precursor are shown in 
this table.  
 
 
 
 
 
 
 
 
 
 
 +4 (V) +7 (V) +14 (L) +23 (V) +24 (L) 
oDhbF A→V x 2 - M - M L →I x 1 - F 
oPvdD T →I x 5 - I Q→L x 2 - V F →L x 3 
slPvdD T→I x 3, T→A x1 - I - Q - V F →I x 3 
slEntF - M A→V x 2 - V - V - M 
 -3 (G) +1 (L) +2 (I) +6 (L) +17 (S) 
oDhbF - G - L L→H x 5 - M E→K x 4 
oPvdD - G - L - L V→M x 6 - D 
slPvdD G→S x 1 - L - L - V - D 
slEntF - G L→I x 6 - L - L - Q 
-17 (R) -16 (R) -8 (D) -1 (N) 
G→E x 1 V→A x1 N→D x3 H→Q x1 
-39 (R) -5 (E) +2 (I) +8 (R) +15 (Q) +26 (S) +38 (R) 
R→L x2, R→C x1 E→D x1 L→Q x 2 S→F x 1 G→L x 1 R→W x 2 R→T x 1 
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6.12 – Discussion 
 
6.12.1 – Interpretation of results from T-domain swapping experiments. 
Unless otherwise stated, the position of residues and mutations described in the remainder of 
this chapter is given relative to the 4’-PP attachment site of a T-domain, the serine at this 
position is absolutely conserved in all T-domains. In all instances, substitution of the WT 
BpsA T-domain by a foreign T-domain resulted in a drastic reduction in pigment synthesis in 
vivo. This result is consistent with disruption of native T-domain interactions impairing 
enzyme function. Irrespective of the swapping scheme used, two substitutions resulted in 
complete ablation of activity: the aryl carrier protein (ArCP) from the E. coli PKS enzyme 
EntB; and the first T-domain from the P. aeruginosa NRPS PvdD. In the case of the EntB 
swap, the loss of activity was not surprising, given that ArCPs interact with a very different set 
of partner domains in PKS enzymes. Restoration of function for recombinant BpsA 
harbouring the EntB ArCP by directed evolution was attempted (results not shown), however 
in spite of screening over 106 clones from an epPCR library, no functional variants were 
recovered. The reason for loss of function arising from the PvdD T-domain substitution is less 
obvious. Analysis of the sequence of this T-domain reveals the presence of a thr residue 
located at +4. As described in Appendix 1, alignment of 60 different T-domains showed that a 
hydrophobic residue was always present at this position in T-domains immediately upstream 
of a TE-domain. This finding suggests that the PvdD T-domain may have been unable to 
correctly interact with the TE-domain of BpsA due to the thr residue at +4 in this domain. In 
contrast, the remaining T-domain substitutions did not completely destroy BpsA function, and 
in all cases a hydrophobic residue was present at position +4 in the substituted T-domain. It is 
also interesting to note that the two alternative T-domains that resulted in recombinant BpsA 
enzymes with the highest activity (EntF and PsT) are both found upstream of TE-domains in 
their native setting. The results of the T-domain swapping experiments conducted therefore 
suggest that specific features of T-domains located upstream of a TE-domain are specialised 
for interaction between the two domains. Further support for this idea can be found in the 
bioinformatic analyses described in appendix 2 and discussed in 6.2.1. Since disruption 
between the T and TE-domains of BpsA is the most likely reason for loss of activity in 
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recombinant protein, it is reasonable to assume that many of the mutations recovered from 
directed evolution experiments act to reduce this disruption.  
 
 
6.12.2 –Structural analysis of type I mutations from first round evolution 
experiments 
There were five separate locations at which type I mutations occurred in first round directed 
evolution experiments. These positions were +4, +7, +14, +23 and +24. In the native T-
domain of BpsA, each of these positions is occupied by either a val or leu residue. Figure 
6.13A shows these positions mapped onto the structural model of the native BpsA T-domain 
in the TE-state. The leu located at position +24 forms part of the hydrophobic interface 
between the T and TE-domains as indicated in Figure 6.13B. Of particular note, previous 
mutational analysis of the T-domain of EntF found that mutation of the EntF equivalent of +24  
destroyed enzyme function by disrupting T-TE communication [93].  
 
Positions +7, +14 and +23 are occupied by val leu and val respectively. None of these residues 
are predicted to be involved in the interface between the T and TE-domains in the BpsA 
model. However, one common feature of the hydrophobic sidechains of these residues is that 
they are all orientated toward the core of the T-domain itself, so may be involved in 
stabilisation of the TE- interaction conformation of the T-domain. Alternatively they may be 
involved in interaction with the A or Ox-domain of BpsA. Unfortunately, due to lack of 
suitable templates structures, models for T-domain interaction with the A and Ox domains of 
BpsA could not be generated.  
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Figure 6.13 – Structural analysis of type I mutations 
A- The locations of all type I mutations from first round directed evolution experiments are 
mapped onto a structural model of the BpsA T-domain in the TE-state. 
B- leu +24, shown in red, forms part of the hydrophobic interface between the T and TE-domains 
in the structural model of BpsA. Side chains of other residues forming the interface are shown. 
Residues in green are part of the TE-domain, whereas the yellow phe is part of the T-domain. 
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As outlined in appendix one and section 5.4, evidence from bioinformatic analysis and domain 
swapping experiments suggests that position +4 in a T-domain may play an important role in 
the interaction with downstream domains. For interactions with TE-domains, sequence 
comparisons suggest that a hydrophobic residue is required at +4. Consistent with this 
hypothesis, mutations giving rise to a hydrophobic residue at this position were recovered 
multiple times in improved clones arising from the evolution of oPvdD, slPvdD and oDhbF. 
Analysis of in vivo pigment synthesis data from the two PvdD evolution experiments reveals 
that a T→I mutation at this position results in the largest relative increase in pigment 
production of any of the mutations recovered.  
 
In the structure 2roq, solved for the T/TE-domains of EntF [192], a met is located at +4. This 
methionine protrudes from the start of helix 2 of the T-domain and its side chain is oriented 
toward helices 4 and 5 of the TE-domain. In the elucidation of this structure, 20 similar 
confomers were observed. In these conformations helices 4 and 5 of the TE-domain are 
particularly mobile. This mobility was interpreted as providing a fluidity that might facilitate 
delivery of the 4’PP arm and attached substrate to the active site of the TE-domain, prior to 
product release [192]. A selection of conformations highlighting this fluctuating motion is 
shown in Figure 6.14A. It is possible the presence of a hydrophobic residue at S+4 actually 
serves to destabilise interaction between the T and TE-domains (i.e. preventing formation of 
strong interactions such as H-bonds or salt bridges), with the resulting mobility promoting 
entry of the 4’PP arm and attached substrate into the active site of the TE-domain (Figure 
6.14B). In addition to promoting mobility that might be important for substrate transfer, this 
might prevent overly stable interactions of the T-domain with any individual partner domain, a 
situation which would be detrimental to interaction with other domains.    
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6.12.3 – Interpretation of type II mutations from first round evolution 
experiments 
Type II mutations were recovered at five separate locations in improved clones from first 
round directed evolution experiments. Since these mutations result in residues of a substituted 
domain becoming less similar to those found at the equivalent location in the native BpsA T-
domain, they are unlikely to represent positions which are crucial for interaction between the 
native T and TE-domains of BpsA. Perhaps the most important information to be gleaned 
from these mutations is that there are many different ways in which T-domain function can be 
optimised. This situation has also been observed in directed evolution of the T-domain of 
EntB, where a diverse set of mutations was recovered [92]. Since interaction depends not only 
on direct contacts and interface with a partner domain, but also on the ability of a T-domain to 
Figure 6.14 – Dynamic nature of T-TE structure in EntF 
A- A selection of NMR conformers elucidated for the T and TE-domain of EntF are shown. Helices 4 and 
5 of the TE-domain (yellow) were determined to rapidly fluctuate, and overlap helix 2 (blue) of the T-
domain. Position +4 in this structure is occupied by a met (green). The side chain of this met comes into 
close proximity (<2.5 Å) to a ser and Thr residue protruding from the loop between helices 4 and 5 of the 
TE-domain. 
B-If met +4 is replaced with a potential H-bond donor/acceptor this might result in reduction of mobility 
by formation of inter-domain H-bonds. This possibility was investigated by substituting a Thr residue at 
S+4 in the structure 2roq. As illustrated this could potentially result in formation of inter-domain H-bonds 
(dashed green lines). Structure was generated using the mutate, torsion and energy minimisation functions 
of Deep View.  
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adopt a particular conformation, these mutations may represent novel solutions to the 
conformational demands placed on a foreign T-domain located in BpsA. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15 –  Locations of type II mutations mapped onto a structural model of the 
BpsA T-domain 
Identity of the mutations recovered at each location as follows -3 = G→S, +1 = L →I, +2= L →H, +6 = V →M, 
+17 E →K 
 
6.12.4 –Interpretation of results from second round evolution experiment 
For second round evolution experiments, the T-domain of the improved slPvdD variant 3kf0 
was used as starting template. This clone showed the highest activity of any improved slPvdD 
variants and harboured type I mutations at positions +4 and +24. As discussed in the preceding 
sections, these mutations are likely to improve function by optimising interaction with the TE-
domain of BpsA. The most immediately obvious difference between the patterns of beneficial 
mutation recovered from this second round of evolution, when compared to first round 
evolution is the increased diversity in location and identity of aa changes. In the 45 clones 
analysed from four separate first round experiments, there were a total of 10 locations at which 
13 different aa changes were recovered. In the 14 clones analysed from a single second round 
evolution experiment, there were 11 locations at which 12 different mutations were recovered. 
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The location of these mutations has no overlap with those recovered from first round 
experiments. It is possible that the mutations recovered in the second round evolution 
experiment did not show up as hits in the first round experiments as they only improve 
function when acting synergistically with the S+4 and S+24 mutations already present in 3kf0. 
A subtly different possibility is that only mutations which addressed the primary barrier of T-
TE communication restored activity in first round experiments and once this barrier had been 
overcome it revealed the effect of mutations which would otherwise have been masked. One 
clear conclusion that can be drawn from data arising from both first and second round 
evolution experiments is that the positive effect of mutations on activity is, at least in some 
cases, additive, as illustrated in Figure 6.17.  
 
 
  
 
 
 
 
 
 
 
 
6.12.5 – A proposed model for T-domain interaction with the TE-domain 
of BpsA 
 
The picture of T-domain interaction that is emerging, from this and previous studies is one of 
dynamic fluctuation. The interaction between the T-domain and other NRPS domain partners 
must be sufficiently stable to allow for processing of the relevant reaction intermediate. On the 
other hand, overly stable interaction with one partner would lead to a situation in which a T-
 +2 +4 +15 +24 
slPvdD - - - - 
3pf2 - - - F→L 
3kf0 - T→I - F→I 
Pr2H2 I→Q T→I - F→I 
Pr2H3 I→Q T→I Q→L F→I 
Figure 6.16 – Additive effect of mutations on 
activity of slPvdD 
The graph compares in vivo pigment synthesis activity of 
slPvdD and four improved derivatives of this protein 
recovered from first and second round evolution 
experiments. The table above shows the mutations present in 
each strain and gives their location relative to the site of 4’-
PP attachment in the T-domain. Error bars are presented as 
+/- one standard deviation for quadruplicate cultures. 
0.03
0.08
0.13
0.18
0.23
0.28
0.33
0.38
0.43
sl
P
vd
D
3P
F2
3K
F0
P
R
2H
2
P
R
2H
3
W
T+
ve
Strain
O
D
 5
90
 183 
domain is locked in interaction with this domain at the expense of interaction with others. This 
chapter focused primarily on interaction between the T and TE-domains of BpsA, because this 
enzyme does not have a C-domain, and because no structural models for an A-domain 
interrupted by an Ox-domain presently exist. Furthermore, the bioinformatic analysis 
presented in Appendix 2 suggests that T-domain interactions with a downstream partner are 
more specialised than interactions with an upstream partner; and for BpsA, the only 
downstream interaction partner is the TE-domain. Based on the results of the directed 
evolution and structural modelling studies described in this chapter, as well as existing 
biochemical data, a model for interaction between the T and TE-domain of BpsA is now 
proposed. 
 
In the structure 2roq solved for EntF, the interface between the T and TE-domains is 
comprised of buried hydrophobic side chains from both domains. Structural models suggest 
that the same situation exists in BpsA. Data from the directed evolution experiments 
implicates position +24 as a key residue in this interface. Mutagenesis of EntF has also 
indicated that this position plays a key role in T-TE interaction [93]. The T-domain appears to 
adopt a unique conformation, the TE-state, which allows access to the active site of the TE-
domain. This conformation requires that side chains present at the core of the T-domain in the 
H and A/H states be shifted so as to contribute to a shared hydrophobic core between the T 
and TE-domains. In BpsA and EntF, a phe residue located at -6 is at the centre of this 
interface, and is closely associated with hydrophobic side chains extending from loops at the 
end of the T-domain and the start of the TE-domain. Figure 6.17 gives a schematic 
representation of this, for an illustration of the specific residues involved in this interaction in 
EntF and BpsA refer to Figures 6.4A and 6.15B respectively. This interaction is likely to 
depend not only on residues directly involved in the interface between the two domains, but 
also on residues that contribute to stability of the T-domain in the TE-state.  
 
Position +4 was also implicated as being important for correct interaction between the T and 
TE-domains of BpsA. In the structure solved for EntF, this position is occupied by a met, 
whose sidechain extends toward helices 4 and 5 of the TE-domain. These helices are the only 
portion of the TE-domain that overlaps the T-domain in the structure 2roqA, and the loop 
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connecting them contains a ser and thr residue, the side chains of which extend toward that of 
met +4 in the T-domain. As illustrated in Figure 6.14, helices 4 and 5 of the TE-domain are 
particularly mobile and the presence of a hydrophobic residue at +4 might promote this 
mobility or prevent overly stable electrostatic interactions locking the T-domain in interaction 
with the TE-domain. Unfortunately, it was not possible to model the region corresponding to 
helices 4 and 5 of the BpsA TE-domain, due to low sequence identity with solved TE-domain 
structures. Nonetheless, it seems likely that +4 is an important position for interaction between 
the T and TE-domains of BpsA, although the nature of its role is unclear. As discussed in 
chapter 5 this position also appears to be important in correct interaction between T-domains 
and downstream C-domains. It is possible that residues at this position determine correct 
interaction between a T-domain and a downstream partner by different mechanisms in 
different contexts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.17 – Schematic representation of the hydrophobic interface between T and TE-
domains 
Residues contributing to the proposed domain interface are represented by spheres/ovals. These are colour coded 
to allow identification of the residues in an alignment of the EntF and BpsA T-TE interface sequences, shown in 
the bottom panel. 
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6.12.6 – Concluding comments on T-domain function and interactions 
The multitude of NRPS biosynthetic systems in nature have undoubtedly arisen from a 
common set of ancestral proteins, which have diversified through module duplication and 
horizontal gene transfer events. The evolutionary history of NRPS enzymes has therefore 
presumably required a single ancestral T-domain protein to diversify in response to many 
functional niches; the result of this is a diverse set of information rich sequences sharing a 
common structural motif [92-94, 193, 199-201]. Elucidation of T-domain structures both in 
isolation, and in combination with other domains, has revealed a high degree of structural 
plasticity [44, 53, 192] and there is evidence that conformational switching is central to 
modulating interactions with other domains and proteins [3, 11, 44, 64, 192]. Bearing this in 
mind, a great deal of the information encoded in diverse T-domain sequences may govern 
these conformational dynamics. It is likely that the A and A/H structures that have been 
elucidated for T-domains in isolation represent stable base conformations from which other, 
less stable interaction conformations are adopted. There is structural evidence for the presence 
of such interaction conformations as already discussed in 6.2.2, and data from the domain 
swapping and directed evolution experiments described here, as well as directed evolution 
experiments previously conducted on the ArCP of EntB [92], show that there are a diverse set 
of sequence options that can allow a T-domain to function correctly in a particular setting. 
Perhaps what is most important for T-domain function is the balance between stability of 
various conformations, a balance which can be achieved in many different ways.  
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Chapter 7 – BpsA as a tool for the characterisation and 
discovery of phosphopantetheinyl transferase enzymes  
 
7.1 – Introduction 
 
As described in chapter 6, the unique ability to synthesise a readily detectable pigment in E. 
coli makes the single-module NRPS BpsA a powerful tool for probing NRPS domain 
interactions. In order for pigment synthesis to occur, BpsA must first be activated by post-
translational attachment of a 4’-PP group to the active site serine of its T-domain. This 
activation is catalysed by a cognate PPTase enzyme, which is able to recognise specific 
sequence elements in the T-domain of BpsA. Since the native PPTase enzymes of E. coli are 
unable to fulfil this role, co-expression of an activating PPTase enzyme is necessary for BpsA-
mediated pigment synthesis to occur. The dependence on PPTase-mediated activation allowed 
preliminary development of new assays for characterisation of these enzymes, comparing the 
efficiency of different PPTases both in vivo and in vitro. BpsA was also used as a reporter for 
the discovery of new PPTase enzymes and secondary metabolite clusters from an 
environmental DNA library. 
 
7.1.2 – Aims and overview 
The aim of this work was to develop BpsA based tools for the characterisation and discovery 
of PPTase enzymes. A test was developed using WT and modified BpsA enzymes to assess 
PPTase specificity in vivo. This provided a useful qualitative assay but did not allow accurate 
quantification of efficiency of T-domain activation by a particular PPTase possibly due to 
variation in expression levels in vivo. An in vitro assay was subsequently developed in which 
the rate of pigment synthesis by BpsA was monitored as an indirect measure of T-domain 
activation by a given PPTase. This in vivo assay was found to be quantitative, allowing 
relative rates of T-domain activation to be assigned for the three PPTases examined. Detailed 
kinetic analyses were also conducted for two of these PPTases. Finally, a protocol was 
developed that allowed high throughput screening of environmental DNA for the presence of 
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novel PPTase enzymes. Using this method, three previously uncharacterised PPTase enzymes 
capable of activating BpsA were recovered from an environmental DNA library. Analysis of 
one of the sequences recovered from this screen also revealed characteristic features of a 
secondary metabolite cluster, suggesting that the screen may also be applicable for the 
discovery of novel secondary metabolite clusters from uncultured organisms. 
 
7.2 – In vivo characterisation of PPTase enzymes using BpsA 
 
In order to ascertain whether BpsA could be used to assay PPTase specificity in vivo, plasmid-
encoded copies of the WT BpsA enzyme as well as the active T-domain variants oDhbF, 
oPsT, slEntF were transformed into three different PPTase expression backgrounds. The 
construction of hybrid genes and PPTase over-expression strains is described in detail in 
section 6.5. The aim was to compare the ability of three different PPTases to recognise four 
different T-domain substrates. The PPTase enzymes examined were: Sfp from B. subtilis, 
PcpS from P. aeruginosa and PP1183 from Pseudomonas putida. All of these enzymes have 
previously been reported as having broad substrate specificity [40, 69, 202]. 
 
Once each test strain had been created, a master 96 well plate containing three separate 
glycerol stocks for each strain was established allowing rapid inoculation of triplicate 
overnight cultures for each strain using a 96 pin inoculating tool. The following day, assay 
cultures were inoculated to uniform density in pigment development medium in a 96 well 
plate, which was then incubated for 12-72 hrs at 18 °C. Following growth, pigment levels in 
culture supernatant were assessed by measuring absorbance at 590 nm in a microplate reader. 
Although qualitative, in that it was possible to determine whether a particular PPTase was 
capable of activating a particular T-domain as evidenced by presence or absence of 
pigmentation, quantitation of relative efficiencies proved impossible due to variation within 
and between assay repeats. The assay is nonetheless a valuable tool for initial assessment of 
substrate specificity of PPTase enzymes. It was found that each of the PPTases tested was 
capable of recognising the T-domains of all BpsA reporters. In the case of the reporter slEntF, 
which contained the T-domain from the E. coli NRPS EntF, pigmentation was observed even 
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in the absence of an exogenous activating PPTase due to this T-domain being a substrate for 
the native E. coli PPTase EntD [42]. When WT BpsA was used as a reporter, pigmentation 
was also observed in the absence of an exogenous activating PPTase, although this was weak 
and only became apparent after 48-72 h incubation. In contrast, co-expression of Sfp, PcpS or 
PP1183 with WT BpsA resulted in strong pigmentation appearing after 60-120 min. 
 
7.3 – In vitro activity of BpsA 
 
The first step toward developing BpsA as an in vitro reporter for PPTases was to establish 
reliable protocols for protein purification and subsequent assessment of activity. An in vitro 
protocol for measuring the rate of pigment formation was successfully established, and used to 
derive kinetic parameters for BpsA.  
 
7.3.1 – Purification of his-tagged BpsA and PPTases 
For purification of BpsA, expression was conducted using auto-induction medium at 16 °C as 
described in 2.9.1.5. Owing to the FMN group bound to the Ox domain, BpsA enzyme 
preparations have a characteristic bright yellow colouration [80], a feature which assisted the 
monitoring of enzyme solubility and purification. Following lysis and separation, the soluble 
fraction was discernibly yellow, indicating good yield of soluble protein. This indication was 
confirmed by subsequent SDS PAGE analysis which revealed a large band corresponding to 
BpsA in the soluble fraction and very little BpsA in the insoluble fraction (not shown).  
 
In an initial purification attempt using 200 mL of induced culture it was found that it was 
difficult to apply sufficiently stringent washing conditions to separate BpsA from major 
contaminating species without losing the BpsA band also. For subsequent attempts a 2000 mL 
culture was used as described in 2.9.2.4; this gave soluble protein in vast excess to the binding 
capacity of the column used. This excess of target protein resulted in a much lower level of 
contaminants, with the final protein appearing sufficiently pure for subsequent biochemical 
analyses (Figure 7.1).   
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Three broad specificity PPTase enzymes were also purified using Ni-NTA affinity 
chromatography (Figure 7.1). These were B. subtilis Sfp, P. aeruginosa PcpS, and P. putida 
PP1183. Expression of PPTase enzymes was conducted at 16 °C using auto-induction medium 
as described in 2.9.1.5 with subsequent purification as described in 2.9.1. 
 
 
 
 
 
 
 
 
  
 
 
 
 
7.3.2 – Initial in vitro characterisation of BpsA 
For in vitro analysis of indigoidine synthesis, purified BpsA was first incubated with purified 
PP1183 and appropriate substrates to bring about 4’-PP attachment as described in 2.13.1. 
Indigoidine synthesis reactions were then set up in a 96 well plate as described in 2.13.2. 
Reactions were initiated by addition of activated enzyme solution followed by continuous 
measurement of A590 in a Versamax™ microplate reader. As shown in Figure 7.2, reactions 
exhibited a decrease in absorbance after the maximum value was reached. Interestingly, the 
rate of decrease in product concentration after the peak value was proportional to the rate of 
increase before. The reason for this phenomenon was investigated in more detail.  
Figure 7.1 – SDS Page analysis of 
purified BpsA and PPTases 
Purified, buffer exchanged enzymes are 
shown. 1-BpsA. 2- MW marker. 3-PcpS . 4-
PP1183 . 5- Sfp .   
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Figure 7.2 – Preliminary analysis of indigoidine formation catalysed by BpsA 
Reactions were set up in a 96 well plate as described in 2.13.2 and initiated by addition of purified BpsA. Product 
concentration was then monitored by measuring A590 every 10s in a microplate reader. The final concentration of 
L-gln present in each reaction is indicated, the concentration of all other reactants was constant between 
reactions. Notice that absorbance decreases after a peak value is reached, and that this decrease is proportional to 
the previous rate of increase. A similar pattern was seen when using increasing concentrations of ATP at a set 
concentration of L-gln. 
 
It was noted that the supernatant from BpsA-expressing cultures reached a much higher A590 
(~1.2) than the maximum achieved from any in vitro experiments (~ 0.3) (not shown). It was 
reasoned that since indigoidine produced and exported from a cell in vivo would be effectively 
removed from exposure to intracellular enzymes, the loss of product seen in vitro might be due 
a second reaction catalysed by an enzyme present in the in vitro assay preparations.  This 
could have been BpsA itself, the activating PPTase or an undetected contaminating species. 
To test this possibility, filter sterilised culture supernatant containing indigoidine was 
incubated with various concentrations of each enzyme preparation used for in vitro assays. 
However, no difference in pigment levels resulted from this treatment and it was concluded 
that the loss of pigmentation seen in vitro was not enzyme catalysed. Each of the other assay 
reagents was subjected to similar analysis and it was found that only addition of sodium 
phosphate buffer (pH 7.8) to a final concentration of 50 mM resulted in decolouration of 
culture supernatant. A more detailed analysis of the relationship between pH and pigment 
stability was then conducted. The results of this analysis, illustrated in Figure 7.3A, showed 
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that decolouration occurred to a greater extent at higher pH. This finding was consistent with 
previous observations that indigoidine is unstable at alkaline pH [206]. Although the optimal 
pH for BpsA function is reported to be 7.8 [80], the sensitivity of this enzyme to changes in 
solution pH was now tested in the hope that it might be possible to use a lower pH buffer. As 
illustrated in Figure 7.3B, BpsA activity was found to be very pH sensitive, with deviations of 
0.2 units either side of 7.8 resulting in a severe reduction of activity. Based on the results 
described, it was concluded that the loss of pigmentation observed was due to non-enzymatic 
degradation of indigoidine by an unknown mechanism and that this degradation was 
unavoidable at the optimal pH for enzyme function. 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 – The effect of pH on Indigoidine stability and BpsA reaction rate 
A- Diluted sterile supernatant from an indigoidine producing culture was incubated for 20 min with 50 mM 
sodium phosphate buffer at each of the indicated pH values in triplicate. Loss of colouration was then assessed by 
measuring A590. Error bars are presented as +/- one standard deviation. 
B- Indigoidine reactions differing only in the pH of the buffer used are shown. Deviation from pH 7.8 by as little 
as 0.2 units was found to noticeably impair function. 
 
7.3.3 – Kinetic studies  
 
For the derivation of kinetic parameters for BpsA, triplicate reactions in a 96 well plate were 
set up across a two fold dilution series of ATP as described in 2.13.2. The maximum velocity 
(V0) of product formation for each substrate concentration was derived from the five data 
points that gave the highest linear gradient, as illustrated in 7.4. Gradients were then converted 
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into rates of product formation (µmol/min) using the reported extinction coefficient of 
indigoidine ( A590 of 0.1 = 8.54 µM indigoidine for 0.6 cm path length used in expt.) [206]. 
The resulting data was analysed using SigmaPlot® allowing derivation of Km and Vmax values 
by the one site saturation regression function (assessing fit of data to the Michaelis-Menten 
equation). Figure 7.5 shows plots of V0 vs. substrate concentration for ATP. Table 7.1 gives a 
summary of the kinetic parameters derived from these experiments. 
 
 
 
Figure 7.4 – Determination of pigment synthesis velocity 
In order to determine maximum velocity for a particular substrate concentration, the six consecutive data points 
(50 sec) which gave the steepest gradient were determined. Illustrated here are triplicate reactions for a single 
concentration of ATP, the vertical black bars indicate the region which was used for maximum velocity 
derivation. This strategy was used to determine maximum velocity for each concentration of substrate for 
subsequent determination of kinetic parameters.  
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Figure 7.5 – Derivation of kinetic parameters for BpsA 
Maximum velocity of indigoidine formation for a serial dilution series from 10 to 0.078 mM ATP. Curve was 
fitted using the Sigmaplot one site saturation regression function and used to derive kinetic parameters for BpsA 
with this substrate. Data points were determined from three independent repeats, and error bars are presented as 
+/- one standard deviation. 
 
 
 
 
 
 
 
 
 
 
 *0.078 - 10 mM ATP with [L-gln] fixed at 2 mm, 
 
Table 7.1 – Kinetic parameters* for BpsA  
Km (mM) 11.26 +/- 0.3 
Vmax (nmol.min-1.mg-1) 2791 +/- 54 
kcat (min-1) 241.3  +/- 4.4 
kcat/Km (min-1.mM-1) 21.62 +/- 1.02 
 194
7.4 – Determination of kinetic parameters for PPTases using a BpsA 
reporter system 
 
Having established a reliable protocol for determination of pigment synthesis rates and an 
estimate of kcat and Km for BpsA, it was now possible to use this enzyme to quantify PPTase 
function. Reactions containing BpsA purified from E. coli, an activating PPTase, and the 
necessary substrates for both the 4’-PP attachment and pigment synthesis reactions were 
established as described in 2.13.3. Using this assay it was possible to determine kinetic 
parameters for PPTase enzymes by monitoring the acceleration of the indigoidine synthesis 
reaction of BpsA (Figure 7.6).  The derivation of kinetic parameters is based on the 
assumption that the rate of indigoidine synthesis is directly proportional to the concentration 
of activated BpsA, therefore the change in rate of indigoidine synthesis is directly proportional 
to the rate of BpsA activation by the PPTase included in the reaction. 
 
 
 
 
   
 
 
 
 
 
 
 
Figure 7.6 – Derivation of kinetic parameters for PPTase enzymes using the BpsA 
reporter assay 
A) Absorbance at 590 nm for reactions containing inactive BpsA and an activating PPTase was measured every 
10 s. B) The average gradient between every three points of the curve (20 s) was measured to provide an estimate 
of instantaneous velocity. C) Instantaneous velocity vs. time is graphed, and the steepest portion of the curve 
determined. This gradient represented the maximum rate of BpsA activation for an individual PPTase at a 
particular concentration of CoA. Rates of BpsA modification were determined across a range of substrate (CoA) 
concentrations; these were then used to derive kinetic parameters for the activating PPTase.   
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Three PPTases were assessed using the BpsA reporter assay and kinetic parameters derived 
for two of these. Reactions for each PPTase were set up in duplicate across a two fold serial 
dilution series of CoA as described in 2.13.3 and data points (A590) were measured every 10 s. 
Figure 7.7 shows a sample of the raw data from this experiment and the gradient values that 
were derived from one of the reactions. 
 
Figure 7.7 – Raw and processed data from PPTase comparison experiment 
A) Data from duplicate reactions for the three PPTases and a no PPTase control for a single concentration of 
CoA. Measurements were taken at six different CoA concentrations (2 fold dilution series 25.0-0.78 µM). The 
red box indicates the region from which the gradient values shown in panel B were taken. 
B) A plot of instantaneous gradient for one of the PcpS reactions shown in panel A. The points connected by a 
straight line were used to derive a value for the maximum velocity of PcpS modification of BpsA at this 
concentration of CoA. In all cases a minimum of three consecutive data points was used for determination of 
PPTase velocity for a particular reaction.  
 
Using the process outlined, duplicate values for maximum velocity of BpsA activation were 
obtained at final concentrations of 25.0, 12.5, 6.25, 3.13, 1.56 and 0.78 µM CoA. The 
resulting set of data was used to derive kinetic parameters for both PPTase enzymes using the 
one site saturation regression analysis function of SigmaPlot. As shown in Figure 7.8 the 
derived data gave a very good fit with the Michaelis-Menten equation. 
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Figure 7.8 – Derivation of kinetic parameters for PcpS and PP1183  
Plots of maximum acceleration in rate of pigment synthesis vs. concentration of CoA are shown. Maximum 
acceleration of pigment synthesis is proportional to maximum rate of BpsA modification by the PPTase being 
assessed. Curve was generated using the SigmaPlot one site saturation regression function and used to derive 
kinetic parameters for PPTase modification of BpsA. Data points were determined for duplicate independent 
reactions, and error bars are presented as +/- one standard deviation. 
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The Y axis units for the data shown in Figure 7.8 are change in reaction velocity per second. 
In order to convert these units into a rate of modification of BpsA the assumption was made 
that reaction rate was directly proportional to the amount of BpsA in a reaction that had been 
activated by a PPTase during the time period from which the data was derived. This is a 
reasonable assumption given that BpsA fits the Michaelis-Menten model (Figure 7.5) and for 
all acceleration values obtained, the relationship between instantaneous gradient and time was 
linear (Figure 7.7B). The previously determined kinetic parameters for BpsA were then used 
to derive a theoretical maximum velocity for pigment synthesis by that amount of BpsA under 
the conditions of the assay (i.e. the theoretical rate of pigment synthesis if all BpsA has been 
activated by a PPTase). Having established a relationship between pigment synthesis rate and 
amount of active BpsA present, the Vmax values obtained could be converted from change in 
gradient to amount of BpsA modified per second, which is the same as amount of CoA 
consumed per second. The kinetic parameters determined for PcpS and PP1183 are 
summarised in table 7.2. A more detailed explanation of the conversion of change in gradient 
values to rate of activation values is given in appendix 2. 
 
Table 7.2 – Kinetic parameters for PcpS and PP1183 
*0.78 – 25.0 µM CoA with [BpsA] fixed at 1.64 µM 
 
  
7.5 – BpsA as a tool for discovery of PPTase genes in environmental 
DNA libraries 
 
Since BpsA depends on activation by an exogenous PPTase for function in E. coli, it has the 
potential to serve as a reporter for the discovery of PPTases in eDNA libraries. A protocol for 
recovery of PPTases was developed and used to recover novel PPTase genes from a small 
insert, plasmid based eDNA library.  
Parameter* PP1183 value PcpS value 
Km (µM) 10.7 +/- 1.4 13.4 +/- 1.13 
Vmax (nmol.min-1.mg-1) 27.4 +/- 1.7 56.1 +/- 2.3 
kcat (min-1) 0.733 +/- 0.045 1.54 +/- 0.060 
kcat /Km (min-1.mM-1) 68.7 +/- 13.2 115.5 +/- 14.2 
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7.5.1 – Screening of an eDNA library and recovery of hits 
For screening purposes, an E. coli strain harbouring a plasmid-encoded copy of the bpsA gene 
was used as a reporter. The eDNA library used for these experiments was kindly provided by 
Nadia Skorupa Parachin of Lund University. This library contained small insert genomic DNA 
fragments in the plasmid pRSET1. The genomic DNA was isolated from a soil sample and 
prepared so that the size inserts would be between 500 and 3000 bp. Library DNA was 
delivered to reporter cells by electroporation and approximately 1x106 of the resulting clones 
were assessed for colour development on pigment production agar as described in 2.14. Nine 
of these clones developed colouration and the plasmid-encoded eDNA fragment from these 
was isolated and sequenced. Figure 7.9 shows a representative screening plate on which a hit 
was recovered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9 – Recovery of PPTases from an eDNA library 
Pigmentation arising form PPTase mediated activation of BpsA allowed rapid and unambiguous identification of 
PPTase harbouring clones. A plate on which such a clone was recovered is pictured.  
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7.5.2 – Sequence analysis of hits from eDNA library screen 
Plasmid DNA was isolated from each of the nine clones recovered from the screen and the 
nucleotide sequence of the eDNA inserts analysed. It was found that three unique sequences 
had been recovered multiple times. Each of the three unique nucleotide sequences was 
translated in all six reading frames and the resulting aa sequences analysed by BLAST search 
against the non-redundant protein sequence collection of NCBI. This enabled the identification 
of entire PPTase genes for all three fragments, as well as additional partial and complete genes 
isolated by virtue of proximity to the PPTase genes. The organisation and identity of partial 
and complete genes identified in each eDNA fragment is illustrated in Figure 7.10.  Of 
particular interest were two partial genes recovered in one of the eDNA fragments which 
indicated that of part of a NRPS/PKS secondary metabolite cluster had been recovered. 
 
 
 
 
 
 
 
 
 
 
Table 7.3 – partial and complete genes found in eDNA fragments 
 
Gene Top match from BLAST search Species in which top match is 
found 
Percent 
identity 
PPTase1 Sfp type PPTase Nostoc punctiforme PCC 73102 43 % 
PPTase2 Sfp type PPTase Streptomyces sviceus ATCC 29083 35 % 
PPTase3 Sfp Type PPTase Burkholderia oklahomensis C6786 40 % 
TE Type II thioesterase – partial  Planktothrix agardhii 47 % 
KS PKS KS-domain – partial  Cyanothece sp. CCY0110 52 % 
NTR Nitroreductase Nitrococcus mobilis Nb-231 50% 
DUS Dihydrouridine synthase Nocardia farcinica IFM 10152 55 % 
Mg Magnesium transporter Xanthomonas campestris 55% 
Figure 7.10 – Genomic DNA 
fragments isolated from eDNA 
library screen. 
Arrangement and identity of partial and 
complete genes found in the three unique 
eDNA fragments isolated. Refer to table 
7.3 for a description of the genes. PPTase1 
was isolated along with partial sequences 
indicative of a secondary metabolite 
cluster. 
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7.6 – Discussion 
 
The results outlined in this chapter establish the BpsA protein as a powerful tool for 
characterisation and discovery of PPTase enzymes. The use of BpsA and modified variants to 
probe PPTase specificity in vivo allows rapid determination of the compatibility of a T-
domain-PPTase combination by a simple co-transformation experiment, whereas the in vitro 
activity assay allows rapid and accurate assessment of kinetic parameters for PPTase enzymes. 
Finally, the eDNA mining procedure allows unambiguous identification of novel PPTase 
enzymes with a minimum of manual input. The validity of the various BpsA assays and the 
possible applications are now discussed. 
 
7.6.1 – Interpretation of BpsA kinetic data 
BpsA presents a unique opportunity to study the kinetics of an entire NRPS module using a 
simple colourimetric assay. The final version of the protocol as described in this chapter and 
2.13.2 allowed triplicate maximum velocity values for eight substrate concentrations to be 
determined simultaneously in a single 96 well plate. The standard deviation between replicates 
was very small and the final data set fit very well with the Michaelis-Menten equation (Figure 
7.5, R2 = 0.9995). Formation of indigoidine requires a number of enzymatic steps catalysed by 
BpsA (Figure 6.2). The first of these steps is activation of L-gln by the A-domain, with ATP 
being a second substrate in this reaction. The Km value derived for ATP therefore pertains 
specifically to the A-domain of BpsA at a fixed concentration of L-gln. However, activation of 
a substrate by an A-domain is not the rate limiting step in NRPS directed biosynthesis, with 
subsequent transfer to the T-domain believed to be slower than activation [30, 169, 207]. The 
Vmax derived for BpsA therefore pertains to the maximum possible rate of indigoidine 
synthesis by the entire enzymatic complex, dictated by whichever step in the process is rate 
limiting. The derivation of kinetic parameters for BpsA was an important enabling step in the 
subsequent development of a PPTase kinetic assay, as they allowed a theoretical maximum 
velocity value to be assigned for fully activated BpsA under the conditions used in this assay. 
This value is the theoretical maximum velocity of the pigment synthesis reaction, if all BpsA 
present had been activated by 4’-PP attachment. Assuming that pigment synthesis rate is 
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directly proportional to amount of active BpsA in a reaction, this allows the conversion of 
change in gradient values to rates of modification of BpsA by a PPTase as outlined in 
appendix 2.  
 
7.6.2 – Interpretation of PPTase kinetic data and assay validation 
 
The kinetic analysis revealed that PcpS is a more efficient PPTase for the modification of 
BpsA than PP1183. The data derived for PPTases using the BpsA assay system fits well with 
the Michaelis-Menten equation (Figure 7.8), indicating that the technique provides an accurate 
assessment of PPTase reaction rate. Further validation of the assay comes from comparing the 
data derived from this experiment to that from alternative forms of PPTase assay. PcpS has 
been previously characterised using a standard HPLC based protocol for determination of 
modification rate. A Km for CoA was not determined in these experiments; however a kcat of 
3.0 +/- 0.1 min-1 was determined for PcpS with an NRPS T-domain substrate [40]. This value 
is in good agreement with the value of 2.08 +/- 0.08  min-1 obtained using the BpsA assay.   
 
7.6.2 – Utility of BpsA for recovery of novel PPTases and secondary 
metabolite clusters. 
 
BpsA proved to be an effective tool for recovering PPTase enzymes from eDNA samples. 
Using the protocol developed it was possible to screen and recover hits from 106 clones in less 
than one week. There were no false positives recovered from this screening process, with each 
of the nine clones recovered containing a PPTase gene upon sequence analysis. There were 
only three unique sequences represented in these nine clones, each of which was recovered 
multiple times. A BlastP search using translated gene sequences revealed that none of the 
three PPTase genes recovered had been previously characterised. Of particular interest was the 
recovery of one of the PPTase enzymes along with partial NRPS/PKS gene sequences. This is 
in accordance with previous observations that PPTase genes are commonly associated with 
NRPS secondary metabolite clusters, and to a lesser extent, with PKS clusters [4, 208]. The 
insert size of the plasmid-based genomic DNA library used was relatively small (0.5-3.0 kb), 
limiting the number of associated sequences recovered with PPTase genes. By using BAC, 
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cosmid or fosmid vectors, soil eDNA libraries with average insert sizes in excess of 40 kb are 
easily achievable [209]. The creation and screening of such libraries using the BpsA reporter 
system would be an effective means for recovery of novel NRPS and PKS genes and could 
even be used for the recovery of entire, functional secondary metabolite clusters. Even if entire 
clusters were not recovered in a single clone, subsequent primer walking experiments could be 
used to recover missing cluster regions. In its present format clone numbers in excess of 106 
can easily be assessed by a single researcher, without automation, in a single week. With 
further refinement, this screen has the potential to comprehensively assess large eDNA 
libraries for novel PPTases and associated secondary metabolite clusters. 
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Chapter 8 – Conclusions 
 
8.1- Research motivation 
 
The study of NRPS enzymes is of immense scientific interest due not only to the unique 
chemistry catalysed by these enzymes, but also to their integral role in bacterial physiology. 
NRPS enzymes are comprised of a series of interacting catalytic centres, the individual 
function of which is well understood. It is becoming increasingly apparent however, that 
understanding the complex mechanisms of interaction between these centres presents a rich 
new avenue of scientific investigation. The research described in this thesis investigates the 
function of NRPS enzymes at a molecular level as well as their natural role in bacteria. 
 
The initial aim of this research was to first characterise the pyoverdine biosynthetic NRPS of 
P. syringae, which were to serve as raw material for subsequent domain swapping 
experiments. This afforded the opportunity to investigate not only the mechanism of 
pyoverdine synthesis, but also the physiological significance of the siderophores of P. 
syringae. As part of this characterisation, determination of the substrate specificity of seven A-
domains was attempted. This proved to be a challenging exercise, requiring systematic 
investigation of protein expression, purification and characterisation techniques.    
 
Two separate but related aspects of NRPS domain interaction were then investigated. The first 
of these was specificity of the C-domain for the donor substrate of a condensation reaction. 
The second was interaction between the T-domain and other NRPS domains, with particular 
focus on T-TE interaction. Understanding both of these phenomena is an important 
prerequisite for developing NRPS enzymes as a robust platform for the synthesis of novel 
bioactive compounds. 
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8.2 – Key findings 
 
8.2.1 – Biosynthesis and physiological significance of siderophores in P. 
syringae 
Ps1448a has the genetic capacity to produce three different siderophores however only two of 
these, pyoverdine and achromobactin, were detectable as active siderophores under the various 
conditions examined. Pyoverdine, synthesised in part by NRPS enzymes, has a higher affinity 
for iron than achromobactin and is more efficient at scavenging iron from the environment. 
Analysis of the Ps1448a genome resulted in identification of five candidates for pyoverdine 
biosynthetic NRPS genes. The role of each of these in pyoverdine synthesis was confirmed by 
gene deletion. For all five genes, deletion completely abrogated pyoverdine production, as 
evidenced by loss of fluorescence and increased sensitivity to iron starvation. 
 
The specificity of the seven A-domains directing aa incorporation into the pyoverdine peptide 
sidechain could not be determined biochemically owing to an inability to purify active 
recombinant enzyme. In order to assign A-domain specificity a combination of in silico 
analysis of the pyoverdine locus and MS analysis of the purified molecule was used. The 
results from these two analyses were congruent allowing confident allocation of specificity for 
each A-domain. Interestingly, MS analysis revealed that Ps1448a produces two pyoverdine 
isoforms differing in mass by 71 units. Fragmentation analysis of these species suggested that 
the heavier isoform was an as yet uncharacterised pyoverdine variant which may contain an 
extra alanine residue in the peptide side chain, located between the chromophore and the 
lysine residue of the molecule.  
 
Achromobactin is synthesised by an NRPS-independent pathway. MS analysis of the purified 
siderophore, coupled with in silico analysis of its biosynthetic locus, suggests that Ps1448a 
synthesises achromobactin of the same structure and by the same mechanism as in D. dadantii 
[134]. Production of achromobactin in Ps1448a is temperature regulated, with growth at 22 °C 
resulting in higher levels of achromobactin than growth at 28 °C. Deletion of the 
achromobactin biosynthetic gene acsA did not result in a detectable phenotype under any of 
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the conditions examined, with pyoverdine able to completely compensate for loss of this 
secondary siderophore. Deletion of acsA from a pyoverdine null background however, 
resulted in increased sensitivity to iron starvation. Neither siderophore is required for 
pathogenicity of Ps1448a in Phaseolus vulgaris.   
 
8.2.3 – Manipulation of pyoverdine biosynthetic NRPS in P. aeruginosa 
Previous module swapping experiments conducted using the pyoverdine biosynthetic NRPS of 
P. aeruginosa led to the proposal that C-domain specificity for peptide donor substrates in a 
condensation reaction is a major barrier to NRPS manipulation [85, 143]. The experiments 
described in chapter five aimed to more rigorously test this hypothesis. Recombinant pvdD 
genes, in which the C and A-domains of the terminal module were substituted for foreign 
domains were created and assessed for their ability to complement a pvdD mutation. Using 
this strategy, it was found that a C-domain known to process L-fhOrn as a donor substrate in 
nature, was also able to efficiently process L-thr. This result clearly refuted the initial 
hypothesis of C-domain donor specificity. A second recombinant gene, in which the terminal 
A-domain specified ser instead of thr was found to restore fluorescence to a PAO1::∆pvdD 
indicating that the manipulation had successfully resulted in production of a novel pyoverdine 
molecule with a new aa installed at the terminal position of the peptide sidechain. Analysis of 
the pyoverdine produced this strain is presently being conducted as part of the doctoral 
research of Mark Calcott. If confirmed this will be the first example of residue swapping in 
pyoverdine using artificially recombined NRPS modules. Finally, a recombinant gene 
containing a C-domain that processes L-thr as a donor substrate in its native setting was not 
able to perform the same role when substituted into pvdD. This led to the proposal that the 
inactivity observed in this recombinant NRPS may have stemmed from failure of the 
substituted C-domain to correctly interact with one or both of the T-domains in PvdD. This 
hypothesis was supported by bioinformatic analysis of T-domain sequences, which found that 
the identity of residues at specific locations in T-domains correlated with the type of domain 
located immediately downstream.  
 
 206
8.2.4 – Substitution and directed evolution of T-domains in BpsA 
 
The interaction between T-domain and partner NRPS domains was more closely examined 
using a novel reporter system based on the pigment-synthesising NRPS BpsA. This single-
module enzyme is capable of synthesising a strong blue coloured pigment in E. coli without 
the need for additional synthetase enzymes, making it a powerful tool for investigation of 
NRPS function in vivo. It was found that substitution of the native T-domain for foreign T-
domains resulted in severe or complete disruption of enzyme function, consistent with the idea 
that T-domains have evolved specifically for optimal interaction with other NRPS domains in 
their native setting. It was particularly interesting to note that the alternative T-domains that 
yielded recombinant BpsA enzymes with the highest activity were taken from NRPS modules 
that are also required to interact with a TE-domain immediately downstream in their native 
setting. This result suggests that T-domain communication with a TE-domain is particularly 
specialised, and that there are particular features of T-domains immediately adjacent to a TE-
domain that are unique, facilitating interaction between the two domains. This observation was 
supported by previous biochemical data [92-94] and the bioinformatic analysis described 
above.  
 
A directed evolution approach was then used to improve in vivo function of recombinant bpsA 
genes by random mutagenesis of the substituted T-domain, coupled to a pigment based screen 
for improved function. Using this approach, it was possible to recover improved variants of 
four different recombinant bpsA genes and derive a structural map of mutations that resulted in 
increased function. The screen developed is an extremely powerful tool for T-domain directed 
evolution, allowing clone numbers in excess of 106 to be qualitatively assessed in a matter of 
days, with a facile second tier of screening permitting subsequent quantification of the activity 
of improved clones. In combination with structural modelling and sequence alignment 
analyses, the results of these directed evolution experiments were used to derive a model for 
interaction between the T and TE-domains of BpsA. In this model, interaction requires that the 
T-domain adopt a specialised conformation, in which hydrophobic side chains previously at 
the core of the T-domain are shifted so that they form a shared hydrophobic interface between 
the T and TE-domains. A set of key residues involved in this interface was proposed based on 
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the directed evolution data. A more general model for T-domain interaction was also derived 
from results of this study as well as previous structural and biochemical data [53, 92-94, 192]. 
In this model interactions are mediated by conformational changes, and optimal function 
requires that a balance between the various conformational states be reached. On one hand 
formation of a particular interaction state must be stable enough to allow processing of a T-
domain linked intermediate, but on the other hand, if a single state is overly stable this might 
be detrimental to formation of other interaction states required for function. Interaction 
between a T-domain and other NRPS domains is therefore dependent not only on residues that 
stabilise or destabilise the interface between two domains, but also on residues within the T-
domain that govern the stability of a particular conformation. The models generated fit well 
with the data derived in this and other studies, and will provide a basis for subsequent 
biochemical studies of T-domain interactions in NRPS enzymes. Interaction models aside, this 
work has clearly shown that achieving optimal T-domain interactions is critical for the success 
of NRPS manipulation experiments; with directed evolution a powerful tool for optimising T-
domain function in recombinant NRPS. 
 
8.2.5 – Discovery and characterisation of PPTases 
 
BpsA was also used as both an in vivo and in vitro reporter for characterisation and discovery 
of PPTase enzymes. In vivo characterisation showed that the three broad specificity PPTase 
enzymes (Sfp, PcpS and PP1183) were all capable of recognising and activating T-domains 
from P. aeruginosa, P. syringae, E. coli, B. subtilis and S. lavendulae. An in vitro 
characterisation assay was developed in which the rate of T-domain modification in BpsA 
could be indirectly determined by measuring the rate of increase in velocity of the pigment 
synthesis catalysed by BpsA. Using this assay it was possible to derive kinetic parameters for 
PcpS and PP1183. This assay presents a novel means for rapidly assessing the relative activity 
of PPTase enzymes that is considerably more convenient than existing HPLC and 
radiolabelling techniques. This same assay could also be applied to measure rates of 
regeneration of misprimed T-domains by type II thioesterases. 
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A high throughput in vivo screen was developed and implemented to recover novel PPTase 
enzymes from eDNA libraries. Using this technique three previously uncharacterised PPTases 
were recovered based on their ability to activate BpsA. Sequence analysis revealed the 
presence of NRPS and PKS genes in association with one of the recovered PPTase genes, 
indicating that this technique is also applicable to the discovery of novel secondary metabolite 
clusters from eDNA. 
 
8.3 – Research applications 
 
This research finds its most exciting application in the manipulation of NRPS enzymes to 
generate novel bioactive compounds. NRPS enzymes provide a diverse set of modular 
catalytic functions which can, in theory, be recombined to produce new molecules, either by 
targeted rational modification or combinatorial biosynthesis [13, 20, 81]. Combinatorial 
biosynthesis has the potential to generate vast libraries of bioactive molecules, which when 
combined with high-throughput activity screening would serve as a rich source of lead 
compounds for new pharmaceuticals [14-16]. An ideal tool box for NRPS mediated 
combinatorial biosynthesis would consist of a set of domains, each catalysing a desired 
reaction, that could be randomly combined in any order [82]. The diversity of molecules 
arising from such a tool box would derive primarily from the number, specificity and order of 
A-domains. This diversity could be augmented by alternative chain release mechanisms 
catalysed by different TE-domains [54, 60, 210], and the action of various tailoring enzymes 
[71, 72]. The main barrier to achieving this ideal situation is a lack of understanding of how 
NRPS domains interact during synthesis.  
 
This study addressed two key issues impeding the development of combinatorial biosynthesis 
platforms. The first of these issues is that of C-domain specificity. In order for a recombinant 
NRPS to be functional, all C-domains contained therein must be able to process the donor and 
acceptor substrates encountered in their new setting. The in vivo results described in this study 
support findings from previous in vitro studies [48, 49], suggesting that C-domains do not 
exhibit specificity for the aa sidechains of donor substrates. Instead, the evidence points to 
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sub-optimal T-domain interactions being responsible for the inability of hybrid pvdD genes to 
restore pyoverdine synthesis in this and previous [85, 143] studies.  
 
The domain swapping experiments and directed evolution experiments conducted using BpsA 
provide information on T-domain interactions that is highly relevant to potential combinatorial 
biosynthesis applications of NRPS. It was found that T-domain communication is central to 
correct function in recombinant NRPS enzymes, and that directed evolution of T-domain 
sequences in such enzymes can be used to improve function. The models developed for T-
domain interaction and the map of key residues derived from directed evolution provide 
insight into why recombination of NRPS modules might fail, and how best to avoid or rectify 
this failure. This research contributes toward a more complete understanding of the role and 
mechanism of T-domain interaction in NRPS function, an understanding which may find 
application in the design of combinatorial biosynthesis platforms. Certain T-domain residues 
appear to be crucial for correct interaction with a specific partner domains [93, 94] however as 
evidenced by the results of directed evolution conducted in this and a previous study [92], a 
diverse set of sequence solutions exists for a single interaction. It would appear that the 
success or failure of NRPS manipulation experiments is dependent to a large extent on the 
dynamics of T-domains contained therein; accordingly determination of the rules governing T-
domain dynamics and interactions is an essential pre-requisite for the development of NRPS 
based combinatorial biosynthesis platforms. 
 
Another essential pre-requisite for the activity of hybrid NRPS systems, is that all carrier 
proteins in an enzyme system be activated by post translational attachment of a 4’-PP group 
by a cognate PPTase [40]. As the application of recombinant NRPS systems to production of 
new bioactive molecules increases, so to will the demand for PPTase enzymes capable of 
efficiently activating a diverse set of T-domains within a single host. The BpsA based system 
described in this thesis addresses this need by providing a convenient tool for rapidly assessing 
the activity of PPTases with a variety of T-domain substrates both in vivo and in vitro. It has 
also proven to be a simple and robust method for discovery of novel PPTase genes present in 
environmental DNA. Since PPTase genes are often found in association with the NRPS and 
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PKS genes they serve to activate, this system also has great potential for the discovery of new 
secondary metabolite clusters.  
8.4 – Future directions 
 
8.4.1 – Siderophore characterisation 
The immediate continuation of this research into siderophore biosynthesis could focus on 
answering two questions. First, why do P. syringae and other fluorescent pseudomonads 
produce more than one siderophore? Pyoverdine was found to be superior to achromobactin 
for the scavenging of iron, and no phenotype could be detected for deletion of an 
achromobactin synthetase unless pyoverdine was also absent. So what is the physiological role 
of achromobactin and other secondary siderophores in these bacteria? A plausible hypothesis 
is that achromobactin acts as a first response to iron starvation, which is always present at low 
levels and allows cells to cope with sudden onset of iron starvation while synthesis of 
pyoverdine is established. A similar hypothesis has been put forward to explain the role of 
achromobactin in D. dadantii, however this was not experimentally verified [134]. An 
effective experimental approach to shed light on the functional role of achromobactin and 
pyoverdine would be the creation of lacZ fusion constructs to report on expression from the 
promoters of achromobactin and pyoverdine biosynthetic genes. This would allow 
determination of expression levels in response to varying degrees of iron starvation and would 
reveal whether low level constitutive expression of achromobactin biosynthetic genes is 
present. The role of other environmental cues such as temperature, nutrient availability and 
population density could also be investigated using this approach. Quantitative RTPCR is 
another method for determining transcript abundance that would be applicable. The second 
question is: What is the structure of the heavier of the two pyoverdine iso-forms detected, and 
how is it synthesised? The best starting point for investigation would be the separation of the 
two isoforms by HPLC followed by elucidation of a solution structure using NMR. 
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8.4.2 – T-domain function and interaction 
 
A combination of structural modelling and bioinformatic analysis allowed meaningful 
interpretation of results from the domain swapping and directed evolution experiments 
described in this chapter however more a more detailed biochemical examination is required 
to test the hypotheses derived from this in silico study. In particular, the question of whether 
T-domains are specialised for interaction with a particular type of downstream domain should 
be addressed. A starting point for such examination would be to substitute a variety of 
additional T-domains into BpsA, to determine whether recombinant genes harbouring T-
domains that interact with a TE-domain in nature have higher activity. Improvement of 
additional non-functional substitutions by directed evolution should also be conducted in order 
to refine the set of important residues already derived.  
 
The role of individual residues in inter-domain communication could be determined by site 
directed mutagenesis of the native T-domain in BpsA. Non-functional enzymes recovered 
from mutagenesis studies could then be subjected to further biochemical characterisation to 
determine the precise cause for loss of functionality. By incubating non-functional enzymes 
with radiolabeled L-gln, it should be possible to determine whether function loss is a result of 
failure of a T-domain to interact with the A-domain of BpsA. If this were the case, the 
radiolabeled substrate would not be tethered to the enzyme and as a result would not be 
recovered along with precipitated protein. If on the other hand, product release was impaired 
due to inability of a mutant T-domain to interact with the TE-domain of BpsA one would 
expect to recover elevated levels of radiolabeled L-gln along with precipitated protein, due to 
the stalling of the substrate on the enzyme.  
 
The hypothesis that the inactivity of the recombinant pvdD gene Ps(Thr)Thr is due to a 
breakdown in interaction between the substituted C-domain and the T-domains of PvdD will 
be tested using a directed evolution approach similar to that described in this thesis. This work 
will be conducted as part of the doctoral research of Mark Calcott. Experiments have already 
been designed to test this hypothesis. In these experiments each of the T-domains of 
Ps(Thr)Thr will be subjected to random mutagenesis followed by selection of variants that 
have restored function. The first tier of this selection process will be qualitative selection of 
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viable clones able to grow under severe iron starvation. The use of KB agar containing 200 
µg/mL EDDHA will provide unambiguous selection for the first tier as only clones which 
have gained the ability to synthesise functional pyoverdine will be viable. If viable clones are 
recovered from this first tier, the intrinsic fluorescence of pyoverdine will enable a second, 
quantitative tier of screening. The establishment of an alternative directed evolution system for 
identification of residues involved in T-domain interactions will enable the generality of the 
models proposed in this thesis to be tested. In particular if successful, this second system will 
facilitate identification of T-domain residues important for interaction with both TE and C-
domains. By substituting only the A-domain of pvdD for foreign domains specifying L-thr, it 
should be possible to determine whether improper communication between A and T-domains 
can also abrogate function in recombinant NRPS. If so, a map of key residues involved in this 
process could also be derived by directed evolution. 
 
8.4.3 – Discovery and characterisation of PPTases 
 
Concerning the application of BpsA for discovery and characterisation of PPTase enzymes, 
future experiments could aim to recover further PPTases enzymes from environmental DNA 
samples. The most interesting result from this will not necessarily be discovery of the PPTase 
enzymes themselves, but rather novel NRPS and PKS clusters that are usually found in 
association with PPTase enzymes. By creating eDNA libraries with a larger insert size in a 
BAC vector, it may even be possible to recover and characterise entire secondary metabolite 
clusters.  
 
This system also lends itself to high throughput screening of libraries of compounds for 
inhibitors of PPTase enzymes in vivo. Since activation of BpsA is dependent on the activity of 
a co-expressed PPTase, inhibition of such a PPTase could be detected based on reduced 
pigment synthesis. The in vitro screen for PPTase characterisation could then serve as a 
second tier of screening allowing precise determination of the efficacy of compounds as well 
as their mode of inhibition. PPTases play an integral role in both primary and secondary 
metabolism of bacteria, and are in many cases essential proteins [40, 69]. As such, the 
discovery of inhibitors is of particular interest from the perspective of drug discovery [211].  
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 8.5 – Concluding remarks 
 
The role of NRPS in bacterial physiology, as well as the molecular mechanisms governing the 
function of these enzymes, presents a challenging and multi-faceted avenue of scientific 
investigation. The present understanding of the function of these enzymes has required an 
amalgamation of molecular biological, structural and chemical approaches and has reached the 
point where detailed mechanistic aspects of function are being illuminated. The 
microbiological research described in this thesis characterises the biosynthetic pathway and 
physiological significance of the NRPS derived siderophore pyoverdine in P. syringae. The 
domain swapping and directed evolution experiments conduced demonstrate the utility of two 
model systems for studying NRPS function. These model systems were the pyoverdine 
biosynthesis NRPS of P. aeruginosa and the pigment synthesising NRPS BpsA from S. 
lavendulae. Common to both of these models is the production of readily detectable products 
that are indicative of function of recombinant proteins. The results form these experiments 
contribute toward the understanding of how individual NRPS modules interact during the 
biosynthetic process, an understanding which is crucial for the success of future manipulation 
endeavours aimed at generating novel bioactive compounds. The protein BpsA also provided 
the basis for novel methods of PPTase characterisation and discovery which have potential 
applications in the discovery of secondary metabolite clusters from eDNA libraries as well as 
the discovery of PPTase inhibitors from libraries of chemical compounds. 
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Appendix One – Sequence alignments 
 
A1.1 – Phylogenetic analysis of T-domains 
 
It was theorised that since T-domains do not differ in their core function as carriers of 
substrates and intermediates, it is likely that the diversity of sequence information represents 
specialisation to interact with a particular domain or set of domains in a synthetase enzyme. In 
order to test this theory a simple bioinformatic analysis was carried out. Sequence diversity of 
NRPS T-domains from the genus Pseudomonas was compared to diversity of carrier proteins 
(ACPs) involved type two fatty acid synthesis (type II FAS) in the same genus. In contrast to 
NRPS T-domains, type II FAS ACPs interact with a limited and invariant set of proteins 
during synthesis of fatty acids [212, 213] so based on the theory outlined above would be 
expected to have much lower sequence diversity. As shown in Figure A1.1 the sequence of 
ACPs from 16 different species of Pseudomonas is highly conserved; in contrast the sequence 
of T-domains is highly divergent. This analysis is somewhat biased in that the single ACP in 
each species is likely to have arisen from a common ancestral protein whereas the multiple T-
domains present in each species have been shaped by horizontal gene transfer and gene 
duplication events [124], however a comparison of ACP sequences from phylogenetically 
disparate bacteria (A1.1c) reveals that ACP sequences from multiple phyla are more highly 
conserved than T-domain sequences taken only from the genus Pseudomonas.  
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Figure A1.1 – Comparison of sequence diversity for T-domains and ACPs from type II 
FAS 
A- Alignment of 17 randomly selected NRPS T-domains from various Pseudomonas species reveals a high level 
of sequence diversity. 
B- By contrast type II FAS ACPs are highly conserved within the genus Pseudomonas 
C- Alignment of ACPs from members of 16 different genus’, representing 9 different phyla reveals a higher 
degree of conservation than is observed for T-domains taken exclusively from Pseudomonas species.  
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The initial analysis described, supported the theory that T-domains have evolved for optimal 
interaction with particular partner domains prompting a more detailed bioinformatic 
assessment of T-domain sequences. T-domains are required to interact with both upstream and 
downstream catalytic partners in an NRPS assembly line. There is less variation in the variety 
of upstream interaction partners, with most T-domains being required to interact with 
upstream A and C-domains. Downstream domain interactions are more varied, with three 
commonly occurring variations in downstream interaction partner: T-domains located in an 
elongation module must interact with a C domain, a subset of T-domains within elongation 
modules are also required to interact with a downstream E-domain and T-domains in a 
termination module have only a TE-domain as a downstream partner.  In order to determine 
whether the type of downstream interaction partner correlated with specific sequence elements 
in a T-domain, a set of 16-20 sequences was compiled for each of the three downstream 
domain possibilities outlined. All T-domain sequences were taken from genome sequenced 
Pseudomonas species. Sequences were limited to a single genus in order to maximise the 
proportion of sequence variation arising from differences in downstream interaction partner. 
The alignment resulting from this set of sequences is shown in Figure A1.2; selected features 
that are specific to T-domains with a particular downstream interaction partner are 
highlighted. A subset of these positions, at which mutations were recovered during directed 
evolution, is also indicated. Table A1.1 gives a summary of the alignment analysis.  
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Figure A1.2 – Interaction specific features of T-domain sequences 
Sequences are grouped according to downstream interaction partner (C, E or TE-domain) as indicated on the left. 
Boxes indicate positions at which residue identity correlates with downstream interaction partner. Blue boxes 
indicate positions at which mutations leading to improved function were recovered in directed evolution 
experiments (Chapter 6) 
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Table A1.1 – Summary of alignment features shown in Figure A1.2 
 
 -12 -8* -1* +1* +2* +3 
C Always G Variable Always H Always L Always L A (1 x V) 
E Always G Always N Always D Always I V, L, I, M Always S 
TE G or S Variable Variable L or I Variable Variable 
 
 +4** +10 +12 +24*** +27 
C Variable Variable Insert F (1 x L) Variable 
E L, I Always Q Gap Always F Always Q 
TE V, L, I, M Variable Insert V, L, I, M Variable 
 
Left hand column indicates downstream interaction domain. Top row indicates position in T-domain. Positions 
marked * were altered in directed evolution experiments. Position marked ** was altered in directed evolution 
experiments and implicated in T-TE communication using structural modelling. Position marked *** was altered 
in directed evolution experiments implicated in T-TE communication using structural modelling (this study) and 
found to be important in T-TE communication in a previous mutagenesis study [93] 
 
A1.1.1 – Examination of a module duplication event in PvdD 
The two modules of the P. aeruginosa pyoverdine NRPS PvdD both specify L-thr. The high 
level of identity between the CAT domains of these two modules (90%) suggests the 
occurrence of a module duplication event in the evolution of PvdD. Examining the individual 
domains in these putative duplicated modules reveals that the A-domains have the highest 
sequence identity (99.5 %) followed by the C-domains (80 %) and finally the T-domains (72 
%). Interestingly, the two T-domains of PvdD are 97 % identical in the region before the 4’-PP 
attachment site and only 20 % identical thereafter (Figure A1.3). The divergence in the 
sequence of the two T-domains over this region may have been driven by requirement of each 
to interact with a different downstream partner (C-domain vs. TE-domain) following 
duplication.  
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Figure A1.3 – T-domain sequence divergence following a putative module duplication 
event in PvdD 
Alignments of the two A-domains and the two T-domains of PvdD are shown. It is likely, given the high level of 
identity between them; that the two CAT modules of PvdD are the product of a module duplication event. The 
divergence in T-domain sequence after the 4’-PP site may reflect specialisation of the domains for interaction 
with different downstream partners. 
 
 
 
 
 
 
A1.2 – Complete alignments for all improved clones 
 
Complete alignments for all improved clones are shown, in each case the top row is the 
unimproved sequence, immediately below this is the T-domain of BpsA, and the remaining 
sequences are improved clones. Alignments are annotated according to the key shown on the 
following page.  
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Improved clones from directed evolution of oDhbF 
 
 
 
 
 
 
 
Improved clones from directed evolution of oPvdD 
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Improved clones from evolution of slPvdD 
 
 
 
 
Improved clones from evolution of slEntF 
 
 
 
 
 
Improved clones from second round evolution of 3kF0 
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Appendix 2 – Unit conversion for PPTase kinetic 
parameters 
 
The raw data input into SigmaPlot for derivation of kinetic parameters for the PPTases PcpS 
and PP1183 was maximum change in indigoidine (Ind) synthesis reaction rate (change in 
gradient per second) vs. Concentration of CoA present in the reaction. The Vmax values given 
by SigmaPlot therefore had the units “Change in gradient per second” The assumptions made 
and calculations used to convert this into a slightly more useable unit are given below. 
  
Analysis of Ind synthesis reaction rates for various concentrations of ATP had previously 
revealed a good fit to the Michaelis-Menten equation. As such the assumption can be made 
that reaction rate for this enzyme is directly proportional to the concentration of active enzyme 
according to the equation: 
 
V0= Kcat [E] [S]/Km +[S] 
 
For the reactions used in derivation of kinetic parameters of PPTases, [BpsA] =[E]= 1.64 uM. 
[S] = [ATP] = 1mM. Kcat (BpsA) = 241.34 min -1, Km  (ATP/BpsA)  =11.12 mM. 
 
Substitution of these values into the above equation gives a theoretical maximum velocity of 
32.487 uM/min if all BpsA present in the reaction is activated by the PPTase. 
 
The gradient units for the data input into SigmaPlot were gradient of 1.0 = change in A590 of 
0.001/min (assigned by SoftmaxPro, don’t blame me!). 
 
The relationship between [indigoidine] and A590 for the path length used in the assay is A590 
of 0.001 = 0.0854 uM Indigoidine. Therfore the maximum gradient attainable if all BpsA is 
active is 32.487/0.0854 = 380.409. 
 
A concentration of 1.64 uM BpsA in a 200 uL reaction means the amount of BpsA present is 
328 pmoles.   
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Going back to the original assumption that velocity is proportional to concentration of active 
BpsA in a reaction. If 328 pmoles active BpsA give a gradient of 380.4 then the theoretically 
the amount of active BpsA that would give a gradient of 1.0 is 328/380.4 = 0.86 pmoles 
 
This establishes a relationship between gradient and concentration of active BpsA which 
allows the conversion of “change in gradient per second values to” to amount of BpsA 
activated per second. For example if the instantaneous gradient were measured at a given 
point, and one second later and found to have increased by 1.0, the above relationship tells us 
that an extra 1.1587 pmoles of active BpsA are present.  
 
This relationship was used to convert the units of the Vmax values given by SigmaPlot form 
“Change in gradient pre second” to “pmoles BpsA activated per second”. Since BpsA has only 
one T-domain, one molecule of CoA is used to activate one molecule of BpsA and the amount 
of BpsA activated per second = amount of CoA consumed by PPTase per second.   
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